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Summary
This work deals with four main topics: The influence of the glycosylation of membrane
proteins onto their spatiotemporal dynamics; the adhesion of bacteria to human cells;
the uptake mechanism of targeted siRNA into neuronal cells; and the effect of the en-
dothelial glycocalyx onto nanoparticle uptake.
Using metabolic labeling and high-resolution live-cell microscopy, we show that two
classes of membrane glycoproteins, namely sialic acid-bearing proteins and mucin-
type proteins, differ in their spatiotemporal dynamics due to different engagement
into the galectin lattice. The galectin lattice is a supramolecular network that consists
of the carbohydrate binding galectins and mucin-type proteins that are interconnected
by them. This decreases both the spatial mobility and the turnover rate of mucin-type
proteins in comparison to sialic acid-bearing proteins which are not interconnected by
galectins. Furthermore, we present a straightforward method by which the spatiotem-
poral mobilities of membrane glycoproteins can be artificially tuned in an exact way.
Regarding bacterial adhesion, we report on a method to switch the adhesion of E. coli to
the membrane of living cells. This is achieved by controlling the orientation of man-
nose, the ligand to which the bacteria bind, via a photoswitchable azobenzene. We
also show that the properties of inhibitors of E. coli adhesion are drastically affected
by shear stress and strongly differ from the properties determined under static condi-
tions.
We further investigated how nanoparticle uptake by live endothelial cells is altered by
the presence or absence of the endothelial glycocalyx. Therefore, we employed two
model nanoparticle types, aminated and carboxylated ones. The first were shown to
be toxic when internalized, whereas the latter were found to be inert. We reveal a clear
protection effect of the endothelial glycocalyx against uptake of both types of nanopar-
ticles. Experiments to analyze a possible link between the reduced uptake to a lower
mortality are underway.
V
Summary
Finally, we present a detailed analysis of the uptake mechanism of siRNA targeted to
the cannabinoid receptor system by the anandamide ligand and to glucose transporters
by glucose. For the anandamid-modified siRNA, we show that the internalization is ef-
ficient and receptor-specific. This was proven for model neuronal cells, neuronal stem
cells, and in vivo in a murine model. For the glucose-modified siRNA, we report on
very high transfection efficiency for multiple cell lines and on the uptake mechanism.
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1 Introduction
One of the main topics of this work is protein glycosylation and the glycosylation of
membrane proteins in particular. Even though it has been known for a long time
that almost every protein is glycosylated,1, 2 many aspects of this modification have
not been elucidated. Especially, the enormous complexity of membrane protein gly-
cosylation is still a mystery: Cells install a vast amount of sugars on their surface,3, 4
constituting the so called glycocalyx, by using numerous biosynthetic pathways and,
of course, lot of energy. For some specific mutations, functional implications have
been found,5, 6 however, a definitive explanation why the cell affords this has not been
found so far.7
The main reason is the extraordinary variability of glycan structures. In contrast to
DNA, RNA, and proteins, where one DNA sequence codes for exactly one RNA se-
quence and is eventually translated into exactly one protein,8 sugar structures on pro-
teins seem to be much less regulated. On different copies of one and the same protein,
usually much more than one glycosylation pattern is found.3, 9 It is not clear what gov-
erns this difference, if it is governed at all and not stochastic. However, despite this
"fuzzy" nature of protein glycosylation, it is not arbitrary. If strong - whereat "strong"
is, again, not well defined - deviations occur, the consequences are often severe.10 To
make things even more complicated, there are also examples for the opposite case:
Here, if a glycan is just slightly compromised, the cell reacts very sensitive to it.11
Taken together, one can rightly state that for glycosylation, the link between structure
and function is yet to be unraveled.
Various strategies are pursued to find an answer to this puzzle. For example, glycan
profiling uses mass spectrometry to characterize glycosylation patterns on healthy as
well as on e.g. cancer cells. Then, they are compared in order to find possible implica-
tions of different glycosylation patterns in a disease-related context; and great progress
was made in this field.12–14
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In this thesis, we pursue a different approach which is described in Chapter 6 and
Chapter 7. We decided to investigate the relation between protein glycosylation and
protein properties on a basic, biophysical level. For this, we specifically marked two
classes of membrane proteins, sialic acid-bearing proteins and mucin-type proteins,
by metabolic labeling, and investigated their behavior using different high resolution
microscopy techniques. This allowed us to show that mucin-type proteins exhibit less
spatiotemporal dynamics than sialic acid-bearing proteins due to their engagement
into the so called galectin lattice. In a further step, we employed the specific labeling
of glycan structures on proteins to artificially tune the spatiotemporal dynamics of the
proteins.
Furthermore, a protective role is commonly assigned to the glycocalyx. It is pictured
as some kind of barrier that keeps, for example, pathogens away from the cell sur-
face, preventing infection.15, 16 In this context, we wanted to investigate the role of
the glycocalyx in shielding the cell against nanoparticles. This is an important feature
to be elucidated since the amount of nanosized matter in the environment increases
steadily and numerous investigations claim that, with decreasing size, particles start
to exhibit toxicity.17–19 This so called nanotoxicity is likely to gain significance. There-
fore, the response of cells when subjected to nanosized matter and the natural defense
mechanisms need to be analyzed in order to evaluate the toxicity of nanoparticles cor-
rectly. Since the glycocalyx constitutes the interface between the cell and the exterior,
the assumption seems reasonable that it plays a role in nanoparticle entry. In our
experiments, we turned to a defined setting employing model endothelial cells and
well-characterized model nanoparticles. Indeed, we could show that the glycocalyx
protects the cell from the entry of both toxic and inert nanoparticles.
Another central topic of this thesis deals with the adhesion of E. coli to endothelial
cells. The process of adhesion is highly important in the development of nearly all
diseases caused by bacteria, often constituting the first step of the course of the dis-
ease.20, 21 Although many properties of bacterial adhesion are known, a more detailed
understanding of the process is desirable. Thus, we focused on two main questions.
First, we wanted to investigate whether one can influence the adhesion of bacteria by
changing the properties of the cell surface. This is possible on artificial substrates,22
but, so far, it was not shown on live cell membranes. It turned out that, by metabolic
glycoprotein engineering and incorporation of photoswitchable ligands for bacterial
adhesion, we were able to increase and decrease bacterial adhesion dependent on the
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orientation of the ligand. We are convinced that this will have an effect on how we
judge the interaction between proteins and the cell membrane, e.g. as in our exper-
iment between a bacterial adhesion protein and its ligand. So far, these interactions
are analyzed from an electrostatic and entropic point of view. "Crude" factors like the
orientation have not been in the focus of research.
We were also interested in the influence of shear flow on the properties of adhesion in-
hibitors. We regard this as a relevant question since antiadhesion therapy is a promis-
ing strategy to fight bacterial infections when antibiotics are not available or ineffec-
tive.23–25 This problem is likely to increase due to the increasing number of resistant
bacterial strains.26–28 Therefore, it is important to investigate how inhibitors perform
under physiological conditions. Since almost no process in a living system is truly
static, the impact of shear flow on bacterial adhesion is a major aspect to be ana-
lyzed.29, 30 Here, we could show that the potency of adhesion inhibitors is strongly
increased under flow conditions and, hence, underestimated under static conditions.
Finally, we investigated siRNA delivery via two targeting moieties, anandamide and
glucose. We were interested in a highly specific delivery to neuronal cell in case of
anandamide and in a general delivery to many different cell lines in case of glucose.
The underlying idea is to use the anandamide modification31, 32 to deliver siRNA to an
exact location in the body, namely to neurons and cells of the nervous system where
the cannabinoid receptors are highly expressed, e.g. for gene or cancer therapy.33, 34
For the glucose modification of siRNA, we wanted to show that is a mild method to
deliver any siRNA to cells. In both cases, we could verify that the targeting fulfills the
requirements by dissecting the uptake mechanisms.
Taken together, the investigations presented in this thesis, all connected to sugars and
the cell membrane, underline the importance of protein glycosylation for fundamental
cellular processes. They point out how this key modification can be used for therapeu-
tically relevant problems.
3

2 Membrane Protein Glycosylation
and its Relevance in Cell Biology
2.1 Protein Glycosylation
2.1.1 Posttranslational Modification of Proteins
According to the central dogma of molecular biology, the genetic information encoded
on the DNA is transcribed to messenger RNA (mRNA) which is translated to proteins.8
The remarkable complexity of proteins is often explained by expansion of single build-
ing blocks from four nucleobases in case of DNA and mRNA to the 21 amino acids in
case of proteins.A For example, there are 45 = 1024 DNA or mRNA sequences, but
215 = 4084101 (about 4000 times more) amino acid sequences of length 5. Consid-
ering that proteins are built of hundreds to thousands of amino acids, the number of
possible sequences is enormous.
However, the variety of proteins is not only based on the sheer number of accessible
sequences, but also on alterations that are enzymatically added during or after the
protein was translated, so called posttranslational modifications.36 Generally, a post-
translational modification is the covalent attachment of some chemical residue to the
side chain of an amino acid or to the C- or N-terminus.37 This way, the repertoire
of the amino acids is expanded. Despite the fact that only few amino acids within a
protein are modified and not all, the posttranslational modifications often drastically
influence the functionality of a protein. In fact, for many cases it is true that the be-
havior of a protein is completely determined by the presence of the posttranslational
modification.38, 39
AHumans use the 20 canonic amino acids and selenocystein which was discovered rather late to be a
part of the proteinogenic amino acids.35
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Important examples for posttranslational modifications include:
• Phosphorylation is one of the most abundant posttranslational modifications.40, 41
It adds the phosphate group PO43- to a serine, threonine, or tyrosine by so called
kinases. Rarely, it can also be found on histidine, arginine, lysine, glutamate, and
aspartate.
Protein phosphorylation is a key modification with regard to cellular signaling.42
Importantly, the addition is reversible so that the phosphate group can easily
be cleaved again by phosphatases. Often, addition and cleaving of phosphate
groups leads to "switching" of of a protein, turning it on or off.43, 44 Examples
include G-protein coupled receptors, receptor tyrosine kinases, and epidermal
growth factors: They all are controlled via phosphorylation and dephosphoryla-
tion of signaling domains and small transmitting molecules.45
• Acetylation is the reversible transfer of an acetyl group to a protein, typically
on lysine residues.46 Just as phosphorylation, it plays a central role for the reg-
ulation of protein activity. It is very prominent on the N-terminus of proteins –
in humans, 85% of all proteins are acetylated there.47 It is also crucial for the
regulation of DNA transcription: DNA is wrapped around special proteins, the
histones. If they are acetylated, the DNA is loosened, facilitating to start the
synthesis of mRNA. Of course, the acetylation and deacetylation of histones is
therefore highly regulated to avoid erroneous DNA transcription.48, 49
• Methylation plays, amongst others, a very important role in epigenetics. In this
case, it is not a modification of proteins, but of DNA itself typically at CpG sites,
leading to the conversion of cytosine to 5-methylcytosine, which regulates tran-
scriptional activity.50 Methylation also occurs as posttranslational modification
on protein. Usually, ariginine and lysine are the targets.51, 52 Again, like for
acetylation, methylation of histones influences DNA transcription. However, in
contrast to acetylation, methylation represses transcription, although it may also
indirectly activate it by downregulation of transcription inhibitors.
• ADP-ribosylation introduces one or more ADP-ribose groups to an amine-bearing
side chain of a protein like arginine with the help of the redox cofactor NAD+.53
The modification highly influences cellular functions related to DNA transcrip-
tion and DNA repair. For example, when the cell undergoes high stress, the
poly-(ADP-ribose) polymerases are upregulated, leading to increased poly-ADP-
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ribosylation of proteins and depletion of NAD+. Caspases are activated and
cleave the poly-(ADP-ribose) polymerases. One fragment of the cleaved poly-
merases is translocated to the nucleus where it presumably acts as transcrip-
tion activator for apopototic proteins and/or autoimmune targets.54 Also, the
high poisonousness of many bacterial toxins originates from erroneous ADP-
ribosylation, causing e.g. cholera, diphtheria, and whooping cough.55
• Ubiquitin is a small, highly conserved globular protein of 76 amino acids with
a mass of 8.5 kDa. It can be transferred to lysine residues of other proteins and
is hence an example of posttranslational protein modification with another pro-
tein.56, 57 The most prominent example of ubiquitination is presumably polyu-
biquitination. Here, a chain of several ubiquitins linked to each other is attached
to the target protein. This is a signal for the proteasome to degrade the protein,
e.g. because it is not correctly folded.58 Other tasks of ubiquitination include
signal transduction and cell-cycle control.59–61
These are just a few examples for posttranslational modifications, and much more ex-
ist. However, in the following, we would like to single out one specific posttransla-
tional modification since most of this thesis is somehow related to it: Glycosylation of
proteins, and especially of membrane proteins.
2.1.2 Glycosylation Pathways of N- and O-Glycans
There are two major groups of glycans: N-glycans and O-glycans. As the name sug-
gests, N-glycans are attached to the respective proteins via an N-glycosidic bond to
asparagine residues whereas O-glycans are attached via an O-glycosidic bond to an
oxygen atom in the amino acid sequence. The oxygen atom is provided by serine
or thereonine. In the following, the central biosynthetic aspects of these two glycan
classes will be shown.
N-glycans
N-glycans are attached to the protein via an asparagine which is part of the consensus
sequence Asn-X-Ser/Thr where X denotes any amino acid except proline. Sometimes,
N-glycans are also found at the sequence Asn-X-Cys.62 However, not every consensus
sequence is modified – in fact, up to now, it is not understood under which conditions
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exactly an Asn-X-Ser/Thr sequence receives a glycan. There are examples for identical
proteins where some carry a glycosylation and some do not at the same position. Nev-
ertheless, predictions can be made. For example, if the sequence is buried inside the
protein, glycosylation is very unlikely.63
In animals, N-acetylglucosamin (GlcNAc) in β-configuration is the sugar that almost
exclusively follows asparagine. N-linked glycans feature a quite unique biosynthetic
pathway. It starts with the synthesis of a precursor glycan on the cytosolic side and in
the lumen of the endoplasmic reticulum (ER) on a dolichol molecule in the ER mem-
brane. For this, phosphorylated GlcNAc from UDP-GlcNAc is added to dolichol phos-
phate (Dol-P) which generates Dol-P-P-GlcNAc on the cytosolic side. Subsequently,
fourteen sugars are added. During the process, the precursor is flipped to the lumenal
side of the ER, a process not yet understood in detail. Then, the precursor is transferred
en bloc to the protein to be modified by a multimeric protein complex (oligosaccharyl-
transferase).64 This is schematically depicted in Figure 2.1.
Figure 2.1: ER-associated steps in N-glycan synthesis
First, GlcNAc-P is added to Dol-P via ALG7. Then, fourteen sugar residues are
added by different members of the ALG proteins. During the process, the precur-
sor is flipped from the cytosolic to the lumenal side of the ER. After finishing the
precursor synthesis, the whole glycan is transferred to the protein. The final struc-
ture of the precursor (Glc3Man9GlcNAc2 is shown at the bottom. cf. Figure 12.1
for the key to the sugar symbols. Figure taken from reference65
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After this, the early glycan is processed.66, 67 The first step is the removal of two glu-
cose residues, changing Glc3Man9GlcNAc to GlcMan9GlcNAc. This is important for
the quality control of protein folding and will be discussed in detail in Chapter 2.1.3.
Often, additionally one mannose residue is cleaved, yielding GlcMan8GlcNAc. Cor-
rectly folded proteins are transported to the Golgi apparatus where further modifi-
cations are applied. They are manifold but all include the removal of several man-
nose groups and the addition of one or more GalNAc residues to yield, for instance
Man5GlcNAc2. The final structures of N-glycans after the processing steps are very
diverse, but they all share a common sugar sequence (Man3GlcNAc2) and can be cat-
egorized into three different classes, dependent on the modification type.65 They are
depicted in Figure 2.2.
Figure 2.2: The three classes of N-glycans
Although their structural diversity is high, all N-glycans share the Man3GlcNAc2
core and can be divided into the oligomannose, the complex, and the hybrid type,
dependent on the structure of the modifications that were attached during process-
ing. Figure taken from reference65
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Figure 2.3: Branching of N-glycans
Multiple GlcNAc residues can be attached to the terminal mannoses of the core
structure of hybrid and complex N-glycans, leading to branching of the N-glycans.
These modifications depend strongly on the nutrient state of the cell and play a key
role in, for example, receptor homeostasis. Figure taken from reference65
After completion of the processing steps, N-glycans are usually transported to the
plasma membrane. It would exceed the scope of this introduction to cover even a small
fraction of the various structures of N-glycans that can be found on proteins. Amongst
others, branching of complex N-glycans as depicted in Figure 2.3 is highly dependent
on the nutrient state of the cell and plays a central role in receptor homeostasis. This
will be discussed in more detail in Chapter 2.1.4. Other ways of processing include, for
example, the modification of the common core structures, the addition of sialic acids
and other sugar residues to the glycan termini, and other elongations of the glycan an-
tennae. All those alterations play important roles for the function and behavior of the
modified protein, and there is a continuously growing amount of findings underlining
this.68, 69
10
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O-glycans
O-glycosylation refers to the covalent attachment of a glycan structure to a serine or
threonine residue. Amongst them, the most prominent representatives are the mucin-
type O-linked glycans where an N-acetylgalactosamine (GalNAc) is α-linked to the
OH-group of serine or threonine; but also other sugars can be used for O-glycosylation
like mannose, galactose, fucose, or xylose.69 However, in this chapter we will discuss
mucin-type O-glycans because they are important representatives of the group. Fur-
thermore, in the later described experiments we will refer to them.
At a first glance, one may suspect to find similarities between O- and N-glycosylation,
but, in fact, the two processes strongly differ. First, in contrast to N-glycans, no con-
sensus sequence for O-glycosylation has so far been identified, and the variety of se-
quences that is modified via O-glycosylation indicates that some amino acids are just
preferred in comparison to others. For example, the vicinity of proline seems to in-
crease O-glycosylation whereas charged amino acids are not favorable.70
If the OH-group of a serine or threonine is to be mucin-type O-glycosylated, the biosyn-
thesis starts with the transfer of N-acetylgalactosamine from UDP-GalNAc by the en-
zyme polypeptide-N-acetyl-galactosaminyltransferase (ppGalNAcT). Again in contrast
to N-glycosylation, the synthesis does not take place in the ER, but from the very be-
ginning in the Golgi apparatus. Also, it does require neither a dolichol-precursor nor
glycosidases that trim or process an already synthesized glycan. Importantly, the posi-
tioning of ppGalNAcT inside the Golgi apparatus strongly affects the resulting glycan
structure. Roughly, the later a ppGalNAcT acts on the protein, the shorter the result-
ing mucin-type O-glycan will be.71
After the transfer of GalNAc, the synthesis continues. Once more different from N-
glycosylation, the core structure common to all O-glycans is finished with the attach-
ment of GalNAc. Afterwards, the synthesis routes diverge, giving rise to eight different
core structures (Table 2.1 and Figure 2.4).72 Figure 2.5 shows the stepwise synthesis of
the core 1 and core 2 structure and the required enzymes as an example.
These core structures are not equally installed within all tissue types. Different glyco-
syltransferases are differently up- and downregulated throughout the organism, tun-
ing the type of core structure synthesized.69 However, the first attached sugar GalNAc
only is typically not found in healthy cells, but often in tumors, suggesting that the ex-
tension and branching of O-glycans is likely to be abolished in certain cancer cells.73
Synthesis of different O-glycan structures is mainly controlled by the affinities of the
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Table 2.1: Core structures of mucin-type O-glycans
Core Structure
Core 1 (T antigen) Galβ1-3GalNAcαSer/Thr
Core 2 GlcNAcβ1-6(Galβ1-3)GalNAcαSer/Thr
Core 3 GlcNAcβ1-3GalNAcαSer/Thr
Core 4 GlcNAcβ1-6(GlcNAcβ1-3)GalNAcαSer/Thr
Core 5 GalNAcα1-3GalNAcαSer/Thr
Core 6 GlcNAcβ1-6GalNAcαSer/Thr
Core 7 GalNAcα1-6GalNAcαSer/Thr
Core 8 Galα1-3GalNAcαSer/Thr
Tn antigen GalNAcαSer/Thr
Sialyl-Tn-antigen Siaα2-6GalNAcαSer/Thr
glycosyltransferases to the substrates.74, 75 For example, in Figure 2.5 one can see
that from the core 1 structure a N-acetylglucosamine can be attached by 2GnT or
by β3GlcNAcT-3. As soon as the glycosyltransferase C2GnT has acted on the core 1
structure, β3GlcNAcT-3 cannot attach a second N-acetylglucosamine. Furthermore, as
mentioned above, the localization of the glycosyltransferases within the Golgi appa-
ratus limits the time they can act on the protein, roughly determining the size of the
attached glycans. Other control types include classical cofactors like metal ions.76
2.1.3 Functions Classically Attributed to Protein Glycosylation
Although the importance of protein glycosylation is becoming clearer now, some func-
tions were already attributed to glycosylation for a long time. In this section, we will
highlight three of the most well-known tasks ascribed: Quality control during protein
folding, increasing of solubility, and blood group determination.
Quality control during protein folding
Although the central dogma of molecular biology is usually termed as "DNA is tran-
scribed to mRNA which is translated to proteins", it is often claimed that it should be
expanded to "DNA is transcribed to mRNA which is translated to an amino acid chain
which is folded to a protein".77 This is to highlight the significance of protein folding
12
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Figure 2.4: Four examples for mucin-type O-glycan cores
The respective core structure is highlighted with a gray box. For each core, a typical
extension is depicted. Figure adapted from reference65
since without proper folding, the amino acid chain is not functional and, even worse,
will tend to associate with other misfolded amino acid chains into possibly danger-
ous aggregates.78, 79 Therefore, in all higher organisms, sophisticated methods exist
to fold amino acid chains correctly on the one hand and to detect and degrade mis-
folded amino acid chains on the other hand.80, 81 Here, protein glycosylation plays a
very important role by regulating the calnexin-calreticulin cycle.82 Among the many
processes related to folding quality control, it is maybe the most important one.
The two chaperones calnexin and calreticulin bind to proteins that contain a single N-
linked α-linked glucose residue. As it was described above, the core structure common
to every newly synthesized N-glycan contains such a single α-linked glucose at the end
of the ER-localized part of the synthesis. Therefore, they bind to calnexin/calreticulin
and folding begins. When the last glucose residue is removed, the protein cannot bind
to the calnexin-calreticulin complex anymore. If the protein was correctly folded, it is
13
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Figure 2.5: Synthesis and modification of core 1 and core 2 structures.
After the transfer of GalNAc to an OH-group of serine or threonine, the Tn anti-
gen is obtained. This can be sialylated (both the Tn and the sialyl-Tn are common
in cancer cells) or modified by galactose to yield the core 1 structure. From there,
several modifications can be introduced. If an N-acetylglucosamine is added to the
initial GalNAc via a β6-linkage, the core 2 structure is obtained which can also be
further modified. Note that two possibilities exist to add N-acetylglucosamine to
the core 1 structure which mutually exclude each other. Figure taken from refer-
ence65
transported from the ER, where the N-glycan synthesis started, to the Golgi appara-
tus. However, if a problem occurred during folding, the incompletely folded protein
is reglycosylated, again binds to calnexin and calreticulin which will try to fold the
protein once more. If the protein is still misfolded after some time, the cleaving of
mannose groups begins. This indicates that the protein is irreparably misfolded (so
called "mannose removal clock"). In this case, the protein is exported to the cytosol
and degraded by the proteasome.83 The whole process is sketched in Figure 2.6.
14
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Figure 2.6: Quality control of protein folding.
Newly synthesized N-glycans are located in the ER where they are N-glycosylated
with Glc3Man9GlcNAc2. In the ER, also the first two steps of trimming of the gly-
can take place, i.e. the removal of two glucose units. One glucose residue is retained
which, therefore, is recognized by calnexin/calreticulin. If the protein is correctly
folded, it is exported to the Golgi apparatus. However, if not, the misfolded pro-
tein is reglycosylated and enters the calnexin/calreticulin cycle one more. If it
stays misfolded, mannose groups are removed which is a signal for export of the
misfolded protein to the cytosol where the rest of the N-glycan is removed and the
amino acid chain is degraded by the proteasome. Figure taken from reference65
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Protein solubility
Sugar molecules are hydrophilic structures and hence located at the outer, hydrophilic
areas of a folded protein and not on the hydrophobic core. Therefore, it was early
assumed that glycosylation helps folding and increases protein solubility,84 either by
reducing the free energy of the folded state or by increasing the free energy of the
unfolded state as schematically depicted in Figure 2.7. This is an obvious idea since
the folding of a protein is determined by the energy landscape of all the conformational
states of the amino acid chain85 which is in turn defined by the features of the amino
acid chain. Here, it is fair to assume that glycosylation will play a role.
Figure 2.7: Free-energy profile of a glycosylated and non-glycosylated protein.
Intuitively, a protein should be stablilized by glycosylation, either by destabilizing
the unfolded state (∆GGlyco−∆GWT > 0) or by stabilizing the folded state (∆GGlycoF −
∆GWTF < 0). Figure taken from reference
86
However, the experimental verification is not trivial. Protein folding itself is far from
being completely understood. Although all proteins (or protein subunits) are in the
end made up by one amino acid chain, some of them collapse into their folded state at
once, others domainwise, and again others seem to mix these ways.87–89 It is hence not
easy to single out the effect of glycosylation on the process of folding. Nevertheless,
progress has been made in the last years. As an example, a recent investigation86 using
theoretical calculations should be discussed briefly.
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In this study, the folding of the SH3 domain was calculated in dependence on its gly-
cosylation state. Although SH3 is naturally not glycosylated, it is a good starting point
since its folding mechanism has been extensively studied: SH3 has a size of only 56
amino acids which makes its folding path easier to access than in case of a large pro-
tein. One of the key results of this investigation is depicted in Figure 2.8.
Figure 2.8: Influence of glycosylation on the folding temperature of SH3.
With increasing amounts of both short and long glycans (empty and filled circles)
on the protein, the folding temperature T Glycof increases. Experimental measure-
ments (red circles) show good agreement. Figure taken from reference86
As it can be seen, adding more and more short and long glycans to the formerly not
glycosylated wild-type (WT) SH3 protein leads to an increase in the folding tempera-
ture T Glycof (i.e. the temperature at which the protein folds when being cooled down
from a heat-unfolded state) which is given in relation to the folding temperature of
the WT protein, TWTf . With six glycans attached (short, empty circles; and long, filled
circles), the folding temperature increases by about 1%. This change may seem small,
but one should consider that usually the stabilizing forces, keeping the protein folded,
are just a little bit larger than the destabilizing forces that try to unfold the protein.90
A change of 1% is hence remarkable. Moreover, a comparison with experimental data
of two other studies91, 92 (red empty and filled circles), where glycans of similar sizes
were attached to proteins, shows that the experimental values agree nicely with the
simulated ones.
17
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Blood group determination
A lot of ways to categorize blood groups exist, but the ABO-system is the most impor-
tant and, as well, the oldest. It was established around 1900 by Karl Landsteiner.93
He observed that blood of different patients might agglutinate when mixed. This was
of course of high relevance for blood transfusions as any agglutination inside blood
vessels has severe, often lethal consequences. Subsequently, four blood groups were
established – A, B, AB, and O. It was found that blood group O only allows O as donor,
A allows O and A, B allows O and B, and AB finally allows O, A, B, and AB. The reason
for this remained a mystery for long time. It took around 60 years until the underlying
biochemistry was elucidated: The reason for the different blood groups are glycans on
the red blood cells.94 They are depicted in Figure 2.9.
Figure 2.9: The four blood groups in the ABO-system
Sugar structures on red blood cells that give rise to the four different blood groups
O, A, B, and AB.
In the blood plasma, antibodies against the glycan structure that is not found on the
respective blood cells are present as listed in Table 2.2. If a patient with blood group
O would receive, for example, blood of group A, the anti-A antibodies in her plasma
would bind to the presented A-antigens on the foreign blood, causing agglutination.
Therefore, she may only receive blood group O, but since there are no antigens on her
blood, she can donate to anyone. On the other hand, a patient with blood group AB
has no antibodies in her body, and therefore, can receive blood of any blood group. Be-
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cause of this, group O is often called "universal donor" and blood group AB "universal
recipient".
Table 2.2: Core structures of mucin-type O-glycans
Group O Group A Group B Group AB
Antigens on red blood cells — A B A and B
Antibodies in plasma anti-A and anti-B anti-B anti-A —
Until now, it is not understood what gave rise to blood groups.B Theories include, for
example, exposure to environmental antigens that led to cross-reactions; labeling of
own cells making it easier for the immune system to fight pathogens; or random mu-
tations that persisted.96
In any case, it is remarkable that the variations in the glycan structures that determine
the blood group are minimal – all antigens share the GalGlcNAcGalFuc-core which is
also the glycan structure of group O. A and B have only one sugar added – GalNAc or
Gal, respectively –, and AB is just a combination of A and B. Nevertheless, this small
change has the described, large consequences. Considering this finding on the one
hand and the vast, seemingly not strictly controlled glycan structures on proteins on
the other hand, this leads to one, maybe even the most important question of mod-
ern glycobiology: Why do small changes have enormous influence in some situations
whereas in other situations much larger changes have apparently no impact at all?
2.1.4 Galectin-Glycan-Interactions
Besides the above mentioned examples of functions of protein glycosylation – in which
it is rather passive modification – recent investigations have elucidated that protein
glycosylation is capable to fulfill various regulative tasks. This happens via a complex
interplay between glycan structures and specialized proteins binding to them, called
lectins.97, 98 According to textbook definitions, a lectin is a protein that is able to bind
to some specific carbohydrate structure, but does not show enzymatic activity. The
terminus lectin is, hence, despite their large variety and obvious relevance for many
cellular processes, still rather unconventionally defined: Compared to other classes of
BIn this context, it should be mentioned that the ABO-system is the best-known categorization of blood
groups, but that it is by far not exhaustive. Many other factors determine the blood group, for
example the Rhesus factor.95
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proteins, it is remarkable that the definition is negative. This reflects that for a long
time after the discovery of lectins, their regulative functions has not been known, so
proteins that showed affinity to carbohydrates, but seemingly did not do anything else,
were just put into the group "lectins".
In the following, we will focus on one of the most important families of proteins among
lectins, the galectins. Galectins specifically bind to β-galactosides.99 Up to now, there
are 15 galectins known. 10 of them (1, 2, 3, 4, 7, 8, 9, 10, 12, and 13) have been found
in humans, the others (4, 5, 6, 11, 14, and 15) as well in other mammals, but also in
amphibians, fish, and fungi.100
Figure 2.10: Galectin families
There are three different types of galectins: Homodimers of identical monomers
(dimeric, left); pentamers of identical monomers that assemble via a non-lectin
domain (chimera, middle); and a divalent form where two subunits are solidly
connected via a peptide bridge and hence do not assemble (tandem, right).
One of the first detailed analysis of how the interactions between galectins and gly-
cans influence global cellular processes was performed by Dennis et al. in 2006.101 As
it was discussed above, N-glycans can be processed in many different ways. A cen-
tral modification is their branching from mono- to multiantennary N-glycans. Impor-
tantly, branched N-glycans act as binding partners for galectins. Since galectins exhibit
more than one binding site for β-galactosides and one protein carries more than one
β-galactoside if glycosylated with branched N-glycans, one glycoprotein can be bound
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by multiple galectins. This gives rise to the so called galectin lattice, a supramolecular
complex of glycosylated membrane proteins and galectins.102
Membrane glycoproteins engaged in the galectin lattice exhibit enhanced cell surface
residence times and reduced internalization rates.103, 104 The degree of branching
critically affects these parameters because glycoproteins carrying highly branched N-
glycans (tri- or tetraantennary) show much higher affinity for galectins than lower
branched N-glycans.105 Importantly, the degree of branching is not random, but strictly
controlled via the hexosamine pathway, a nutrient-sensing pathway that synthesizes
amongst others N-acetylglucosmine which is required for the decoration of proteins
with branched N-glycans.106
Strikingly, Dennis et al. found out that growth promoting receptors exhibit high num-
bers of N-glycans whereas receptors responsible for triggering of differentiation and
growth arrest exhibit low numbers of N-glycans. If the nutrient state of the cell is good,
this leads to high branching of growth-promoting receptors which, in turn, increases
their residence time on the cell-surface due to the high affinity of highly branched N-
glycans to galectins. The receptors triggering differentiation are also decorated with
highly branched N-glycans, but at first not enough to increase their cell-surface res-
idence time. However, if the nutrient state of the cell is good over a sustained time,
branching of receptors carrying also low numbers of N-glycans is sufficient to let them
engage in the galectin lattice in a switch-like response: They start to signal, induce
growth arrest and differentiation. A schematic depiction is given in Figure 2.11. There-
fore, via controlling the glycan-galectin interaction the cell is able to ensure that dif-
ferentiation only starts when the time is right in terms of nutrient supply. Although
proteins and posttranslational modifications of proteins are far downstream of DNA,
the glycosylation type and degree together with secreted galectins lead to transcrip-
tional control.
Of course, there are not only lectins specific for β-galactosides. For example, a promi-
nent and very important group of lectins are the selectins which specifically bind to
sialyl Lewis X structures (NeuAcα2-3Galβ1-4(Fucα1-3)GlcNAc).107, 108 They are crit-
ical to the first steps in leukocyte adhesion as depicted in Figure 2.12.109
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Figure 2.11: Regulation of signaling by membrane protein glycosylation and galectins.
High flux through the hexosamine pathway increases UDP-GlcNAc levels in cells,
leading to stronger N-glycan branching. First, the cell surface residence time of
growth promoting receptors, carrying high numbers of N-glycans, is increased
(black arrows). However, as soon as a threshold is reached, also growth arresting
and differentiation promoting receptors like TβR, which are decorated with few
N-glycans, exhibit enough branched N-glycans to engage in the galectin lattice.
In a positive feedback loop, this leads to growth arrest and differentiation (red
arrows). Figure taken from reference101
Figure 2.12: Regulation of leukocyte adhesion by selectins.
If P- and E-selectin on the surface of endothelial cells are activated, leukocytes
that normally roll over the cell surface are bound. This leads to the further activa-
tion of CAM-molecules that firmly attach the leukocyte to the membrane which,
in turn, triggers the migration of the leukocyte through the endothelium. Figure
taken from reference109
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2.1.5 The Glycocalyx
The totality of extracellular glyoproteins, proteoglycans, and glycolipids, both an-
chored and secreted, is called glycocalyx.110 Important constituents are, for example,
the glycans covalently attached to membrane proteins; long, polymeric species like
glycosaminoglycans or hyaluronic acid; and sulfated polymers like chondroitin sulfate
and heparan sulfate which contribute to the overall negative charge of the extracellu-
lar part of the cell membrane (Figure 2.13). Of special interest in this context is the
endothelial glycocalyx that one can picture as a thick layer (several tens of nanometers
up to micrometers dependent on the vessel diameter) surrounding every endothelial
cell at the interface to the blood stream.111 Since the endothelial glycocalyx is one of
the most important examples for the glycocalyx, we will discuss its role briefly here.
Figure 2.13: Composition of the glycocalyx
Various types of sugar structures constitute the glycocalyx: Covalently attached
glycosylations of membrane proteins (green); glycolipids (violet); long, polymeric
species like hyaluronic acid (cyan); or sulfated polymers like chondroitin, hep-
aran, dermatan, or keratan sulfate (yellow) to which positively charged species
like Ca2+ or arginine attach. From hyaluronic acid as backbone and sulfated poly-
mers that are connected to it via linker proteins, also feather-like proteoglycans
can be built.
Many observations indicated the presence of the endothelial glycocalyx long before the
term was invented. For example, when investigating the rolling of leukocytes by sim-
ple light microscopy, it is evident that the moving leukocytes do not touch the vessel
23
2 Membrane Protein Glycosylation and its Relevance in Cell Biology
wall but seem to be kept away by some barrier.112 This is even more clearly detectable
when large molecules like fluorescently labeled dextrans are injected and observed: If
they exceed a certain size, they do not reach the vessel wall either.113 Another early
indication for the presence of the endothelial glycocalyx was the significantly low-
ered tube hematocrit (i.e. the volume fraction of red blood cells in the blood, typically
around 40-45%) in microvessels in comparison to larger vessels.114, 115 It was proposed
that some kind of exclusion zone reduces the diameter of microvessels such that the
fraction of red blood cells has to decrease, and calculations predicted a prominent size
in the range of some tens of nanometers even for the small microvessels and capillar-
ies.116
Unfortunately, no experimental evidence was found when sections of blood vessels
were investigated with electron microscopy (EM). This puzzling finding was not solved
until it was realized that the method of probe preparation for EM destroys the glyco-
calyx:117 Usually, samples to be investigated by EM are dehydrated and then treated
with contrast agents. Although the glycocalyx is stable even under high flow rates in
blood vessels, it is destroyed when dehydrated (Figure 2.14 bottom). Hence, the early
EM investigations could not detect the true size of the glycocalyx, but just its remains.
When special protocols were developed that did not perturb the hydration state of the
glycocalyx, its impressive structure was quickly verified (Figure 2.14 top).
Up to now, it is an ongoing debate whether cultured cells express a glycocalyx, too.
There are findings claiming that if this is the case, it is a thin, truncated form at the
utmost.111 Other studies suggest that it is again only a question of sample preparation
and claim to have proven a glycocalyx even in the µm range in vitro.118 This question
is yet to be conclusively decided, however, investigations that found some form of a
glycocalyx on cultured cells are in the majority.
Besides the rather passive function of building an exclusion zone, it quickly became
clear that the glycocalyx fulfills important tasks. Many of them are closely related to
mechanotransduction:119, 120 For example, the force that is created by the continuous
flow of blood over the glycocalyx is sensed by the glycocalyx fibers and passed into the
cell where reorganization of the actin cytoskeleton is effected. This triggers several sig-
naling pathways that finally cause the expression and regulation of adhesion proteins,
the determination of the cell’s polarity, and the installation of cell-to-cell-junctions. If
the glycocalyx is cleaved by enzymes, these processes are impaired or even completely
blocked. Considering that cell polarity is one of the features nearly all cancer cells
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Figure 2.14: EM images of the glycocalyx in its intact state and after dehydration.
If special, protective protocols are applied, the structure of the glycocalyx is pre-
served (top). However, when the glycocalyx is dehydrated, in this case by is-
chemia, it is largely destroyed (bottom). Figure taken from reference111
have lost, this is an indication of how manifold the topics are where the glycocalyx
plays a role.
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Figure 2.15: Mechanosensing and -transduction by the enothelial glycocalyx
The shear flow of the blood causes the fibers of the endothelial glycocalyx to bend,
resulting in an inwards torque and reorganization of the actin cytosceleton inside
the cell (green sawtooth lines). This leads to the formation of adherence and cell-
to-cell junctions (purple), determining the polarity of the cell. Figure taken from
reference119
2.2 Bacterial Adhesion and Its Inhibition
A large part of this thesis deals with bacterial adhesion to human endothelial cells and
its inhibition. At the first glance, it may seem as if this has not much to do with sugars,
but in fact, also in this area sugars play a central role. In the following, we will discuss
the significance of sugars for bacterial adhesion and present how they can be employed
to inhibit unwanted adhesion of (pathogenic) bacteria.
2.2.1 Principles and Relevance
Generally, bacteria can be classified in two different categories: On the one hand, they
float freely in solution, on the other hand, they attach to a surface as single bacteria
or in a group.121 While both types may feature pathogenicity such as secretion of bac-
terial toxins, it is the second form of bacteria that usually causes serious infections
since floating bacteria can just be washed away. Therefore, the adhesion of bacteria
is one of the key steps in almost every process where bacterial colonization leads to
diseases.122, 123,C Hence, a detailed understanding of the mechanisms of bacterial ad-
hesion is relevant.
CNote that not all bacterial colonization is harmful, e.g. symbiotic bacteria in the gut or on the skin.
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Since we will discuss the roles of fimbriae in adhesion in the next chapter, we will fo-
cus here on other mechanisms of bacterial adhesion and cell entry. Figure 2.16 gives
three examples of how bacteria attach to and enter cells.
Figure 2.16: Entry of Yersinia, Salmonella, and Shigella into host cells.
All three bacteria attach to the cells via specialized protein complexes and secrete
effectors activating cellular proteins that lead to uptake of the bacterium by the
host cell. Figure taken from reference124
Yersinia employs invasin which interacts with β1 integrins and activates Rac1. This
causes a local change in phospatidylinositol metabolism, leading to actin polymeriza-
tion and increased membrane fluidity and finally to internalization: The actin poly-
mers act as "guide" for the membrane and the bacterium is sucked into the cell.125
The uptake of Salmonella is based upon the translocation of some type three secretion
system (TTSS) proteins into the target cell. The TTSS itself functions also as an anchor,
keeping the bacterium in place while SipC and SopE cause actin bundling and Rho
GTPase activation. Again, actin polymerization is increased which causes the mem-
brane to ruffle. As soon as the bacterium is internalized, the secreted SptP inhibits the
Rho GTPases which helps the membrane to close behind the bacterium.126
Also Shigella adheres to the bacterium by anchoring via the TTSS. It then translocates
several effectors into the cell: IpaC, nucleating actin polymerization; VirA, stimulating
Rho GTPases to further induce actin bundling while inducing microtubule depolymer-
ization to lower membrane rigidity; IpgD, promoting the ruffling of the membrane by
affecting the phosphatidylinositol pathway; and IpaA, activating vinculin that depoly-
merizes actin in order to close the membrane once the bacterium is internalized like
SptP in case of Salmonella.127
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As one can see, bacteria have developed highly sophisticated methods to force cell en-
try by combining own attachment proteins with hijacking of cellular pathways. Once
the bacteria are inside the cells, it is much harder to fight them, and the host cells are
lost from the moment of entry. This highlights the importance of a deep understand-
ing of bacterial adhesion as the prerequisite for the following entry in order to fight
diseases caused by bacteria from the very start.
2.2.2 FimH-Mediated Adhesion of E. coli
The bacterium investigated in this thesis is E. coli. It adheres to cells via FimH that
is located at the very tip of the fimbriae protruding from the bacterial cell wall128 as
it can be seen in Figure 2.17. The fimbrium produced by E. coli belongs to the type I
fimbriae, exhibiting a length of up to 200 nm while being only about 7 nm think. Each
bacterium carries several hundred fimbriae that together cause efficient attachment.
Figure 2.17: Electron micrograph of an E. coli bacterium with clearly visible fimbriae.
Figure taken from reference129
The architecture of the fimbrium is quite complex. It is schematically depicted in
Figure 2.18. Each Fim protein is cotranslationally injected into the periplasm of E. coli.
FimC, a chaperone, helps folding and brings it to the channel FimD. The chaperone
activity of FimC originates from an "extra" β-sheet: Every Fim protein in the fimbrium
is missing one β-sheet in its core and features one extra β-sheet (with the exception of
the tip protein FimH wh9ch does not exhibit an extra β-sheet). This extra β-sheet is
inserted into the gap of the next Fim protein which in turn completes the subsequent
Fim protein and so on, leading to high stability of the fimbrium. In case of FimC,
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the extra β-sheet acts as nucleation point for folding. The fimbrium itself consists of
several hundreds to a few thousand FimA subunits and the three tip proteins FimF,
FimG, and FimH.129
Figure 2.18: Architecture of E. coli fimbriae.
FimH is located at the very tip of the fimbrium. Below, FimG, FimF, and a polymer
of several hundreds to a few thousands FimA units follow. Each Fim protein
is cotranslationally injected in the periplasm via SecYEG where the chaperone
FimC helps it folding and translocates it to the channel FimD. Figure taken from
reference129
FimH is responsible for the attachment of the bacterium to the host cell. It binds to
N-linked glycans of the high mannose type.23, 130 A crystal structure of FimH in com-
plex with mannose is shown in Figure 2.19.131 The interaction between FimH and
mannose features a special characteristic, the so called catch bond mechanism:132, 133
The strength of normal protein-protein interactions ("slip bonds") decreases when in-
creasing force is applied, or more precisely, the lifetime of the bond decreases with
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increasing force. In contrast, the life time of catch bonds first increases with increas-
ing force and decreases after the force exceeds a certain value. This can be compared
to a person standing in a moving bus while keeping one hand on a handle. As long as
the bus just drives with more or less constant velocity, the grip around the handle will
not be strong. However, when the bus suddenly stops, the person will strongly hold
onto the handle. If the force is finally too high, she will at some point not be able to
maintain the grip any longer.
Although this is an illustrative picture, it cannot explain the molecular basis for catch
bonds. In case of FimH, the catch bond mechanism is caused by a complex transition
between a stressed and a relaxed state of FimH while binding to mannose. Roughly,
when FimH binds to mannose with no or little force applied, FimH is in a stressed
state, reducing the affinity to mannose. If force is applied, FimH undergoes a confor-
mational change to a relaxed state which increases the affinity to mannose. If the force
is increased further, the interaction between FimH and mannose is at some point too
weak to persist.
2.2.3 Inhibition of Bacterial Adhesion
Since many severe diseases are caused by pathogenic bacteria, effective medication
against bacterial infections is unquestionably needed. Of course, antibiotics are a com-
mon treatment for such infections, however, this therapy is not unproblematic. One
of the main drawbacks of treating bacterial infections with antibiotics is the increas-
ing number of resistant strains,27 and the widespread use of antibiotics in the food
industry has made this worse in the last decades.134 Therefore, it seems like a good al-
ternative to not treat the infection with bacteria after its outbreak, but to stop bacterial
adhesion in the first place, preventing the infection.135, 136 For this, potent antagonists
of FimH are required.
It was already discovered some decades ago that mannose alone is a rather poor li-
gand for FimH, but that modification of the aglycon of α-d-mannose often drastically
increases the potency of the inhibitors.137, 138 However, not all modifications, even of
similar size, have this effect, hence, a specific interaction was assumed. This puzzle was
solved when FimH was crystallized. The structure unrevealed that at the entrance of
the binding pocket (or carbohydrate recognition domain, CRD) two tyrosine residues
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Figure 2.19: FimH in complex with its natural ligand mannose Figure taken from refer-
ence,131 PDB-ID: 1KLF
are located. They can form favorable π-π-interactions with certain modifications of the
aglycon.139, 140 The structure of the so called "tyrosine gate" is shown in Figure 2.20.
The understanding of the tyrosine gate makes it possible to rationally design antago-
nists of FimH. For example, the introduction of aromatic groups into the aglycon often
leads to even better results than simple alkyl chains,23 however, one must be careful
not to overstress the tolerance of the CRD. If the modifications become too large or
change the electronic density of the mannose group, the favorable π-π-stacking effect
vanishes.
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Figure 2.20: The tyrosine gate at the entrance of the CRD of FimH.
At the top, the configuration of the two tyrosine residues in the open conforma-
tion is depicted. This indicates that the ligand mannose is not inducing favorable
π-π-interactions. However, if butyl mannose is used, it interacts with the ty-
rosines which closes the gate and increases the affinity for FimH. Figure taken
from reference23
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To investigate the potency of inhibitors, one has multiple options, however, they dif-
fer often drastically in their sensitivity and robustness. Besides established techniques
like ELISA141 or surface plasmon resonance,142 one of the most elegant and sensitive
ways is the use of a fluorescence based assay in combination with a well-defined set-
ting143 as depicted in Figure 2.21.
Figure 2.21: Detection of bacterial adhesion via a sandwich method and by direct fluores-
cent readout
E. coli adhering to an artificial, mannose-covered surface can be detected either
via a sandwich-based method employing biotinylated bacteria and horseradish
peroxidase-linked streptavidin (left), or directly via fluorescence readout (right).
Figure taken from reference143
Here, the stepwise assembly of the artificial surface that is covered with the E. coli
ligand mannose ensures that the system gives reproducible results. There are two
main benefits to use fluorescence instead of a sandwich-based methods: First, biotin-
modification of fimbriae may alter the adhesion properties of the bacteria. Second,
detection via fluorescence is direct and does not require an intermediate step like incu-
bation with streptavidin. This reduces the error of the system and therefore increases
reliability and sensitivity. However, one must keep in mind when quantifying bacte-
rial adhesion in such artificial environments that the situation in living systems could
be strongly different. Chapter 9 will discuss one important aspect.
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3 Metabolic Labeling
The technique of metabolic labeling is based on a simple, yet very effective idea: In-
stead of addressing a certain part of the cell with e.g. antibodies, the cellular meta-
bolism is employed to incorporate a label into the structure that should be analyzed. If
it comes to investigation of glycosylation and its effects, this approach is particularly
powerful because antibodies against glycan structures often show poor affinity and
selectivity144 – in contrast to metabolic labeling where these two parameters are very
good. Since we rely heavily on metabolic labeling in the experiments described in this
thesis, its development and method are presented in the following chapter.
3.1 Historical Development
In the mid-90s, Werner Reutter and coworkers investigated the response of living cells
when subjected to three unnatural mannosamine derivatives (Figure 3.1).145, 146 The
naturally occurring N-acetyl mannosamine is used to synthesize sialic acids in the cell
which can be found at terminal positions of many glycans on membrane proteins.
The modifications Reutter et al. investigated were mannosamines that featured an N-
propanoyl, N-butanoyl, or N-pentanoyl group instead of the regular N-acetyl group.
It was surprising that the cells did not reject these unnatural derivatives: On the con-
trary, they were taken up and incorporated into glycans on the cell surfaces where
they were easily detected after some incubation time using mass spectrometry. Reut-
ter et al. rightly concluded that the intracellular synthesis machinery responsible for
the construction of the sialosides on the cell membrane must be able to tolerate these
modifications.
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Figure 3.1: The stem compound and the three unnatural sugars introduced by Reutter et al.
into membrane glycans
a) N-acetylmannosamine; b) 2-deoxy-2(porpanoyl-amido)-d-mannose; c) 2-deoxy-
2(butanoyl-amido)-d-mannose; d) 2-deoxy-2(pentanoyl-amido)-d-mannose.
Of course, Reutter et al. were not satisfied with just to show the installation of unnatu-
ral alkyl chains onto the cell surface but wanted also to demonstrate a functional impli-
cation. They were able to show that the sialic acid-dependent interaction between the
cell surface and two viruses, the B-lymphotropic papovavirus and the human polyoma
virus BK, was strongly altered when the cell surface was modified with the unnatural
mannosamines.146 This effect also led to a reduced infectivity of the viruses. One may
assume that this observation was just due to a general shielding effect when cells are
covered with alkyl chains, but it was shown that this is not the case: Only the adhesion
and infectivity of viruses interacting with the cell via sialic acids were affected. Viruses
that attach employing other ligands like the also investigated SV40 did not behave dif-
ferently when the cells were treated with the modified mannosamines. Moreover, the
altered infectivity also vanished when cells were treated with sialidase, cleaving the
modified sialic acids.
These experiments, proving that the cellular metabolism responsible for the sialylation
of membrane proteins tolerates the presence of large, unnatural modifications can be
seen as the birth of metabolic labeling. However, from a chemical perspective, the
incorporation of alkyl chains is not very exciting due to their unreactive nature.
36
3.2 Metabolic Labeling with Azido Sugars
3.2 Metabolic Labeling with Azido Sugars
The alkyl chains incorporated by Reutter et al. into glycans via metabolic labeling
are quite inert and do not provide a platform to perform reactions, at least under
conditions compatible with living cells. To make metabolic labeling a powerful tool, it
is necessary to introduce more reactive groups. However, the problem of more reactive
groups is their reactivity: Such a group should have the potential to perform reactions,
but must also be stable enough that it does not interfere with the molecules present in
the cell which would certainly lead to toxicity. Moreover, one does not gain anything
if, for example, a hydroxy group is introduced since they are abundant on the cell
surface – the introduced group must be unique. All the requirements that a functional
group employed for metabolic labeling must fulfill can be summed up by the term
"bioorthogonality".147 In detail, this means the following:
• Sufficient reactivity to be addressed, but not interfering with cellular compo-
nents;
• Small enough to be tolerated by the synthesizing enzymes;
• Not present in the cell;
• Specifically addressable under physiological conditions, i.e. in water at ambient
temperatures and pH 7 and so on.
This is schematically shown in Figure 3.2. It is not surprising that it was challenging to
find such a chemical modification. However, a well-known chemical group is perfectly
suited, as Bertozzi et al. discovered around 2000:149 The azido group. In Figure 3.3,
the underlying principle of metabolic labeling using the bioorthogonal azido group
is depicted. The growth medium of cultured cells or even whole organisms150, 151 is
supplemented with unnatural azido sugars ("input"). Due to the bioorthogonal nature
of the modification, they are internalized by the cell and incorporated into glycans via
the normal biosynthetic pathways.152 After a while, membrane and cytosolic proteins
carry an azido group at specific sugars. The sugar residue modified in the glycan on
the protein (the "output") is dependent on the input: Ac4ManNAz and Ac5SiaNAz lead
to metabolic labeling of sialic acids, AcAc4GalNAz targets mucin-type O-glycans, and
AcAc4GlcNAz β-O-GlcNAc bearing proteins. Also, azido-modified fucose can be used
to label fucose-bearing glycans.
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Figure 3.2: Requirements for bioorthogonal labeling of biomolecules
a) The putative bioorthogonal reaction X+Y→ X−Y must tolerate all the other func-
tional groups like oxygen, water, amines, phosphates etc. typically present in liv-
ing systems while not interacting with them. b) A typical bioorthogonal reaction is
pictured as follows: A normal biomolecule is chemically modified with a group X.
The biomolecule is incorporated into the cell in its usual environment since X does
not interfere with the metabolism. Due to the bioorthogonal nature of X, it can be
specifically addressed by a second functional group Y that reacts only with X. Y can
carry any tag needed for detection, for example a fluorophore. Figure taken from
reference148
After incorporation of the azido groups onto proteins, one must of course detect them
in order to, for example, visualize the glycans via fluorescence microscopy. So far,
three common options exist. They are depicted in Figure 3.4. The first method devel-
oped was the Staudinger ligation using a reactive triphenylphosphine that reacts solely
with the azido groups.149 However, the generated methanol can be a problem when it
comes to live-cell experiments, moreover, the reaction rate is rather low. Another alter-
native is the detection via alkynes where copper-catalyzed click chemistry is employed
which connects the alkyne and the azide selectively via a [3+2] Huisgen cycloaddition.
The reaction is very fast, but the use of cytotoxic copper(I) is not feasible for sensitive
cells.154 Nevertheless, protocols have been developed where this detection method can
be used also for live-cell experiments.155 The main idea here is to i) shield the copper
by a complexing agent, preventing it from performing toxic side-reactions; ii) reduce
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Figure 3.3: Principle of metabolic labeling
Unnatural, azido-modified sugars are internalized by the cell and incorporated into
glycans where they can be detected after a while (left). The nature of the modified
sugar residue in the glycan is dependent on the unnatural sugar (right). Figure
taken from reference153
the temperature to slow down cellular processes; and iii) reduce the reaction time to a
few minutes. This is possible due to the very high rate of this reaction – even at 4◦C and
a reaction time of five minutes, it is high enough to label all accessible azido groups on
the membrane as we will show later. Finally, if one wants to avoid the use of copper(I),
cyclooctynes can be used.156 They avoid the cytotoxicity of copper(I) while still exhibit
high reaction rates. In Figure 3.4, a simple cyclooctyne is depicted which exhibits low
reaction rates. However, one can boost the rates by several orders of magnitudes by
activating groups attached to the cyclooctyne like fluorine and benzene rings. Also in
this case, the alkyne part of the cyclooctyne and the azide are connected via a [3+2]
Huisgen cycloaddition.
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Figure 3.4: Detection of azido groups.
Shown are three common detection methods for azido groups and the resulting
reaction products: Staudinger ligation with triphenylphosphines (top), copper-
catalyzed click chemistry (middle), and copper-free click chemsitry with cyclooc-
tynes (bottom). R and R’ denote arbitrary chemical groups. If applied in biological
systems, R is the label to be attached, e.g. a fluorophore, and R’ the azide-bearing
sugar on the protein.
3.3 Chemical Background of Copper-Catalyzed
Alkye-Azide-Ligation
Since we do not only use copper-free click chemistry in our experiments, but also
copper-catalyzed ligation of alkynes and azido groups, the mechanistic basis should
be briefly highlighted here as shown in Figure 3.5.
Several studies suggest the existence of a dynamic equilibrium between different cop-
per(I) acetylides in solution.158 These are formed via the attack of copper on the π-
system of the alkyne which strongly acidifies the proton. It is suggested that the pKa is
lowered by almost 10 units, making water a sufficiently strong base to deprotonate the
alkyne. When the azide attacks, it first coordinates a second copper ion that is not part
of the acetylide. It seems like this second atom fulfills two tasks: On the one hand, it
activates the copper(I) from the acetylide, on the other hand, it serves as first binding
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Figure 3.5: Simplified mechanism of the copper-catalyzed reaction between alkynes and
azides
The catalyzing Cu+ is complexed by some ligand and binds to the triple bond of the
alkyne. Some base cleaves the acidified hydrogen, yielding the copper(I) acetylide.
Then, the azide attacks. Via several intermediate steps, the final product of the cy-
cloaddition is formed and the catalyzing species as well as the base are regenerated.
R1 and R2 denote an arbitrary chemical residue. Figure adapted from157
partner for the azide. This coordination reduces the electron density of the alkyne,
making it possible for the azide to attack it, leading to cyclization.
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4 siRNA in Cell Biology and
Therapeutic Applications
Chapter 11 deals with the internalization of targeted small interfering RNA (siRNA)
into model neuronal stem cell and into live mouse brains. We will in this chapter
briefly introduce the mechanism of siRNA-mediated gene expression and how it can
be utilized for gene therapy.
4.1 siRNA-Mediated Control of Gene Expression
After the transcription of DNA to mRNA, the mRNA is prepared for translation by
processes like splicing, polyadenylation, and capping.159 The processed mRNA is
then translated many times. However, at some point it will be desirable to decrease
again the synthesis of the protein encoded by the mRNA. Also, it may happen that
the situation of the cell changes in a way that the production of the respective pro-
tein is no longer wanted. Since the proteins translated in excess would be useless or
even harmful, cells have developed several mechanisms to intercept mRNA. Among
them, siRNA-mediated posttranscriptional control of gene expression is the most com-
mon.160
The molecular basis of siRNA-mediated gene expression, commonly termed RNA in-
terference (RNAi), is schematically depicted in Figure 4.1. siRNAs are RNA molecules
that are encoded on the DNA just as normal mRNA.161–163 Usually, they consist of 21
nucleotides with two unpaired nucleotides at each end and 17 paired nucleotides in
the middle. RNA Pol II or III transcribe the RNA that will later become siRNA. How-
ever, right after transcription, the synthesized RNA is several thousand nucleotides
long and features a cap and poly-A tail just like normal mRNA. This so called pri-
miRNA is exported from the nucleus into the cytoplasm by Drosha or RNase III and
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the cofactors DGRCS and Exportin 5.164 There, the endonuclease Dicer with its helper
proteins TRBP and PACT specifically cleave the pri-miRNA into small pieces.165 This
yields siRNA.
The resulting siRNA has two strands. One of the strands is complementary to the tar-
get mRNA. It is therefore called antisense-strand or guide strand. The other strand has
the same sequence as the mRNA and is termed sense-strand or passenger strand, un-
derlining that this strand just comes together with the antisense strand. The double-
stranded siRNA is recognized by the RISC loading complex (RLC) and loaded into
RNA-induced silencing complex (RISC).166 RISC unwinds the siRNA and splits it. The
sense-strand is degraded in the process while the antisense-strand stays in the RISC.
With this, everything is set for RNAi. In case of perfect match between the mRNA and
the siRNA, the mRNA is cleaved by AGO2 which completely shuts down translation.
In case of a two to seven matching nucleotides, the mRNA is not degraded, but stays
bound to RISC, which in turn reduces translation.167
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Figure 4.1: Processes during RNAi.
After synthesis of pri-miRNA, it is exported into the cytosol where it gets processed
by Dicer. The resulting siRNA is loaded into RISC by RLC. The corresponding
mRNA is recognized. In case of perfect match, the mRNA is degraded, otherwise, it
stays in the RISC. In the first case, complete silencing, in the second case, reduction
of translation results. Figure taken from81
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4.2 siRNA in Therapeutic Applications
The possibility to alter gene expression by RNA interference makes siRNA an inter-
esting tool to treat diseases: After identification of proteins crucial for a disease or
infection, the respective translation can in principle just be shut down by RNA inter-
ference which fights the disease. About 15 siRNA constructs are currently investigated
in clinical phases I-III.168
One of the first drugs employing RNA interference, Bevasiranib, is a simple siRNA
directed against the vascular endothelial growth factor (VEGF).169 VEGF activity is
mainly responsible for neovascularisation of the macula, leading to age-induced mac-
ula degeneration.170 The idea behind the treatment is to downregulate VEGF expres-
sion in order to suppress neovascularisation, hence fighting the main cause for macula
degeneration.
Another example is Miravirsen (SPC3649) which is a miRNA-based drug currently in
phase II.171 The RNA interference is directed against miR-122, a mRNA crucial for the
development of the Hepatitis C virus.172 Miravirsen is built by so called locked nucleic
acid ribonucleotides which are spaced throughout a DNA phosphorothioate sequence.
It was shown that Miravirsen binds to mature miR-122 which blocks interaction with
hepatitis C virus RNA. This inhibits assembly of the virus, fighting the infection.
An important aspect of siRNA-mediated therapy is the delivery of the siRNA to the
target cell. For this, various possibilities exist.173–176 In this work, targeting employ-
ing anandamid (N-Arachidonylethanolamid, AEA), a derivate of arachidonic acid, was
prominently used.31 AEA binds to the cannabinoid receptors 1 and 2 which are G-
protein coupled receptors.32, 177, 178 Cannabinoid receptor 1 is predominantly located
in neuronal cells, especially in the hippocampus. The cannabinoid receptor 2 is found
on cells related to the immune system, osteoblasts, and osteoclasts. Corresponding
to their location, the cannabinoid receptor 1 is involved in brain plasticity and neu-
rotransmission, whereas cannabinoid receptor 2 plays an important role in immune
response.
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5.1 Principles of Fluorescence Microscopy
Fluorescence microscopy is a powerful tool to elucidate processes within living sys-
tems.179, 180 Although microscopy in general and also fluorescence microscopy are
techniques established already some time ago, they are still pushed further. New
methods with increased capacity and applicability are continuously developed. The
most prominent example amongst them may be the discovery of super-resolution micros-
copy about 15 years ago which was awarded with the Nobel Prize for Chemistry in
2014.181 However, all fluorescence microscopy techniques have a common basis: The
principles of optics and the physical processes underlying fluorescence. As almost
all experiments described in this thesis are connected to fluorescence microscopy, its
basics are introduced in the following.
5.1.1 Fluorescence
The ability of certain physical systems like e.g. atoms, molecules, or quantum dots to
emit light after excitation with electromagnetic radiation is called fluorescence. These
systems are generally termed fluorophores. Although atoms, molecules, and quantum
dots differ strongly in their properties, they have in common that, in order to func-
tion as fluorophores, they need to possess one or more electrons that are able to be
excited by photons. In the following, we will discuss the phenomenon of fluorescence
for molecules since most fluorophores used in this thesis were organic dyes like the
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AlexaFluor dyes.A The central processes underlying fluorescence can be visualized
and explained using the so called Jablonski diagram (Figure 5.1).182 It schematically
depicts the relevant energy levels of the molecule influencing the process of fluores-
cence.
In order to emit a photon, i.e. fluoresce, a molecule must first absorb energy. In the di-
agram, this is depicted by the blue arrow: An electron is excited within femtoseconds,
for example from the highest occupied molecular orbital to the lowest unoccupied
molecular orbital. The system is hence transferred from the electronic ground state
S0 to a vibrational state of an excited electronic state, e.g. S2. From this high-energy
level, the system does not return to the ground state immediately: It first undergoes vi-
brational relaxation (dark red arrow) and internal conversion (light red arrow). These
two processes occur within picoseconds and are therefore about three orders of mag-
nitudes faster than fluorescence. Via vibrational relaxation, the system loses energy
to its environment, e.g. via collisions with other molecules, and arrives in the vibronic
ground state of S2. From there, it crosses into energetically overlapping, highly excited
vibrational states of S1. Again, the system undergoes vibrational relaxation and arrives
at the vibrational ground state of S1. From there, it falls down to the electronic ground
state S0 within nanoseconds, emitting a photon that can be detected as fluorescence
(green arrow). Usually, the system does not arrive in the vibronic ground state, but
in an excited state from where it is again transferred to the vibronic ground state via
vibrational relaxation. Because the system therefore loses energy due to the relaxation
processes, the emitted wavelength is usually shifted towards lower energies, i.e. higher
wavelengths, which is called Stokes’ shift.183
Besides this path, there exists the possibility that the system undergoes a transition
from the vibronic ground state of S1 to the triplet ground state T1 (yellow arrow). This
is a rare event because the process is forbidden by quantum mechanics, hence, it is also
not meaningful to give a timescale for this process. However, if it occurs, the system
AFor some experiments, quantum dots were used. The basis of fluorescence in their case is different
than of organic dyes, however, the underlying principle is rather simple: The size of a quantum dot
is in the range of the wavelength of an electron (λ = h/
√
2mekBT ≈ 7.7 nm at 22◦C), hence, quantum
confinement of the electron-hole pair after excitation occurs. This electron-hole pair can be modeled
as one particle, an exciton, that is positioned in a potential well. The resulting energy levels, defining
the emitted fluorescence, can be approximated using the simple particle in a box model. Considering
this, it is also easily understandable why the emission wavelength of a quantum dot depends mainly
on its size.
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is "trapped" in T1 because the emission of a photon to return to S0 is now of course
also forbidden. Hence, the related phosphorescence (orange arrow) takes much longer
(microseconds to minutes). Since these photons are often not usable for the detection
of fluorescence due to their long delay, phosphorescence is an unwanted effect in many
applications.
Figure 5.1: Jablonski diagram
The system is excited from the electronic ground state S0 to an excited electronic
state like S2. Then, it undergoes internal conversion to reach the vibronic ground
state of S1. From there, it usually returns to S0, emitting a photon which is detected
as fluorescence. Sometimes, it may undergo intersystem crossing into the triplet
state T1, a process forbidden by quantum mechanics. From there, the system falls
back to S0, but on a much longer time scale than in case of fluorescence since the
return from T1 to S0 is again forbidden.
5.1.2 Optical Imaging and Resolution
If the signal of a fluorescent emitter is recorded using an optical system like a micro-
scope, diffraction occurs. This has an important consequence: The microscope does
not show the actual size of the fluorophore, but a blurred spot of much larger size.
In the following, the physical reason for diffraction will be discussed using the most
simple example for diffraction: Light diffracted at a small aperture.
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Light can be described as an electromagnetic wave.184 Therefore, it must satisfy the
wave equation
∇2~E(x,y,z, t) = 1
c2
∂2~E(x,y,z, t)
∂t2
, (5.1)
where ~E(x,y,z, t) is the electric field (the magnetic field can be treated equally), c is the
speed of light, and t is time. To solve this equation, we assume harmonic plane waves
traveling from the aperture to describe the propagation of the field
E(x, t) = E0cos(~kx −ωt) =<(E0ei(
~kx−ωt)), (5.2)
where (~k is the wave vector or spatial frequency and ω is the temporal frequency. If we
put this ansatz into the wave equation, we get:
−~k2E = −ω
2
c2
E. (5.3)
Considering that ω is related to the frequency f via ω = 2πf and the wave vector to
the wavelength via k = 2π/λ, we obtain
4π2f 2
c2
=
4π2
λ2
, (5.4)
which results in a well-known equation:
c = λf . (5.5)
Therefore, the ansatz is a solution of the wave equation. In order to evaluate how
the field evolves, we consider that the electrical field needs to fulfill the Helmholtz
equation:
(∇2 +~k2)E(x,y,z) = 0. (5.6)
For simplicity, we switch to the frequency domain via a 2D-Fourier transformation.
The waves travel in the x-y-plane whereas they are constant in z:
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E(x,y,z) =
∫ ∫
E(~kx,~ky , z)e
i(~kxx+~kyy)d~kxd~ky . (5.7)
Hence, we obtain:
∇2
∫ ∫
E(~kx,~ky , z)e
i(~kxx+~kyy)d~kxd~ky +~k
2
∫ ∫
E(~kx,~ky , z)e
i(~kxx+~kyy)d~kxd~ky = 0. (5.8)
This equation can be solved with the following ansatz:
E(~kx,~ky , z) = E(~kx,~ky ,0)e
±i~kzz. (5.9)
This implies that, from the field at z = 0, we can calculate the field at any position
along z. Since this sort of transfers the field at z = 0, the term e±i~kzz is often called
optical transfer function. With this, we have in principal already obtained the reason
for diffraction. It is hidden in the term kz in the optical transfer function which is
defined as follows:
kz =
√
k2 − kx2 − ky2. (5.10)
This means that if kx2+ky2 ≤ k2, kz is real. The resulting wave is called the propagating
wave. However, if kx2 + ky2 ≥ k2, kz is imaginary and the resulting wave is called
evanescent wave. It decays exponentially in z-direction. This means that in the far
field the original wave at the aperture loses all frequencies for which kx2 + ky2 ≥ k2.
Hence, at the aperture, we started with a narrow signal in real space, corresponding
to a broad signal in the k-space. As the wave propagates, most frequencies in k-space
are lost, causing a narrow signal. This leads to a broad signal in real space which
causes spatial broadening. This diffracted image is called point spread function or
Airy function.
The diffraction implies that there is an upper limit for the resolution of an optical
system. The equation describing the minimal distance ∆xAbbe that a microscope can
still resolve in an illuminated sample (i.e. not an ensemble of fluorescent emitters!)
was first derived by Ernst Abbe in 1873:185
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∆xAbbe =
λ
2nsinα
, (5.11)
where λ denotes the wavelength of the light used for illumination, n is the refractive
index of the medium, and α half the aperture angle of the objective.
However, for fluorescence microscopy, the situation is a little different. Here, not a
sample is illuminated with light, but the diffraction-limited spots of emitters itself
give rise to the detected signal. Resolution is in this case defined by the so called
Rayleigh criterion186 which is schematically depicted in Figure 5.2. It states that if two
fluorescent emitters are to be resolved, the maximum of the one emitter must lie above
the first minimum of the second emitter or further away.B The corresponding equation
for the minimal resolvable distance ∆xRayleigh is given by:
∆xRayleigh =
1.22λ
2nsinα
. (5.12)
Figure 5.2: Rayleigh criterion
The maxima of two fluorescent emitters are not resolved when they are closer to
each other than the distance between a maximum and the first minimum (left).
If the maximum of the first is positioned above the first minimum of the second,
they are just resolved (middle). If they are separated even more, they can be well
resolved (right). Figure taken from reference188
5.1.3 Wide-Field and Scanning Confocal Microscopy
In this work, we apply two microscopy techniques: On the one hand wide-field fluo-
rescence microscopy, on the other hand scanning confocal microscopy. Since the latter
BThere also exists the so called Sparrow limit187 which assumes two emitters to be resolved if there is
a clear decrease of signal strength between the two maxima. However, it is not used as often as the
Rayleigh criterion, maybe because its definition is not as precise.
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can be seen as a special case of the first, we will first describe the principle of wide-
field microscopy.
In wide-field microscopy, usually an epifluorescent illumination is used. This means
that the laser employed for the excitation of the fluorophores is passing through the
objective (the condenser) which also collects the fluorescence from the sample. The
intensity of the laser can be tuned with an acusto-optical tunable filter (AOTF). Basi-
cally, it employs that certain materials change their permittivity upon the presence of
a mechanical strain, hence, by changing the strain, the transmitted laser light can be
set. To couple the laser into the objective, a dichroic mirror which reflects light below
and transmits it above a certain wavelength is used. The properties of the mirror are
chosen in a way that the excitation light, if it is reflected by the specimen, is again re-
flected by the mirror and only the emission from the fluorophore is collected. To make
sure that all excitation light is blocked, filters are incorporated. If more than one laser
is employed for excitation, additional dichroic mirrors and filters are used. To detect
the emitted fluorescence, an array detector is used. Nowadays, it is usually a charge
coupled device (CCD) camera. The biggest advantages of wide-field microscopy are
the high sensitivity and the fast acquisition time which makes it, for example, suit-
able for single-molecule detection.189, 190 A schematic representation of the wide-field
microscope used for some experiments in this thesis is given in Figure 5.3.
However, the high sensitivity and time resolution of the wide-field microscope also
determines its main drawback: The low spatial resolution, especially in the axial di-
rection. This has led to the development of the confocal microscope.180 Here, two
pinholes are introduced at the camera and at the sample which efficiently block the
emission and the detection of molecules that are not in focus of the objective both in
lateral and axial directions. Therefore, the sensitivity of the wide-field setup is re-
tained while its spatial resolution is drastically improved. However, since the field of
view of the detector is typically at least some microns whereas the detected area now
is only the focus of the objective, i.e. in the size of a few hundred nanometers, the focus
must be scanned across the sample in order to obtain the full image. Unfortunately,
this makes the acquisition very slow: One image needs now seconds to be acquired.
For the spectral investigation of molecules in solids at low temperatures,191, 192 for ex-
ample, this is tolerable, but considering the fast dynamics of cellular components, the
low temporal resolution poses a problem. For this, confocal spinning-disk microscopy
has been developed. It is a compromise between the high spatial resolution of scanning
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confocal microscopy and the high time resolution of wide-field microscopy. The cen-
tral element of such a microscope is a spinning-disk unit as it is schematically depicted
in Figure 5.4.
The laser light passes through the first disc where lenses focus the light. The second
disc, which is synchronous to the first lens, features the pinholes that block out-of-
focus excitation and, when the emission light passes through the disc again, also out-
of-focus emission. The two discs rotate fast (several thousand revolutions per minute).
Hence, the focuses are scanned very often across the sample which reduces the acqui-
sition time down to milliseconds. However, a large fraction of the fluorescence is lost
in comparison to wide-field microscopy which explains the lower sensitivity. Never-
theless, when the signal strength is not the central problem as it is in single-molecule
detection, scanning-disc microscopes are the most powerful instruments, especially
when it comes to life-cell imaging. In Figure 5.5, the setup of commercial spinning-
disc microscope used in our experiments is schematically depicted.
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Figure 5.3: Wide-field microscope for single-molecule detection
Two lasers with wavelengths of 532 nm and 633 nm are used for excitation. They
are directed through a shaken fiber. Behind the fiber, the beam is parallelized and
passed through an aperture from where it is directed through a 100x objective with
a numerical aperture of 1.4 to the sample. A dichroic mirror and filters are used to
separate the emission before the signal is collected by an EM-CCD camera.
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Figure 5.4: A spinning-disk unit
Laser light passes through a lens and a pinhole disc which create several focuses.
They are scanned in parallel across the sample, reducing the acquisition time. Fig-
ure taken from reference193
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Figure 5.5: Representation of the Zeiss Cell Observer SD
Laser light of four different wavelengths is transferred to the spinning-disc unit
via an optical fiber. From there, it is brought to the specimen where it excites
fluorophores in epifluorescent mode. The emission light is collected, filtered, and
detected by two EMCCD cameras, allowing for parallel detection of up to four
fluorophores. For life-cell imaging over extended periods of time (up to days), the
system features also a heated sample chamber with CO2 atmosphere.
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5.2 Principles of Single-Molecule Tracking
Tracking single particles or molecules and evaluating the recorded trajectories makes
it possible to investigate the properties of a system in much more detail than meth-
ods averaging over the whole observed ensemble.194, 195 The reason is that within the
average the behavior of single members of the ensemble is buried. In contrast, the
investigation of individual representatives of the ensemble allows for the detection of
e.g. small subpopulations or local variations. Since single-molecule tracking plays an
important role in this thesis, we will describe the basis of this method briefly in the
following.
5.2.1 Macroscopic Description of Diffusion
Diffusion is caused by random the thermal movement of molecules or particles in a gas,
a solution, or even in solids. According to Fick’s first law,196 the flow J of particles in an
ensemble caused by diffusion is proportional to the concentration gradient ∂c/∂x (here
in one dimension) which runs in the direction opposite to the flow. The proportionality
constant is the diffusion coefficient D(x):
~Jx = −D(x)
∂c(x, t)
∂x
. (5.13)
For the general case of three dimensions one obtains:
~J = −D∇c. (5.14)
Returning to the one-dimensional case, one obtains, considering the conservation of
mass
∂c(x, t)
∂t
= −∂Jx
∂x
. (5.15)
This means that, for any change of concentration at a certain position, the flow must
change in time accordingly. Amongst others, this states that the flow vanishes when
the concentration gradient has disappeared. Substitution of Fick’s first law yields:
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∂c(x, t)
∂t
=
∂
∂x
(
D(x)
∂c(x, t)
∂x
)
. (5.16)
If D(x) is constant it follows:
∂c(x, t)
∂t
=D
∂2c(x, t)
∂x2
. (5.17)
In analogy, the general term for three dimensions is given by:
∂c
∂t
= ∇ · (D∇c). (5.18)
The solution of this equation quickly becomes very challenging and can often be only
numerically approached. However, if one makes some simplifying assumptions (i.e.
constant diffusion coefficient, no boundaries, and N particles starting to diffuse all at
t = 0 and x = 0 along x and do not influence each other) the solution of this equation is
not too complicated:
c(x, t) =
N
√
4πDt
e−x
2/4Dt. (5.19)
The solution is a Gaussian distribution with a mean of zero and variance 2Dt. Consid-
ering the definition of the variance, one obtains:
〈
x2(t)
〉
=
∫
x2c(x, t)dx = 2Dt. (5.20)
We should keep this result in mind for a moment. Now, we turn to the microscopic
description of diffusion using random walks.
5.2.2 Diffusion as Random Walk
We consider a particle that is located at x = 0 at time t0. Its movement consists of single
steps s that are either in direction of +x or −x, i.e. the probability for each direction is
1/2. Furthermore, it moves with a characteristic velocity with the absolute value |v|.
Since the particle behaves randomly, its velocity vector is ±~v. Finally, we define a
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certain time τ the particle needs to make one step. The distance the particle moves is
then:
δ = ±|v|τ. (5.21)
If τ and |v| are constant over all steps s (which does not need to be the case and, in
fact, almost never seems to be true in complex systems197), the particle is at x(s) after
s steps, where x(s) is given by:
x(s) = x(s − 1)± δ = x(s − 1)± |v|τ (5.22)
or
x(s) = ∆xs +∆xs−1 + ...+∆1 =
s∑
i=1
∆xi . (5.23)
Because the probability for the particle to move in direction of +x is the same as mov-
ing in −x (1/2), the expected mean displacement < x > is of course zero. One could
compare it with flipping a fair coin many times: Heads and tails will appear about
equally often. Hence, every particle moves about as often to the left as to the right.
However, this does not mean that the system does not evolve. Only the mean displace-
ment is zero. To account for the evolution of the system, one introduces the mean
square displacement (MSD):
x2(s) =
 s∑
j=1
∆xj

 s∑
k=1
∆xk
 = s∑
j,k=1
∆xj∆xk =
s∑
j=1,j=k
∆x2j +
s∑
j,k=1,j,k
∆xj∆xk . (5.24)
Since every step has the same length δ, we can rewrite as follows:
x2(s) = sδ2 +
s∑
j,k=1,j,k
∆xj∆xk . (5.25)
Because the probability of the particle to move left is the same as to move to the right
(1/2) and we assume the movement of each particle to be independent of other parti-
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cles, the second term becomes zero if we consider a large number of particles. Hence,
we obtain:
〈
x2
〉
= sδ2. (5.26)
Above, we have introduced a characteristic time τ that the particle needs to perform
one step. It is obvious that the number s of steps the particle makes within a certain
time t is equal to t/τ . It follows:
〈
x2
〉
= sδ2 =
δ2
τ
t. (5.27)
The values of τ and δ were both assumed to be constant, so we can define that δ2/τ B
2D. Hence:
〈
x2
〉
= 2Dt. (5.28)
Therefore, we obtain exactly the same result for the value of the MSD as if we analyze
the problem from the perspective of the single particle which of course should be
the case. However, we so far considered only one-dimensional diffusion of a freely
moving particle. Next, we turn towards more realistic environments and discuss which
consequences they have on the MSD curves.
5.2.3 Mean Square Displacement Curves
The movement of freely diffusing particles in isotropic environment results in the so
called normal diffusion. However, diffusion usually does not take place along one,
but in two or three dimensions. Considering the isotropy of the environment, one can
separate the dimensions. Hence, the position vector can be split into two components:
~r = ~x+ ~y. For the MSD, we obtain in two dimensions:
〈
r22D
〉
=
〈
x2
〉
+
〈
y2
〉
= 2Dt + 2Dt = 4Dt. (5.29)
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For three dimensions, ~r can be split into three components (~r = ~x + ~y + ~z), hence the
MSD is in this case
〈
r23D
〉
= 6Dt.
Extension to more than one dimension is of course not sufficient to cover diffusion in
complex systems. In fact, normal diffusion is not the normal case – usually, one finds
deviations from this behavior. Generally, four different types of diffusion are distin-
guished.194, 198 They are schematically depicted in Figure 5.6a-d. The corresponding
equations for the MSD curves are given in Table 5.1 and the MSD curves in Figure 5.6e.
Figure 5.6: Types of diffusion
a) Normal diffusion: The diffusing particle does not encounter any barriers. b)
Anomalous diffusion: The particle encounters obstacles. c) Confined diffusion: The
particle is trapped in a region. d) Diffusion with drift: The particle diffuses freely
and does not encounter barriers, but a constant force drives it in a certain direction.
e) MSD curves: Normal diffusion (black squares) results in a straight line whereas
the MSD curve for confined diffusion (red circles) bends down. However, it does
not reach a limit, in contrast to confined diffusion (blue triangles). Finally, diffusion
with drift (cyan triangles) yields a parabola. Parameters: d = 2, D = 1, α = 0.75, C =
10, A1 = A2 = 1, v = 0.5
62
5.2 Principles of Single-Molecule Tracking
Table 5.1: Diffusion Types and MSD Curves
d = 1,2,3 for one-, two-, or three-dimensional diffusion. v is the drift velocity caused
by the external force.
Diffusion Type MSD Curve
Normal Diffusion
〈
r2
〉
= 2dDt
Anomalous diffusion
〈
r2
〉
= 2dDtα 0 < α < 1
Confined Diffusion
〈
r2
〉
= C
(
1−A1e
−2dA2Dt
C
)
A1,A2 > 0
Diffusion with Drift
〈
r2
〉
= 2dDt + (vt)2
In case of normal diffusion, the MSD curve is a straight line and follows the ideal case
we derived above. As soon as obstacles are present and influence the movement of
the diffusing particle, the MSD curve bends down. The more obstacles exist, the more
convex is the MSD curve, proportional to tα where α takes values between 0 and 1
and is the lower the more obstacles are in the way of the diffusing particle. Hence,
one could picture normal diffusion just as a special case of anomalous diffusion where
α = 1. Confined diffusion is reached if the obstacles are so close to each other that the
diffusing particle cannot escape a certain region. Note, however, that there is a sharp
transition between anomalous and confined diffusion: No matter how small the value
of α is in case of anomalous diffusion, the MSD curve has no upper limit. In contrast, in
case of confined diffusion, such a limit exists (C) since the term in brackets approaches
to 1 for sufficiently large t. The two constants A1 and A2 account for the geometry of
the confinement. Finally, if an external force is present that induces a drift – like an
electric field or a flow of the medium in which the diffusion occurs – the MSD curve is
no longer linearly dependent on t, but quadratic. For increasing t, the quadratic term
naturally dominates.
5.2.4 Tracking and Positioning Accuracy
As discussed in Chapter 5.1.2, an emitting molecule with a size of a few nanometers
appears on a detection screen or a camera as a blurred spot with a size of several hun-
dreds of nanometers due to diffraction within the optical imaging system. The key
idea underlying single-molecule tracking is that although the signal of the molecule
is blurred, one is able to determine its position with much higher accuracy.199, 200 The
63
5 Fluorescence Microscopy, Diffusion, and Single-Molecule Tracking
only requirement is that one really detects a single emitter, but this can be ensured ea-
sily by dissolving the fluorescent species to low concentrations (typical concentrations
are 10−9 to 10−12 m). Provided that the emission originates from a single molecule
and detection takes place in two dimensions, a 2D-Gaussian can be fitted to the flu-
orescence signal where the x- and y-coordinates are the spatial dimensions and the
z-coordinate encodes the fluorescence intensity:C The formula for the 2D-Gaussian is
given by:
f (x,y) = Ae
−
(
(x−x0)2
2σx2
+ (y−y0)
2
2σy2
)
, (5.30)
where A is the amplitude, x0 and y0 are the coordinates of the center in x and y and
σx and σy are the spreads in x and y. The center of the Gaussian is then used as the
position of the emitter as schematically depicted in Figure 5.7. If this way the move-
ment of a fluorophore is recorded over time, for example a fluorescent label attached
to a protein diffusing in a cell membrane, a trajectory T is obtained. Recording many
trajectories is required to reduce statistical variations naturally occurring. From the
coordinates of the emitter at each point in time the MSD can then easily be extracted:
〈
r2(τ)
〉
= lim
n→∞
1
N
N∑
i=1
[~Ti(τ)− ~Ti(0)]2. (5.31)
Since the localization accuracy is of high relevance not only for single molecule track-
ing, but also for super-resolution microscopy, the basis of localization microscopy
should be discussed briefly in the following. As it was derived above, the resolution in
conventional fluorescence microscopy is limited because emitters cannot be separated
if they are too closely together. On the other hand, if one can be sure to detect the signal
of a single emitter only, its position can be determined with nanometer accuracy. The
key idea of all super-resolution techniques is to enforce the emitters densely labeling a
CAs we described above, the signal of the emitter is in fact not a Gaussian, but a PSF. However, for
three reasons fitting with a Gaussian is justified: First, the main contribution of the PSF is the central
maximum, already the first side maximum is very small. The error is therefore small if one neglects
the side maxima. Second, a Gaussian exhibits radial symmetry around the center just as the PSF.
Hence, the error even becomes smaller if one is only interested in determining the position of the
center. Third, a Gaussian is easy to fit which results in low computation times.
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Figure 5.7: Diffraction limited detection and localization accuracy.
When photons are detected from a single emitter, they form a diffraction-limited
pattern called the PSF. The above figures show (a) the original PSF of a single YFP
molecule in a bacteria cell, (b) the pixelated PSF measured on the camera, (c) a two-
dimensional Gaussian fit to the PSF and (d) the high-precision localization of the
emitter determined from the center of the PSF. Figure taken from references201, 202
structureD not to emit all at the same time (which would result in a diffraction limited
image), but sequentially. This can either be in space (localization microscopy)200 or
in time (depletion microscopy).205, 206 In depletion microscopy (stimulated emission
depletion, STED, microscopy), only a very narrow area of emitters is allowed to fluo-
resce normally at a time while the emitters around are forced to emit with a defined
wavelength which is filtered. This allows to image with higher resolution than in con-
ventional fluorescence microscopy. Localization with high precision does not play a
role here. In contrast, precise determination of the position of a single emitter is the
basis common to all localization microscopy techniques (Figure 5.7).
The following text follows "Nobel Prize in Chemistry 2014 for Erik Betzig, Stefan
Hell, and William E. Moerner" by Leonhard Möckl, Don C. Lamb, and Christoph
Bräuchle, Angewandte Chemie 2014
Although the intensity profile of a single fluorescent emitter is subject to diffraction,
its center can be localized with much higher precision: Whereas the size of the emit-
ter molecule is about 1 nm, the fluorescent spot produced by diffraction within the
microscope is actually 200 nm. Figure 5.7a/b shows the intensity profile of such a
diffraction-limited signal referred to as the point spread function (PSF), which can be
DThe dense labeling is necessary because otherwise the structure would not be represented correctly.
The reason for this is the Nyquist sampling criterion203, 204 which was originally formulated for
signal processing applications and time frequencies, but also holds for imaging. It states that a
signal in time can only be represented by a discrete sequence if the distance between the points of
the sequence is not too large, i.e. the sampling rate must not be too low. This can be fully translated
to spatial frequencies.
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approximated by a two-dimensional Gaussian function (Figure 5.7c). Provided the de-
tected signal is generated by only one emitter (i.e. a single molecule), the center of the
PSF determines the position of the emitter with very high accuracy (often called super
localization). As the number of photons detected from a single emitter increases, the
accuracy with which the peak position of the PSF can be determined improves and the
position of a single emitter can be localized more precisely. Hence, Abbe’s formula can
be modified to incorporate the enhanced localization precision:
∆xmin,∆ymin =
λ
2nsinα
· 1√
N
(5.32)
where N is the total number of photons detected. Thus e.g. with 100 detected pho-
tons, the resolution for the localization of a single emitter is increased by a factor of
10 (Figure 5.7d). This high-resolution microscopy paved the way for tracking single
molecules with nanometer localization accuracy (FIONA, 1.5 nm) unraveling, for ex-
ample, the hand-over-hand movement of the motor protein Myosin V208 or the three-
dimensional movement of mRNA particles in yeast cells.209
Whereas one emitter is sufficient for single molecule tracking, microscopy of complex
structures needs many emitters (labels) in order to visualize their features correctly
(Figure 5.8a). However, when all the labels are excited simultaneously (Figure 5.8b),
high-precision localization of the individual emitters is no longer possible due to the
overlapping of the PSFs, leading to a blurred or non-resolved image. This is what is
measured in a conventional optical fluorescence microscope. Unfortunately, sparse
or diluted labeling of the structures, resulting in separated PSFs, is not sufficient for
imaging the structure correctly due to under sampling of the image as described by
the Nyquist-Shannon-criterion.203, 204 In other words, one needs a high concentration
of emitters to resolve the features of the structure correctly while, at the same time,
a low concentration is needed in order to separate the PSFs of the individual emitters
for performing high-precision localization microscopy.
It was Erik Betzig who first made a valuable suggestion210 for a solution to this contra-
diction. His idea was to isolate the emitters by some spectral property. The separated
subsets of emitters each form a sparse set in space. Hence, the position of the emitters
within one subset can be determined with high accuracy. By sequentially measuring
all the subsets, a super-resolution image can be generated by combining all the high-
precision localizations. At that time, the optical property Betzig suggested for sepa-
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rating the individual subsets was the inhomogeneity in the absorption wavelength.211
However, this turned out to be difficult to realize.
It was W. E. Moerner who, after getting the ball rolling, contributed to an alternate
solution. When he investigated mutants of the green fluorescent protein (GFP), he
encountered a strange photophysical behavior of the T203F mutant.212 The mutant
fluoresced when illuminated with 488 nm light and eventually switched into a non-
fluorescent dark state. Amazingly, it was not irreversibly photobleached but could be
reactivated by 405 nm illumination (Figure 5.8c). This finding triggered the search
for other GFP mutants with similar photophysical switching characteristics, although
they were not originally designed with subdiffractive microscopy in mind.213
It took Betzig, returning to university after some years of working in industry, to "con-
nect the dots" and make the final step towards super-resolution microscopy. He rec-
ognized that such photoactivable (pa) fluorescent proteins are capable of solving the
problem of sparse and dense labeling in the following way: The sample is labeled
densely with paGFP molecules that are in a dark state at the beginning of the ex-
periment. With a low-powered laser pulse having the appropriate wavelength, a few
fluorescent proteins are stochastically transferred to the active state so that they form
a sparse subset. They are subsequently visualized by 488 nm excitation in a single
molecule manner until they completely photobleach. After photobleaching, new flu-
orescent proteins are activated in the following frames and the cycle starts over again
(Figure 5.8d). Finally, one obtains the full, complex picture in high resolution by
summing up all the highly resolved single emitters of each frame (Figure 5.8e). The
tremendous gain in resolution is best visualized by two images taken from Betzig’s
2006 landmark publication214 where he introduced the technique as Photo-Activated
Localization Microscopy or PALM with a resolution of typically about 20 nm (Fig-
ure 5.9).
In summary, two key elements are required to create a super-resolution image of a
complex structure by localization microscopy. First, the fluorophores labeling the
structure must be actively controllable in such a way that in every image frame only a
sparse subset of labels are emitting and that hence their diffraction-limited signals are
spatially well separated. Second, each diffraction-limited PSF of a single molecule has
to be fitted with an appropriate model function in order to estimate the position of the
emitter with high precision. The collection of molecular positions determined with
high accuracy allows then the reconstruction of the structure in a pointillist fashion.
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Besides PALM, two other ways of producing super-resolved images by localization mi-
croscopy using different actively controlled fluorophore switching mechanisms were
introduced in 2006: fPALM,215 and STORM.216 In the meantime, numerous sophis-
ticated approaches using actively controlled fluorophore switching mechanisms have
been developed.217 However, there are also limitations to be overcome. One is that
high-quality super-resolution images need a lot of individual localizations, limiting
the overall time resolution. Moreover, image reconstruction needs time-consuming
post processing. In addition, life does not take place in two dimensions, but is three-
dimensional. Numerous new schemes have been developed to account for this. Among
others, astigmatism-218 and double helix PSF-based imaging219 were introduced to
provide super-resolution localization in the z-dimension. Additional advances include
multicolor imaging220 and faster data collection and analysis methods for video-rate
imaging.221
Considering that the high positioning accuracy was known for a long time, it is maybe
a little surprising that it took until the mid 90s for the technique of localization mi-
croscopy to be theoretically described and another 10 years for it to be experimentally
implemented. However, since then it has become a powerful method to elucidate pro-
cesses otherwise not accessible with fluorescence microscopy techniques. Because of
this, and because it changed the way we think about optical resolution, the discov-
ery of super-resolution optical microscopy was awarded the Nobel Prize in Chemistry
2014.181
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Figure 5.8: The principle of localization microscopy.
(a) An arrangement of fluorescent molecules representing La Paloma de la Paz (P.
Picasso, 1961) with a spatial frequency below the diffraction limit. (b) Were this
structure to be visualized by conventional microscopy, Abbe’s criterion forbade
resolution of the individual features. (c,d) However, by stochastically switching
molecules between a fluorescent state and a dark state, the PSF of a few sparse
emitters can be acquired in each acquisition step. Their positions are determined
with high precision and (e), in a pointillist approach, the results of all localizations
are combined to obtain a super-resolved reconstruction of the object. Figure taken
from reference207
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Figure 5.9: Super-resolved images of mitochondria in COS-7 cells.
(a) A Total Internal Reflection Fluorescence (TIRF) microscopy image and (b) the
PALM super-resolution image of mitochondria in COS-7 cells. The mitochondria
were labeled using a photoactivable fluorescent protein (dEosFP) targeted to the
matrix of the mitochondria. Whereas only the approximate shape of the mitochon-
dria can be resolved using TIRF microscopy, PALM microscopy exhibits features
on the length scale of some tens of nanometers, well below the diffraction limit.
Figure taken from reference214
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6 Glycosylation Influences
Spatiotemporal Membrane Protein
Dynamics
This chapter is based on: "Microdomain Formation Controls Spatiotemporal Dy-
namics of Cell-Surface Glycoproteins" by Leonhard Möckl, Andrea K. Horst, Katha-
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6.1 Abstract
The effect of galectin-mediated microdomain formation on the spatiotemporal dy-
namics of glycosylated membrane proteins in human microvascular endothelial cells
(HMEC-1) was studied qualitatively and quantitatively by high-resolution fluores-
cence microscopy and artificially mimicked by metabolic glycoprotein engineering.
Two types of membrane proteins, sialic acid-bearing proteins (SABPs) and mucin-type
proteins (MTPs), were investigated. For visualization they were metabolically labeled
with azido sugars and then coupled to a fluorescent dye, conjugated to cyclooctyne,
by click chemistry. Both spatial (diffusion) and temporal (residence time) dynamics
of SABPs and MTPs on the membrane were investigated after treatment with exoge-
nous galectin-1 or -3. Strong effects of galectin-mediated lattice formation were ob-
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served for MTPs (decreased spatial mobility), but not for SABPs. Lattice formation
also strongly decreased the turnover of MTPs (increased residence time on the cell
membrane). The effects of galectin-mediated crosslinking was accurately mimicked
by streptavidin-mediated crosslinking of biotin-tagged glycoproteins and verified by
single-molecule tracking. This technique allows the induction of crosslinking of mem-
brane proteins under precisely controlled conditions, thereby influencing membrane
residence time and the spatial dynamics of glycans on the cell membrane in a con-
trolled way.
6.2 Introduction
The dynamics of proteins on the cell membrane are essentially characterized by two
processes: diffusion inside the membrane resulting in lateral movement (spatial dy-
namics), and membrane- protein transportation to their destinations on the mem-
brane after biosynthesis and retraction back into the cell after a certain time, thus
resulting in a membrane residence time as a function of the incorporation and inter-
nalization kinetics (temporal dynamics). These spatiotemporal dynamics are influ-
enced by the formation of microdomains, caused by a complex molecular interplay at
the cell surface.101, 223–225 One way for the cell to control microdomain organization
is glycosylation of membrane proteins.104, 226 Glycosylated cell-surface proteins can
assemble into supramolecular structures by interacting with highly abundant lectins
such as galectins.227–229 Both galectin-1 and -3 are N-acetyllactosamine (LacNAc)-
specific; galectin-1 exists as a divalent homodimer, whereas monomeric galectin-3 can
self-associate into multimeric complexes.230, 231 It is known that the interaction be-
tween galectins and glycans is highly regulated.232, 233 Importantly, galectins as scaf-
fold proteins build up the "galectin lattice", thereby leading to, for example, regulation
of receptor signaling.228, 232 However, the effects of galectin lattice formation on spa-
tial and temporal dynamics have not been studied. It is important to understand the
full dynamics of membrane proteins, including the formation of microdomains as this
influences many crucial cellular processes.
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6.3 Results and Discussion
We used fluorescence microscopy with human microvascular endothelial cells (HMEC-
1) and galectin-1 and -3 to demonstrate the effect of the galectin lattice on the spa-
tiotemporal dynamics of glycoproteins. LacNAc-containing mucin-type glycoproteins
(MTPs) were investigated as galectin ligands and compared to sialic acid-bearing gly-
coproteins (SABPs), which are not interconnected by galectins. We also established
streptavidin (SA)-mediated crosslinking of biotinylated MTPs and SABPs as an artifi-
cial and robust, galectin-independent method to induce lattice formation and investi-
gated its influence on spatiotemporal membrane protein dynamics (Figure 6.1).
We employed metabolic labeling to visualize cell-surface glycoproteins by fluorescence
microscopy.149, 156, 234, 235 HMEC-1 were incubated with tetraacetylated N-azidoacetyl-
d-mannosamine (Ac4ManNAz) to target SABPs, or with tetraacetylated N-azidoacetyl-
d-galactosamine (Ac4GalNAz) to target MTPs. In a second step, the azido groups were
addressed by a membrane-impermeable cyclooctyne-AlexaFluor647 derivative in a
bioorthogonal conjugation reaction. This procedure resulted in fluroescence-labeled
SABPs and MTPs, respectively (Figure 12.2, Figure 12.3, Figure 12.4, Figure 12.5),
whereat there may be proteins belonging to both groups (Figure 12.6). In the next step,
3.3 µg mL-1 galectin-1 or-3 was added to the fluorescence-labeled cells to induce addi-
tional galectin lattice formation with cell-surface MTPs. FRAP experiments then were
performed to measure spatial mobility of the labeled glycoproteins (Figure 6.2).236
The bleaching spot was localized at the cell membrane, and each cell was measured
once. Due to carbohydrate- independent mechanisms that decrease the mobility of all
membrane proteins, such as attachment of membrane proteins to the cytoskeleton, the
mobile fraction does not reach a ratio of 1.237, 238
Thus, even prior to the addition of exogenous galectin, the SABP mobile fraction
reached only about 0.3, and for MTPs it was approximately 0.23. The difference might
be a consequence of the MTP-galectin lattice on cultured HMEC-1, thus leading to re-
duced MTP mobility. Indeed, we confirmed the expression of galectins-1 and -3 by
immunohistochemistry (Figure 12.7). Also, galectin expression by HMEC-1 has been
reported before.239–241 However, exogenous addition of galectin-1 and -3 induced a
further, significant decrease in the MTP mobile fraction as expected, whereas the SABP
mobile fraction did not decrease significantly. This also indicates that the fraction of
proteins belonging both to SABPs and MTPs is not dominant, as galectin treatment
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Figure 6.1: Experimental approach.
Membrane glycoproteins (a) were tagged with azido groups by labeling with Ac4-
ManNAz or Ac4GalNAz (b). In a second step, either a fluorescent dye (c) or a biotin
(d) was coupled to the azido groups by copper-free click chemistry. The fluores-
cence of the specifically labeled membrane glycoproteins was used to investigate
their spatial dynamics (diffusion inside the membrane) and temporal dynamics
(incorporation into the membrane and internalization back to the cell interior) as
a function of galectin-induced microdomain formation (e). The biotin tag was em-
ployed to induce artificial, streptavidin-mediated crosslinking of membrane pro-
teins (f). Visualization of the spatiotemporal dynamics used fluorescently labeled
streptavidin.
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Figure 6.2: Effects of exogenous galectin-1 or -3 on spatial mobility of membrane glycopro-
teins determined by FRAP
The mobile fraction of MTPs (galectin ligands) decreases upon addition of 3.3 mg
mL-1 galectin-1 or -3, caused by crosslinking (formation of galectin lattices). For
SABPs, only small decreases are visible. Data are mean ±SEM (n=29 or 30); t-test
*p<0.1.
affects only proteins labeled by Ac4 GalNAz (MTPs) and not by Ac4ManNAz (Figure
S5). Our results are in line with previous studies where the influence of glycosylation
on the behavior of specific proteins was investigated.242–244
To further demonstrate the functional importance of microdomain formation on cell
membrane protein dynamics, we designed a set of experiments to mimic the effects
of galectin lattice formation, again by employing metabolic glycoprotein engineer-
ing. A cyclooctyne-biotin conjugate was added to azidemodified glycoproteins (Fig-
ure 6.1b), thereby yielding biotintagged membrane glycoproteins (Figure 6.1d). The
modified proteins could be crosslinked by SA displaying four binding sites for biotin
(Figure 6.1f), and thus this multivalent interaction enabled lattice formation. By prior
addition of free biotin, the degree of SA-induced lattice formation could be controlled:
for example, the natural tetravalency of SA homotetramers can be switched to a mean
valency of two, resulting in reduced binding capacity for biotin-tagged glycoproteins.
This allowed us to measure glycoprotein mobility as a function of the valency of the
crosslinking SA. Biotin-tagged membrane proteins were incubated with 1.25 mm flu-
orescent di- or tetravalent SA for 20 min to induce artificial SA-mediated network
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Figure 6.3: Effect of di- and tetravalent SA on spatial mobility of biotin-tagged membrane
glycoproteins.
Both di- and tetravalent SA lead to a significant decrease in the mobile fraction.
Data are mean ±SEM (n=27-29); t-test, *p<0.1, ***p<0.0001
formation, then spatial mobility was measured by FRAP. Other than in the case of
carbohydrate-specific galectin crosslinking (Figure 6.2), SA-mediated crosslinking re-
duced the mobile fractions of biotin-tagged SABPs and biotin-tagged MTPs compa-
rably (Figure 6.3). Notably, divalent SA (two ligand-binding sites like galectin-1) re-
sulted in effective reduction of the mobile fraction of membrane proteins: the mobile
fractions of SABPs and MTPs are reduced to about 0.1. crosslinking actually form a net-
work, we investigated the movement of individual SA molecules labeled with Alexa-
Fluor647 by single-molecule tracking.194, 198, 245–249 For this, we used two types of SA:
tetravalent (capable of forming networks) and monovalent (no crosslinking capability,
but able to bind and label biotin-conjugated glycans). Biotin-tagged membrane pro-
teins were incubated for 20 min with 1.25 mm mono- or tetravalent SA. The concen-
tration of fluorescent SA was 0.1 nm, typical for single molecule experiments. Then,
the movement of single SA molecules on the cell surface was tracked (0.0513 s/frame)
and their trajectories were recorded (representative examples in Figure 6.4a; several
hundred to a few thousand trajectories for each condition).194, 198, 248, 249
The single-molecule tracking data corroborated the results obtained from the bulk
measurement by FRAP. Clearly, tetravalent SA resulted in much lower spatial mobil-
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Figure 6.4: Representative tracks of SA on the surface of HMEC-1 with biotin tagged MTPs
or SABPs.
a) Five tracks for each glycoprotein type, shifted to a common origin. b) MSD
(mean square displacement) analysis. The trajectories of tetravalent SA cover a
much smaller area (largely overlapping) than those of monovalent SA, thus indicat-
ing low spatial mobility as a result of effective crosslinking. Accordingly, the slopes
of the MSD curves are significantly lower for tetravalent SA-mediated crosslinking
than for monovalent SA. Dashed lines indicate the linear fit to the linear part at the
beginning of the curves. Error bars are given as the weighted standard deviation
divided by the square root of the number of degrees of freedom.
ity than monovalent SA, as indicated by the small, mostly overlapping area that is
covered by the trajectories displayed in Figure 6.4a. Furthermore, the mean square
displacement (MSD) curves (Figure 6.4b) obtained from the single-molecule trajecto-
ries194, 198, 249 show three different types of diffusion for monovalent and tetravalent
SA: 1) for very short times (dashed lines in Figure 6.4b), diffusion is normal with much
higher slopes for monovalent SA (diffusion coefficientD = 1.21·10−5 nm2 s-1 for MTPs,
1.18 ·10−5 nm2 s-1 for SABPs) than for tetravalent SA (D = 5.98 ·10−4 nm2 s-1 for MTPs,
4.32·10−4 nm2 s-1 for SABPs); 2) anomalous diffusion over larger time ranges for mono-
valent SA, with comparable behavior for MTPs and SABPs; and 3) confined diffusion
for longer time ranges for tetravalent SA, again with comparable behavior for MTPs
and SABPs (confinement area=3.71 · 10−5 nm2 for MTPs, 1.55 · 10−5 nm2 for SABPs).
Our results are in good agreement with a recent study investigating the mobility of
glycans in the membranes of cancer cells.250 The confined diffusion of tetravalent SA
can be attributed to the simultaneous binding of several biotinylated membrane pro-
teins, thereby restricting their movement to a limited area.194, 198 From the data we
obtained on the effects of natural and artificial crosslinking on the spatial dynamics
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of cell-surface proteins, the question arose as to whether lattice formation also in-
fluences the temporal dynamics of membrane proteins (incorporation of glycans into
the cell membrane and internalization back into the cell). The internalization can be
followed more directly than incorporation, as the latter is blurred because of the com-
plex biosynthetic pathways (Figure 12.9). This was done by fluorescent labeling of
the azide-tagged membrane glycoproteins once, followed by observation of the decay
of membrane fluorescence after labeling caused by the internalization of the mem-
brane proteins. Enhanced galectin lattice formation on the cell membrane should lead
to stronger interconnection of membrane glycoproteins, and hence their relative in-
ternalization rate should decrease because of the more difficult internalization of the
crosslinked membrane proteins. Therefore, we fluorescently labeled MTPs and SABPs
once, incubated them with 0, 0.3, 1.3, or 3.3 mg mL-1 galectin-1 and -3, and mea-
sured the residual membrane fluorescence after 5 h. The values were compared, that
is, normalized to the decreased membrane fluorescence of untreated cells after 5 h.
Figure 6.5: Effects of exogenous galectin-1 and -3 on membrane protein internalization.
Internalization of MTPs, and to a lesser extent SABPs, is slowed by increasing
amounts of galectin-1 and -3. Normalized fluorescence intensity: ratio of mem-
brane fluorescence of galectin-treated cells to untreated cells after 5 h. Data are
mean ±SEM (n=28-30).
The membrane fluorescence of galectin-treated cells decreased more slowly than that
of untreated cells; we measured an increase in the normalized membrane fluorescence,
which reached a constant at approximately 1.3- to 1.4-times higher than that of un-
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treated control cells (Figure 6.5). The relative internalization rates of SABPs were also
affected, albeit to a much lesser extent, as expected. (The measured effect is again at-
tributed to some galectin-binding sites on SABPs.) Hence, not only spatial mobility on
the cell surface, but also internalization of MTPs was strongly reduced by exogenous
addition of galectin-1 and -3. We also wanted to demonstrate that artificial lattice for-
mation leads to a decelerating effect on membrane protein internalization. For this,
biotin-tagged membrane proteins were interconnected with 1.25 mm fluorescent di-
or tetravalent SA. Membrane fluorescence was quantified after 5.5 h or directly after
SA-treatment (0 h). The ratio of mean membrane fluorescence after 5.5 h to that at
0 h represents the amount of proteins that remains on the membrane after 5.5 h (Fig-
ure 6.6).
Figure 6.6: Effects of di- and tetravalent SA on internalization of biotin-tagged membrane
proteins.
For both SABPs and MTPs internalization is strongly slowed by addition of di-
or tetravalent SA. The ratio (0.88-0.96) between membrane fluorescence at 5.5 h
and 0 h indicates that little internalization occurred over this time. Untreated
cells showed much higher internalization. Data are mean ±SEM (n=29-30); t-
test:**p<0.01, ***p<0.0001.
Addition of both di- and tetravalent SA to biotin-tagged SABPs and MTPs slowed gly-
coprotein internalization drastically (very little decrease in membrane fluorescence
was seen within 5.5 h), whereas untreated cells showed a significant decrease in mem-
brane fluorescence (Figure 12.8). Furthermore, the change in internalization rate will
certainly affect the incorporation process similarly, as these processes are metaboli-
cally coupled (Figure 6.7). In a model we simulated the mutual dependence of the
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processes (Figure 6.7, Figure 12.10, Figure 12.11). As mentioned above, we chose to
observe internalization because it can be measured directly. Nevertheless, we also de-
tected higher relative incorporation rates for SAPBs than for MTPs ( Figure 12.12 and
Figure 12.13). This finding is fully consistent with our simulations. Taken together, our
experiments confirm that the spatiotemporal dynamics of membrane glycoproteins is
causally linked to their glycosylation type and their engagement into scaffoldinduced
lattice formation. As glycoproteins of the mucin type show higher affinity to galectin-1
and -3 than SABPs, their incorporation into galectin lattices is enforced, thereby result-
ing in prolonged residence on the cell membrane and lower spatial mobility relative
to untreated cells. Using metabolic labeling, we were able to experimentally separate
the two protein types. Artificial, SA-induced lattice formation has the same effect,
however, for both glycoproteins (MTPs and SABPs), as lattice formation in this case
is not carbohydrate-specific. The SA-based approach to mimic lattice formation is a
versatile, artificial, and precisely controllable technique to influence and manipulate
mobility, location, and clustering of cell-surface proteins. As the spatiotemporal dy-
namics of particular cell-surface proteins regulate important cellular processes (e.g.,
cellular signaling), this method will allow researchers to influence key functions of a
cell. In future experiments we intend to employ the regulating potential of artificial
microdomain formation to further investigate the influences of cell-surface glycopro-
tein dynamics on cell biology.
6.4 Simulation of Membrane Protein Internalization
This work was not part of the published article.
As mentioned above, in order to investigate the interplay between membrane protein
internalization and incorporation in more detail, we set up a simple model to test
how the simulated behavior matches the observations. Here, we will describe it in
more detail. In the model, we considered the relevant compartments for glycosylation
and physiologically reasonable correspondence between them. This is schematically
depicted in Figure 6.7.
From this, we derived a straightforward system of coupeled differential equations that
fully describe the system and can be solved numerically with arbitrary accuracy:
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Figure 6.7: Simulation of cellular compartments and metabolite flow through them.
We assume that a constant flow of metabolites is presented from the extracellular
environment. They are internalized and then either used to generate energy or to
build glycan structures.
With[{a = 1, b = 0.5, c = 0.1, d = 1, f = 0.1,
g = 0.05, h = 0.1, k = 0.1, m = 0.1, n = 0.1},
sol = NDSolve[{
v’[t] == -a ,
w’[t] == a - b w[t] - f w[t],
x’[t] == m r[t] - c x[t] + g y[t] - k x[t],
y’[t] == c x[t] - g y[t] - d y[t] - h y[t] + n r[t],
z’[t] == f w[t], u’[t] == h y[t],
q’[t] == k x[t],
r’[t] == b w[t] - m r[t] - n r[t] + d y[t],
v[0] == 0, w[0] == 0, x[0] == 0, y[0] == 0,
z[0] == 0, u[0] == 0, q[0] == 0, r[0] == 0},
{v, w, x, y, z, u, q, r},
{t, 0, 100}]]
The variables are defined as follows: q = Extracellular space (shedding), r = Golgi
Apparatus, u = Catabolism from endosomes, v = Extracellular Space, w = Cytosol,
x = Membrane, y = Endosomes, z = Catabolism from Cytosol, a = kExtra-Cytosol, b
= kCytosol-Golgi, c = kMembrane-Endosomes, d = kEndosomes-Golgi, f = kCytosol-Catabolism, g =
kEndosomes-Membrane, h = kEndosomes-Catabolism, k = kMembrane-Shedding, m = kGolgi-Membrane,
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n = kGolgi-Endosomes, which is also depicted in Figure 6.7. Solving this system gives the
result depicted in Figure 6.8.
Figure 6.8: Development of metabolite concentration in the model.
Parameters: a=1, b=0.5, c=0.2, d=1, f=0.1, g=0.05, h=0.1, k=0.01, m=0.1, n=0.1,
v(0)=0, w(0)=0, x(0)=0, y(0)=0, z(0)=0, u(0)=0, q(0)=0, r(0)=0
Hence, we set the starting concentrations of all compartments to 0 and defined a con-
tinuous flow with 1t from the extracellular space into the cell: The extracellular space is
the only source.A Therefore, the concentration of metabolites there decreases linearly
with slope −1. The metabolites first arrive in the cytosol. There, a stationary state is
reached quickly because the arriving metabolites are not staying there. Two routes are
possible: The metabolites are either directly used for energy generation (catabolism
from cytosol, which increases linearly after a short lag phase that it takes the first
metabolites to arrive in the cytosol) or they enter the Golgi apparatus. Hence, the
metabolite concentration there starts to rise after a little longer lag phase compared
to the cytosol. Again, a stationary state is reached because from the Golgi apparatus,
the metabolites are either transferred to endosomes or to the membrane. From the
membrane, they can be shedded off into the extracellular space or be retracted into the
endosomes. From the endosomes, the metabolites can then be transported to the Golgi
apparatus, back to the membrane, or fed into the catabolism.
ASince the influx is not limited, we set the concentration of metabolites in the extracellular space to
0. The resulting negative concentrations are of course only mathematically meaningful. One can,
however, just consider the absolute values as amount of internalized metabolites.
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The simulation shows that for the only source of the system, the extracellular space,
the metabolite concentration continuously decreases whereas for all sinks (catabolism
and shedding) the concentration rises linearly after a short delay. All other compart-
ments have influx and drains, therefore, their curves show a sigmoid development,
tending to a limit. Notice also that the lag phases correspond to the position in the
system, i.e. the "distance" from the metabolite source: The lag phases for the sinks can
be ordered according to catabolism from endosomes ≈ extracellular space from shed-
ding > catabolism from cytosol. Equally, the lag phases of the compartments reaching
a limit in concentration can be ordered according to membrane ≈ endosomes > Golgi
apparatus > cytosol. Moreover, the rates all together define the metabolite concentra-
tions at a given point in time. In this case, from the 100 metabolites that entered the
cell within 100 time units about 28% are found in the Golgi apparatus, 8% in the ex-
tracellular space due to shedding, 27% in the catabolism from endosomes, 1.5% in the
cytosol, 15% on the membrane, 4.5% in endosomes, and 16% in the catabolism from
the cytosol.
If, for example, the rates are set to values where every metabolite is directed fast to
the membrane, the curves match the situation exactly as depicted in Figure 6.9. Now,
the metabolite concentrations after 100 time units is for all compartments low except
for two: First, as it should be, on the membrane, but second and perhaps a little sur-
prising also in the extracellular space due to shedding. However, if one considers the
high metabolite concentration on the membrane (over 50%), it is reasonable that the
low shedding rate of 0.01 still has a significant effect. A very distinct behavior shows
the curve for the metabolite concentration in the Golgi apparatus. This is because now
the rate between cytosol and Golgi apparatus is, although it is with 0.5 quite large, a
bottleneck: The rate from the Golgi apparatus to the membrane is with 1 even higher.
Therefore, the concentration in the Golgi apparatus increases fast within the first time
units, but then, the arriving metabolites are brought to the membrane, causing the
curve to flatten fast.
Taken together, our model is capable of describing the metabolite flow through cellular
compartments quantitatively. Therefore, we used it to investigate how the incorpora-
tion and internalization rates of membrane proteins are connected and compared it to
the experimental results. These simulations are shown in Figure 12.10, Figure 12.11,
and Figure 12.13.
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Figure 6.9: Development of metabolite concentration in the model.
Parameters: a=1, b=0.5, c=0.01, d=0.01, f=0.01, g=0.1, h=0.01, k=0.01, m=1,
n=0.01 v(0)=0, w(0)=0, x(0)=0, y(0)=0, z(0)=0, u(0)=0, q(0)=0, r(0)=0
6.5 Experimental Section
Cell culture: HMECs (variant 1, CDC, Atlanta, GA) were seeded in collagen coated 8-well LabTek slides
(Nunc, Rochester, NY) with a density of 1.5 · 104 or 1 · 104, respectively, in 400 µL growth medium,
dependent on whether the experiment was performed two or three days after seeding, in order to yield
subconfluent cells. The cells were cultured in MDCB-131 medium with 1% Glutamax, 10% fetal bovine
serum (FBS), 10 ng/mL hEGF (all Life Technologies, Carlsbad, St. Louis, MO), and 1 µg/mL hydro-
cortisone (Sigma-Aldrich, St. Louis, MO) at 37°C in 5% humidified CO2 atmosphere. Cells were fixed
with 4% paraformaldehyde (Sigma-Aldrich) in DPBS+Ca2+/Mg2+ (Life Technologies). Before and after
fixation, it was washed three time with DPBS+Ca2+/Mg2+.
Metabolic Labeling: Growth medium was supplemented with 50 µM Ac4ManNAz or Ac4GalNAz (Life
Technologies). For fluorescent labeling, cells were incubated for 45 min with Click-IT Alexa Fluor 647
DIBO Alkye (350 µL, 5 µM (Life Technologies).
Fluorescence microscopy: Confocal images were obtained using a commercially available spinning-disk
inverted microscope (Carl Zeiss). Single molecule images were obtained on a custom-built Nikon epi-
fluorescence TE200 microscope (Nikon) with a Nikon PlanApo100 objective (NA=1.4). Laser power was
constant for each set of experiments and repeatedly controlled.
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Quantification of membrane fluorescence: The obtained images for each set of experiments were random-
ized. Background was defined as the mean gray value of 5 out-of-cell regions and subtracted. Then,
a line (width=667.5 nm) was drawn manually on the fluorescing cell membrane image, and the mean
gray value along this line was determined. This was defined as the membrane fluorescence intensity.
SA-mediated lattice formation: After biotin-tagging of membrane glycoproteins, AlexaFlour647-labeled
SA (1.25 µM; Life Technologies) was added and incubated for 20 min. For single-molecule measure-
ments, the concentration of non-fluorescent SA was also 1.25 µM, with 0.1 nM fluorescent SA. For
blocking of SA binding sites, biotin solution was added dropwise in a stoichiometric ratio with thor-
ough mixing.
Immunostaining: HMEC-1 were fixed and incubated for 50 min with goat serum (2%) in DPBS+Ca2+/Mg2+
followed by incubation for two hours at room temperature with rabbit monoclonal antibodies against
galectin-1 or galectin-3 (1:100; ab108389/ab76245, Abcam, Cambridge, UK). Cells were then incubated
for 40 min with secondary antibody (1:200).
Statistical methods: Data were first tested for normal distribution, which was always positive. The F-test
always resulted in unequal variances, therefore a two-tailed student’s t-test for unequal variances was
performed to determine p-values.
Software: Images were analyzed using ImageJ. With the Matlab program uTRACK, tracking was per-
formed.251 Tracks were analyzed with the program @msdanalyzer.252 For data visualization and anal-
ysis, OriginPro 8G was used. Simulations were carried out in Mathematica 7 (Wolfram, Hanborough,
UK). FRAP analysis was performed with easyFRAP.253
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7.1 Abstract
We present a method to artificially induce network formation of membrane glycopro-
teins and show the precise tuning of their interconnection on living cells. For this,
membrane glycans are first metabolically labeled with azido sugars and then tagged
with biotin by copper-free click chemistry. Finally, the so obtained biotin-tagged mem-
brane proteins are interconnected with streptavidin (SA) to form an artificial protein
network in analogy to a lectin-induced lattice. The degree of network formation can be
controlled by the concentration of SA, its valency, and the concentration of biotin on
membrane proteins. This was verified by investigation of the spatiotemporal dynam-
ics of the SA-protein networks employing single-molecule tracking. It was also proven
that this network formation strongly influences the biologically relevant process of
endocytosis as it is known from natural lattices on the cell surface.
87
7 Artificial, Tunable Interconnection of Membrane Glycans
7.2 Introduction
The formation of lattices and networks is a crucial mechanism in every living cell. Ex-
amples include the nuclear lamina,254 the cytoskeleton,255 the galectin-glycoprotein
lattice,103 or the flat clathrin lattice.256 From the wide thematic area of these exam-
ples, ranging from nucleus structure to mechanical stability of the cell and membrane
protein organization, the relevance of protein interconnection can be seen. Therefore,
it is not astonishing that the formation and properties of protein networks are in the
focus of both experimental104, 257, 258 and theoretical research.259–261 Moreover, they
are also an inspiration for the development of techniques that allow the assembly of
cellular components into defined structures.262–265 However, so far there are only a
few attempts to actively influence and control the formation of physiological lattices,
such as membrane-localized lattices266 which are relevant in signaling, metabolism,
or cellular communication.101, 243 Much more research deals with the manipulation of
other features of the cell membrane employing, for example, cyclodextrins,267 cavita-
tion,268 nanotubes,269 or optical tweezers.270 In a recent paper,222 we have investigated
the effects of the galectin lattice on membrane protein dynamics and have described
a method to artificially induce network formation on the membrane of living cells.
Here, we have systematically changed all parameters responsible for artificial network
formation and report the results of a detailed analysis performed by single-molecule
tracking. Furthermore, we reveal the influences of this artificial network formation on
endocytosis.
Our method relies on a robust three-step protocol as schematically depicted in Fig-
ure 7.1. First, metabolic labeling with azido-modified sugars is employed to intro-
duce the azido group into glycosylated membrane proteins, suited for bioorthogo-
nal labeling.153 In the second step, biotin is coupled with the azido groups by click
chemistry271 and finally, formation of artificial protein networks is effected by in-
cubation with streptavidin (SA) that can bind up to four biotin moieties. We chose
to target the glycosylation of membrane proteins because this modification is abun-
dant on the cell surface.69 Therefore, most membrane proteins can be addressed this
way and are then available for the following modifications required for artificial net-
work formation. For metabolic labeling, we supplemented the growth medium of hu-
man microvascular endothelial cells (HMEC) with tetra-O-acetylated N-azidoacetyl-
d-mannosamine (Ac4ManNAz) or tetra-O-acetylated N-azidoacetyl-d-galactosamine
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(Ac4GalNAz). These azidosugars are taken up by the cell and processed along the nor-
mal biosynthetic pathways to be incorporated into cell surface glycoproteins.153 This
leads to azido-modified sialic acid-bearing proteins (SABPs) in case of Ac4ManNAz or
mucin-type proteins (MTPs), respectively, in case of Ac4GalNAz.272, 273 For biotin tag-
ging, DIBO-biotin was employed, a cyclooctine-biotin conjugate reacting solely with
azides in a copper-free click reaction;156 no other functional groups present on the
cell surface are involved in this conjugation step. To induce artificial network forma-
tion, SA was used, mainly for two reasons: First, the mechanism of SA-biotin binding
is well understood274 and can even be modified to tune the properties of the interac-
tion.275, 276 Second, the SA-biotin complex is very strong (KD≈ 10−15 M)277 allowing
for the formation of a stable network. It is important to keep in mind that especially
SABPs often carry more than one sialic acid,278 resulting in more than one biotin bound
to the protein. Therefore, the same protein can be bound by different SAs, which is of
course relevant for network formation. To allow investigation of protein networks by
single-molecule tracking we employed fluorescent AlexaFluor647-SA at suitable con-
centrations.
Figure 7.1: Schematic representation of the protocol employed for artificial network forma-
tion.
Supplementation of the cellular growth medium with azido sugars (Ac4ManNAz
or Ac4GalNAz) leads to metabolic labeling of membrane-bound glycoproteins with
azido groups. This allows tagging with biotin (B) by click chemistry using a
cyclooctyne-biotin conjugate. The resulting biotin-tagged membrane proteins can
then be interconnected by tetravalent SA.
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In order to explore tuning of artificial network formation, we systematically modified
the parameters that determine the degree of protein interconnection and investigated
the associated changes in spatiotemporal dynamics of the artificial network. These
parameters are the valency of network-forming SA (free biotin binding sites), SA con-
centration, and biotin concentration on cell surface proteins. They can be easily tuned
in our system by blocking biotin binding sites of SA via preincubation of SA with free
biotin, by varying the concentration of used SA, and by varying the concentration of
used DIBO-biotin, respectively (Figure 7.2). We changed each of these parameters at a
time while keeping the other two constant.
Figure 7.2: The factors that influence artificial network formation.
(a) Statistical tuning of SA valency by preincubation of SA with biotin; increasing
biotin amounts result in gradually reduced SA mean valency from four to three,
two, and one. (b) Tuning of SA concentration was effected by incubation of the
biotin-tagged cells with different amounts of SA. (c) The concentration of available
binding sites for network-forming SA was tuned by incubation of the azido-tagged
cells with different amounts of DIBO-biotin.
7.3 Results and Discussion
First, we investigated the influence of the valency of network-forming SA on glyco-
protein network formation. For this, we incubated HMECs with 50 µM Ac4ManNAz
or Ac4GalNAz, respectively, for two days. After this time, a steady state is reached
in which all natural sugars that can possibly be modified in our approach have been
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replaced by azido sugars.222 Then, we addressed the azido groups by incubation with
5 µM DIBO-biotin, followed by interconnection of the biotin-tagged membrane pro-
teins with SA. For incubation with SA, a total concentration of 1.25 µM was employed
with a concentration of fluorescent AlexaFluor647-SA of 5 · 10−9 M, a typical concen-
tration for single-molecule experiments (cf. Figure 12.14 for exemplary images). The
SA mean valencies varied from four to one (cf. Figure 7.2a). We subsequently tracked
the movement of the fluorescent SA on the membrane of several cells (20-30 for each
experiment) and recorded their trajectories over time.
The changing mobility of glycoproteins upon interconnection by SA of different va-
lency can directly be seen from the trajectories of the single SA units on the cell mem-
brane. Whereas incubation of biotin-tagged membrane proteins with tetravalent SA
leads to trajectories that mostly cover only a small area (Figure 7.3a), incubation with
SAs of mean valency of one results in many long trajectories covering a large area
(Figure 7.3b). Some trajectories show a deviating nature, such as strong confinement
in case of monovalent SA and low confinement in case of tetravalent SA. This can
be attributed to SA of a divergent valency, present in the applied samples due to the
stochastic nature of the biotin blocking process of tetravalent SA, or to tetravalent SA
bound to only one protein, respectively.
To quantitatively investigate membrane protein network formation with SA, we ex-
tracted mean square displacement (MSD) curves194, 198, 279, 280 from the trajectories
(Figure 7.4a/b left). From this, it is clearly visible that for increasing mean valen-
cies of SA the corresponding MSD curves bend more, corresponding to less mobility
and increasing confinement (see Figure 12.15 for a simple simulation of the relation
between network formation and confinement).
From the MSD curves also additional information on the nature of the membrane pro-
tein diffusion process can be extracted. Since the MSD curves show strong bending for
SA valencies larger than one and also tend towards a limit, we decided to fit the MSD
curves following the model of confined diffusion.194, 198 The formula that describes
the MSD in dependence of the delay time is
MSD = C
(
1−A1e−
4A2Dt
C
)
(7.1)
where C stands for the size of the confinement, A1 and A2 are geometrical constants
defining the shape of the confinement, and D is the diffusion coefficient (cf. Chap-
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Figure 7.3: Trajectories of SA on the membrane of HMECs after metabolic labeling with
Ac4ManNAz and tagging with DIBO-biotin.
Left: All trajectories recorded. Right: Zoom in. (a) Incubation with tetravalent SA
results in trajectories that mostly show a high confinement, visible from the small
area that is covered. (b) In contrast, incubation with SA of a mean valency of one
leads to many trajectories that cover a large area, displaying lower confinement and
higher mobility. n=2300-2600 trajectories.
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Figure 7.4: Effect of mean SA valency on network formation.
Both, for incubation with Ac4ManNAz (a) and Ac4GalNAz (b), the MSD curves
(left) bend stronger with increasing mean valency of interconnecting SA. Corre-
spondingly, the apparent diffusion constants Dapp and the confinement area C
decrease (right). Error bars are given as the weighted standard deviation divided
by the square root of the number of degrees of freedom. Dashed lines indicate fit
curves. 2300-4700 trajectories/MSD curve.
ter 5.2.1 and Table 5.1). Unfortunately, one cannot obtain the values of the two free
constants A2 and D just by fitting the MSD curve, only the value of their product is ac-
cessible. However, since it is our goal to qualitatively compare the diffusion constants
of SA in different networks relative to one another, we combined the numerator to the
apparent diffusion coefficient Dapp and used the formula:
MSD = C
(
1−A1e−
Dappt
C
)
(7.2)
The thus obtained values for the confinement area and for the apparent diffusion con-
stants (Figure 7.4a/b right) corroborate the trend that was already displayed by the
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MSD curves. With increasing valency of interconnecting SA molecules, the confine-
ment area and the apparent diffusion coefficient decrease. The fit curves in Figure 7.4
are given as dashed lines which nicely overlap with the experimental data, indicat-
ing that the model of confined diffusion is well chosen. The variation in the C- and
Dapp-values is understandable from the overlapping error bars in the MSD curves. Im-
portantly, the decreasing tendency and the significant difference between monovalent
SA (no network formation) and tetravalent SA (maximal network formation) is clearly
visible.
Confinement is also detected when monovalent SA is applied, although it is not capa-
ble of forming an artificial membrane protein network. This finding is not surprising
as diffusion of cell membrane proteins has been found to be confined already without
artificial interconnection as shown by numerous studies.225, 281, 282 Also, SA of higher
valency that may be present in the sample due to the stochastic blocking of biotin
binding sites could contribute. Clearly, however, SA of higher valency effects artificial
network formation, thus reducing the mobility of the membrane proteins and further
decreasing their confinement area.
It is interesting to compare the effects of artificial network formation depending on
whether the initial azido labeling was performed with Ac4ManNAz, leading to azido-
bearing SABPs, or Ac4GalNAz, leading to azido-bearing MTPs. When monovalent SA
was applied (no artificial network formation), the confinement area of SABPs is larger
than in case of MTPs and also its apparent diffusion coefficient is slightly higher. This
observation can be explained by natural lattice formation. Cultured HMECs express
galectins as proved by immunostaining (see Figure 12.16). These GalNAc-specific
lectins interconnect MTPs to form lattices, whereas SABPs are not involved in this
natural network formation process due to the nature of their glycan portions. Conse-
quently, as long as no artificial network is induced, the mobility of MTPs is lower than
that of SABPs due to their engagement in the natural galectin lattice.222 However, if the
interconnecting SA has a mean valency of two, three, or four, respectively, artificial net-
works are formed in all cases and thus the confinement area and the apparent diffusion
coefficients of both SABPs and MTPs decrease: In this case, the artificial network for-
mation dominates over the other cellular mechanisms that lead to confinement (such
as the formation of galectin lattices). Next, we went on to characterize the effect of SA
concentration on network formation. For this, HMECs were again labeled with biotin
after incubation with 50 µM Ac4ManNAz and 5 µM DIBO-biotin as described above.
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Then, we incubated with 0, 1.25, 2.5, or 5 µM tetravalent SA and recorded trajectories
of fluorescent SAs (c=5 · 10−9 M) on the cell membrane. The MSD curves (Figure 7.5
left), the values for the respective confinement area, and of the apparent diffusion co-
efficient (Figure 7.5 right) show that SA concentration also affects the formation of an
artificial network: Higher concentrations of interconnecting SA lead to stronger bend-
ing of the MSD curves and, correspondingly, to smaller confinement areas and lower
apparent diffusion coefficients
Figure 7.5: Effect of SA concentration on network formation
The bending of the MSD curves increases with increasing SA concentration, dis-
playing decreasing mobility (left) as reflected in the obtained values for the appar-
ent diffusion constant and the confinement area (right). Error bars are given as the
weighted standard deviation divided by the square root of the number of degrees
of freedom. Dashed lines indicate fit curves. 5100-6100 trajectories/MSD curve.
Finally we investigated the influence of biotin concentration on artificial network for-
mation. Biotin concentration determines the number of binding sites for interconnect-
ing SA. For this, we first incubated the cells with 50 µM Ac4ManNAz for two days as
before and then addressed the azido-tagged membrane proteins with 1, 5, 10, 25, 50, or
75 µM DIBO-biotin. To induce network formation, we incubated with 5 µM tetravalent
SA. However, in this case the fluorescent species was not SA, but SA-coated quantum
dots (QDs) at a concentration of 5 ·10−9 M (see Figure 12.14 for example images). They
are incorporated into the artificial network just as AlexaFluor647-SA, but other than
AlexaFluor647 they virtually do not bleach. This advantage makes it possible to fol-
low their movement over a long period of time which allows to observe the MSD curve
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to reach the plateau.A From the MSD curves it is readily visible that the membrane
biotin concentration strongly affects the formation of the artificial network (Figure 7.6
left). For DIBO-biotin concentrations of 1 to 10 µM, the confinement increases with
increasing concentration. However, at 25 µM and above, a threshold is reached with
MSD curves remaining at a very low level, displaying strongly confined diffusion. This
is reflected in the values of the apparent diffusion constant and the confinement area
(Figure 7.6 right), both decreasing with increasing DIBO-biotin concentrations.
It is worth mentioning that the concentration of biotin has by far the strongest ef-
fect on membrane protein mobility and artificial network formation, when compared
to the effect of SA valency and SA concentration. When the latter two parameters
were varied, the effects on confinement and apparent diffusion were less pronounced
and showed larger variations, presumably due to other cellular mechanisms that affect
membrane protein mobility. In contrast, when medium and high biotin concentrations
were applied in our experiment, movement of proteins within the network could be
almost completely shut down. This can be seen from the confinement areas that re-
main constant at a very low level from 25 µM biotin onwards. The apparent diffusion
constants decrease first, but stay at a medium level before also dropping to a very low
value at 75 µM. This observation can be reasoned by two transitions: Between 5 and
50 µM biotin proteins show very strong confinement, but are still able to move a little
within this confinement, which results in the low values for C and the medium values
for Dapp. At 75 µM the confinement is very strong as before, but now the proteins are
almost completely immobile, further decreasing Dapp.
Having shown that our method is suited to artificially induce network formation on
cell membranes in a defined way, we also wanted to secure its relevance in a biological
environment. Hence, we chose to investigate its effect on endocytosis, a fundamental
cellular process. For this, we first induced artificial network formation by incubating
HMECs for two days with 50 µM Ac4ManNAz, followed by incubation with 5 or 50 µM
DIBO-biotin and 0, 1.25, 2.5, or 5 µM tetravalent SA. Then, we added 0.75 mg/mL flu-
orescent 10 kDa dextran, a common endocytosis probe, incubated for 15 minutes, and
AIn the preceding two experiments SA-coated QDs could not be employed as the number of SA
molecules on one QD ranges from 5 to 10. Thus, it is impossible to exactly control SA valency
and SA concentration in this case. Here, we can use them because we investigate the effect of biotin
concentration and not that of interconnecting SA. Furthermore, they are only applied at a very low
concentration.
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Figure 7.6: Effect of cell surface biotin concentration on network formation.
With increasing DIBO-biotin concentration, the MSD curves increasingly bend, in-
dicating a more and more confined movement. At concentrations ≥ 25 µM DIBO-
biotin, the MSD curves remain constant at a very low level, displaying very high
confinement (left). Consistently, the apparent diffusion constant and the confine-
ment area decrease with increasing DIBO-biotin concentration (right). Error bars
are given as the weighted standard deviation divided by the square root of the
number of degrees of freedom. Dashed lines indicate fit curves. 800-3400 trajecto-
ries/MSD curve.
fixed the cells. Then, we quantified the fluorescence signal of several cells within one
confocal slice at the lower part of the cells. The integrated fluorescence density per
slice divided by the number of cells is then a measure for the ability of the cells to in-
ternalize the dextran (Figure 7.7). From the endosomal signals it is clearly visible that
upon artificial network formation, the endocytosis is strongly slowed down. In case
of incubation with 5 µM DIBO-biotin, the signals from the endosomes decrease from
about 22500 a.u. for no addition of SA, i.e. no artificial network formation, to about
2500 a.u. for the presence of 5 µM SA. In case of incubation with 50 µM DIBO-biotin,
the endosomal signal for no addition of SA is lower compared to incubation with 5 µM
DIBO-biotin, presumably due hindered endocytosis as a consequence of the high de-
gree of DIBO-biotin modification. However, it also decreases strongly with rising SA
concentrations, again indicating a significant reduction of the endocytosis rate. There-
fore, artificial network formation physically blocks endocytosis by introducing large
protein clusters on the cell surface that are difficult to internalize for the cell. Over
the time we performed the experiments (one to two hours), we did not detect adverse
effects on the cells. However, one can assume that membrane rigidification, as in case
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of strong artificial network formation, will alter the behavior of a cell, e.g. during
cell division. Therefore, this is an interesting approach to influence cellular behavior.
Experiments to elucidate this in various ways are currently underway.
Our results prove that the spatiotemporal dynamics of membrane glycoproteins can be
easily and reliably tuned by SA-mediated interconnection employing metabolic label-
ing and biotin modification of cell surface glycans. In our approach, the formation of
an artificial network on the cell membrane is effected and can be systematically tuned,
as verified by single-molecule tracking. In general, the mobility of the interconnected
proteins decreases with increasing SA valency, SA concentration, and membrane biotin
concentration. However, these three parameters influence the proteins not equally.
The concentration of biotin has by far the strongest effect on protein mobility whereas
increasing SA valency and SA concentration, respectively, decrease protein mobility
less strongly. By careful setting of these parameters, the mobility of membrane pro-
teins can be adjusted and tuned from physiological values to an almost frozen condi-
tion. Furthermore, we were able to show that artificial network formation also influ-
ences the biologically relevant process of endocytosis which strongly decreases with
increasing network formation. We are confident that our method of artificially influ-
encing glycoprotein networks can be helpful to control membrane protein mobility in
a broad context.
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Figure 7.7: Effect of artificial network formation on endocytosis.
(a) Representative images of HMECs incubated with fluorescent 10 kDa dextran
after artificial network formation with the indicated DIBO-biotin and SA concen-
trations. It is clearly visible that for both cases (5 and for 50 µM DIBO-biotin) the
endosomal signal decreases when rising amounts of SA are used for network for-
mation. At 50 µM DIBO-biotin and 0 µM SA (i.e. no artificial network formation)
endocytosis is lower than in the analogous experiment at 5 µM DIBO-biotin. This
observation is presumably due to the high number of biotin residues present on the
cell surface at 50 µM DIBO-biotin that already hinders endocytosis. Nevertheless,
addition of SA further decreases the endocytosis rate also in this case. (b) Quan-
tification of the endosomal signal reflects the strong influence of artificial network
formation on the endocytosis rate. n=25-94, Scale bar = 30 µm. Error bars indicate
the standard error of the mean and arrows the y-axis corresponding to 5 and 50 µM
biotin, respectively.
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7.4 Step Length Analysis
This work was not part of the published article.
Calculation of the MSD is a very efficient way to characterize the motion of diffusing
particles. However, it may be desirable to have a more intuitive way of describing the
diffusion of a particle. One way is to investigate the number of consecutive steps in
one direction. We will call this a "chain" in the following (Figure 7.8).
Figure 7.8: Definition of chains as consecutive steps in one direction.
Shown is two times the same part of a trajectory. At the top, it is color-coded for
increasing (cyan) and decreasing (magenta) x-values, at the bottom the same way
for y-values. From this, consecutive steps in one direction of "chains" are easily
determined.
Let’s consider the movement of a particle undergoing normal diffusion. If we define
any direction ~a, then the particle has, as described above, ideally the probability 1/2
to make a step in +~a (i.e. the coordinate of the particle along ~a increases). Equally
the particle has also the probability 1/2 to make a step in −~a (i.e. the coordinate of
the particle along ~a decreases). This means that, for example, the probability for the
particle to make five steps into one direction (i.e. chain length 5) is 0.55 = 0.03125.
The other values for chains for a particle undergoing normal diffusion are listed in
Table 7.1.
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Table 7.1: Probability of chain lengths for idealized normal diffusion
Chain length Probability
1 0.5
2 0.25
3 0.125
4 0.0625
5 0.03125
6 0.015625
7 0.0078125
8 0.00390625
9 0.00195313
10 0.00097656
11 0.00048828
12 0.00024414
13 0.00012207
14 6.1035 · 10−5
15 3.0518 · 10−5
16 1.5259 · 10−5
However, this is not true for a particle undergoing confined diffusion. Since the par-
ticle diffuses inside a confinement, the more steps it makes in the same direction, the
more likely it is that it hits a boundary. Therefore, for confined diffusion, if the parti-
cle has made a step in +~a, the probability for the particle to make a step in +~a again
is smaller than to make a step in −~a and the other way around. Of course, the longer
the chain is, the more unlikely it becomes in comparison to a freely diffusing particle:
Sometimes, this is called "memory" of the particle.
Before we investigated our experimental data, we simulated trajectories for particle
undergoing diffusion inside a confinement of different sizes to validate our approach.
For this, we used the same model that is described in Figure 12.15 where particles
can diffuse freely inside a potential L that drives them back to their original position.
Therefore, we varied the size of the potential.B First, we calculated how often chains
of lengths from 1 to 16 occurred. The results are given in Figure 7.9
BOther parameters: NParticles=1000, NSteps=500, dimensions=2,D = 1·10−3 µm2/s, T=37◦C, L=0.05µm
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Figure 7.9: Number of consecutive steps in one direction for different simulated potentials
(a) Normalized histogram for all chains of steps. (b) Detail for longer chains. As
it can be clearly seen, the probability of longer chains decreases the narrower the
potential becomes.
The simulation shows two important aspects of the diffusion process. On the one hand,
for all potential sizes the chain length with the highest probability is one, meaning that
it is always most likely that a particle performs first a step forward and then back. This
is expected, because otherwise a preferred direction would exist: For example, if two
steps in one direction were more likely than one, this would imply drift. On the other
hand, for large confinements, long chain lengths occur whereas they are becoming
more and more unlikely for narrower confinements until for very narrow confinements
they do not occur at all anymore. This is nicely seen in Figure 7.9b. Since the data are
normalized, it follows that the probability for shorter chains increase when longer
chains vanish.
One can also compare the probabilities for the different chains in case of idealized
normal diffusion with the histograms for the simulated diffusion by calculating the
ratio between them. For this, the ideal case of normal diffusion (Table 7.1) just has to
be normalized. The result is given in Figure 7.10.
For large confinement sizes (50 and 100 nm), the ratio is close to one, indicating that
the deviation from the ideal case is small – the particle undergoes pseudonormal dif-
fusion. When the confinement sizes decrease, the ratio deviates more and more from
1 and tends for long chain length to zero, indicating that for increasing confinement
long chain length become highly unlikely. Only at very long chain lengths, the data
points deviate from this trend and start to behave erratically. This can be attributed to
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Figure 7.10: Comparison of chain lengths between the simulated data and idealized normal
diffusion
With decreasing potential size, the ratio deviates towards smaller ratios, indi-
cating that longer chain lengths become more unlikely. The deviations from the
trend at long chain lengths can be attributed to the low statistical power in this
region.
the low statistical power – these chain lengths are anyway highly unlikely, so a small
deviation has a big impact on the ratio.
Finally, one can also calculate the cumulative weighted chain length (CWCL). This is
done by multiplying the normalized frequency fi of a certain length i with the respec-
tive length and then summing up over all the products until the longest observed chain
Nmax:
CWCL =
Nmax∑
i=1
fi · i (7.3)
This value is, as one can easily derive, 4 for idealized normal diffusion. It decreases
for confined diffusion (until it reaches zero for a completely immobile particle) and
increases for diffusion with drift. The result for the simulated data is depicted in
Figure 7.11. It can be clearly seen that for increasing confinement the cumulative
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weighted chain length decreases. For the potential size of 100 nm, it is close to 4, con-
firming the result depicted in Figure 7.10 that for this confinement size the diffusion
is pseudonormal. Moreover, the development is not linear: There is a sharp transition
at a potential size of about 20 to 25 nm, above which the cumulative weighted chain
length is close to four and below which it decreases rapidly. This can be understood
when considering the physical setting: As soon as the confinement exceeds a certain
size, the particle is unlikely to encounter it. In this case, it makes not a big difference
if the confinement is then even larger. On the other hand, as soon as the particle is
affected by the confinement, a further decrease in confinement size has a big impact.
For the parameters of our simulation, the critical size is at about 25 nm.
Figure 7.11: Cumulative weighted chain length
For large confinement sizes, the cumulative weighted chain length is close to 4
which is the expected value for idealized normal diffusion. For smaller confine-
ments, it decreases first slightly, then rapidly.
Having validated the analysis method, we turned to the experimental data described
above. Since we detected the strongest effects for the variation of DIBO-biotin concen-
tration, we decided to analyze the steps for this experiment. Naturally, we investigated
the movement along the two Cartesian coordinates that we obtained for the trajectories
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along ~x and ~y. In Figure 7.12 the histograms for the chains with lengths from 1 to 16
are given. As it can be easily seen from the histograms, the most likely case is a chain
with length one. However, with increasing DIBO-biotin concentration, the probability
for long chains decreases. This can both be seen from the decreasing probability to
make a certain number of steps for rising DIBO-biotin concentrations as well as the
decrease in the longest observed chain which can be nicely seen in Figure 7.12b: For
example, the longest chain for 1 µM DIBO-biotin is 16, but only 9 for 75 µM DIBO-
biotin, indicating more and more confined diffusion.
Figure 7.12: Number of consecutive steps in one direction for varying DIBO-biotin concen-
trations
(a) Normalized histogram for all chains of steps. (b) Detail for longer chains. As
it can be clearly seen, the probability of longer chains decreases for increasing
DIBO-biotin concentrations.
As described for the simulated data, one can also compare the probabilities for the dif-
ferent chain lenghts to the development in case of idealized normal diffusion. For the
experimental data, the result is depicted in Figure 7.13. For all DIBO-biotin concen-
trations, the ratio between the experimentally observed frequency and the theoretical
frequency for normal diffusion is below 1 and tends to zero as it was also observed for
the simulated data. However, in contrast to the simulation, the ratio drops not steadily
to zero, but decreases first and then reaches a limit before reaching zero. This limit
decreases with increasing DIBO-biotin concentrations. This indicates that the situa-
tion in the environment of the artificial network is more complex than just confined
diffusion. One possibility would be that not all particles are completely engaged in the
network, but that some diffuse more or less normal, which elevates the ratio at longer
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chain lengths. Again, at very high chain lengths and low DIBO-biotin concentrations,
some data points do not follow the trend, which can be attributed to the low statistical
power.
Figure 7.13: Comparison of chain lengths between the experimental data and idealized nor-
mal diffusion
For all chain lengths, the ratio is well below 1 (except for very high lengths where
the statistical power is low). This indicates that all diffusion processes are strongly
deviating from normal diffusion towards confined diffusion. This tendency in-
creases for increasing DIBO-biotin concentrations.
Finally, the calculation of the cumulative weighted chain length shows increasing con-
finement for increasing DIBO-biotin concentrations (Figure 7.14). Note that the value
varies between about 2.1 and 2.7, which was for the simulated data the steepest part
of the curve.
Taken together, we could show that by analysis of the distribution of chain lengths one
can easily determine a variety of parameters that further characterize the nature of the
diffusion process. In our case, the values are fully consistent with the above described
MSD analysis and corroborate the results obtained there.
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Figure 7.14: Cumulative weighted chain length
The value of the cumulative weighted chain length decreases for increasing DIBO-
biotin concentrations, indicating stronger confinement.
7.5 Experimental Section
Cell culture: HMECs (variant 1, CDC, Atlanta, GA) were seeded in collagen coated 8-well LabTek slides
(Nunc, Rochester, NY) with a density of 1.5·104 or 1·104, respectively, in 400 µL growth medium, depen-
dent on whether the experiment was performed two or three days after seeding. The cells were cultured
in MDCB-131 medium with 1% Glutamax, 10% fetal bovine serum (FBS), 10 ng/mL hEGF (all Life
Technologies, Carlsbad, St. Louis, MO), 1 µg/mL hydrocortisone, and 1% of a penicillin-streptomycin
solution containing 10,000 U/mL penicillin and 10 mg/L streptomycin (both Sigma-Aldrich, St. Louis,
MO) at 37°C in 5% humidified CO2 atmosphere. Cells were fixed with 4% paraformaldehyde (Sigma-
Aldrich) in DPBS+Ca2+/Mg2+ (Life Technologies). Before and after fixation, it was washed three time
with DPBS+Ca2+/Mg2+.
Tagging of membrane glycans with biotin: For metabolic labeling, growth medium was supplemented with
50 µM Ac4ManNAz or Ac4GalNAz (Life Technologies) for at least two days. Cells were washed three
times with warm growth medium and incubated with 400 µL DIBO-biotin (Life Technologies) solution
at the desired concentration for one hour.
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Artificial network formation: After tagging of membrane glycans with biotin, cells were washed three
times with warm growth medium. Then, it was incubated with 350 µL SA solution at the desired con-
centration for 15 minutes. The concentration of fluorescent SA or of SA-coated QDs, respectively, was
5 · 109 M. It was washed two times with CO2-independent medium (room temperature) supplemented
with 10% FBS (both Life Technologies). For microscopy, cells were kept in CO2-independent medium
and immediately measured at room temperature (21°C) within less than one hour.
Endocytosis assay: HMECs were incubated for two days with 50 µM Ac4ManNAz, followed by incubation
with 5 or 50 µM DIBO-biotin and 0, 1.25, 2.5, or 5 µM tetravalent SA as described above. 0.75 mg/mL
10 kDa dextran-AlexaFluor647 conjugate (Life Technologies) in 400 µL growth medium was added for
15 minutes. Cells were fixed to ensure a defined time within endocytosis could occur. Then, fluores-
cence images of several cells within one confocal slice in the lower part of the cells were collected and
the fluorescence signal within the endosomes was quantified.
Fluorescence microscopy: Single molecule images were obtained with a custom-built Nikon epifluores-
cence TE200 microscope and a Nikon PlanApo100 objective, NA=1.4. Confocal images for the quantifi-
cation of endocytosis were obtained using a commercially available spinning-disk inverted microscope
from Zeiss.
Software: Images were acquired and converted to tif images with Andor SOLIS 4.9. Tracking was per-
formed with the Matlab Program uTrack.251 MSD analysis was performed with the Matlab Class @ms-
danalyzer.252 Simulations were carried out with Matlab. Images were analyzed using ImageJ. For data
visualization and analysis, OriginPro 8G was used. Figures were prepared with CorelDraw12.
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Human Cells
This chapter is based on: "Switching first contact: photocontrol of E. coli adhesion
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8.1 Abstract
We have shown previously that carbohydrate-specific bacterial adhesion to a non-
physiological surface can be photocontrolled by reversible E/Z isomerization using
azobenzene-functionalised sugars. Here, this approach is applied to the surface of
human cells. We show not only that bacterial adhesion to the azobenzene glycoside-
modified cell surface is higher in the E than in the Z state, but add data about the
specific modulation of the effect.
8.2 Introduction
Cell adhesion is a fundamental principle of biology. Many of its aspects have been
elucidated,284, 285 but the molecular details of cell interactions are not fully under-
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stood. As the first contact of cells is mediated through their glycosylated surfaces,
our research on cell adhesion is focused on carbohydrate recognition. All organisms
can recognize and distinguish between carbohydrates with the help of specialised pro-
teins, the lectins.137 Lectin function has been described in the context of, i.a., signaling,
trafficking, and quality control, thus involving indispensable processes of life.286–288
Also bacterial cells utilize their own lectins to mediate adhesion to glycosylated sur-
faces such as the membrane of the target cells.289, 290 Furthermore, bacterial adhesion
enables bacterial colonization, biofilm formation, biofouling, or it precedes infection
of cells.121, 291 Hence, investigation and control of bacterial adhesion is important,
especially in a medical context, given the high incidence rates of infectious diseases
worldwide.292
In recent years we have studied the α-d-mannoside-specific adhesion of Escherichia coli
bacteria,23, 293 which is mediated by the bacterial lectin FimH. FimH is located at the
tips of adhesive organelles, called type 1 fimbriae,294 which are projecting from the
bacterial cell surface. Previously we have shown that type 1 fimbriae-mediated bac-
terial adhesion to a non-physiological surface can be photochemically controlled. In
this specific case azobenzene-functionalised α-d-mannoside derivatives were assem-
bled on a gold surface in the form of a glyco-SAM (self-assembled monolayer).22, 295
Photochemical isomerization of the azobenzene moiety between its E and its Z state
then allowed to reversibly switch the orientation of the attached carbohydrate ligands
between two defined states. In parallel with this E/Z isomerization, the adhesiveness
of the surface was altered leading to reduction of bacterial adhesion in the Z state of
the SAM by 80 % in comparison to the E state.
While the azobenzene photoswitch is long known296 and has been used before for
switching of the properties of designer surfaces,297–300 our work on the control of bac-
terial adhesion through re-orientation of carbohydrate presentation is unprecedented.
Here it has been our goal to challenge our system in the context of cell-cell adhesion,
thus changing the artificial glyco-SAM surface against the plasma membrane of hu-
man cells. For this, we had to incorporate azobenzene mannosides in the cell surface
of live cells, effect their E/Z isomerization to switch the orientation of the attached
mannoside moieties, and to finally test the influence of this isomerization on E. coli
adhesion.
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8.3 Results and Discussion
Our experimental approach is explained in Figure 8.1: Metabolic oligosaccharide en-
gineering (MOE)148, 301 was employed to install bioorthogonal azido functional groups
on the cell surface. This allows their subsequent modification with alkyne-functiona-
lised azobenzene glycosides by well-known click chemistry.302–305 In a final step, pho-
tochemical E/Z isomerization of the installed azobenzene moiety was effected by ir-
radiation with light of the appropriate wavelength, and subsequently bacterial adhe-
sion was measured via high-resolution live-cell fluorescence microscopy. For these
experiments, human microvascular endothelial cells, variant 1 (HMEC-1) and GFP-
fluorescent type 1 fimbriated E. coli PKL1162143 were used.
Figure 8.1: Our approach of switching the adhesivity of cells.
Azido functional groups can be incorporated into cell surface glycoconjugates em-
ploying the synthetic carbohydrates Ac4ManNAz or Ac4GalNAz, respectively, ac-
cording to a known methodology called metabolic oligosaccharide engineering
(MOE). The peracetylated azido sugars are taken up by the cells (HMEC-1) (a),
and processed by the biosynthetic machinery to lead to azido-functionalization of
the cell surface (b). Bioorthgonal click chemistry then allows conjugation of the cell
surface with azobenzene glycosides (such as α-d-mannosides, αMan). Reversible
E/Z isomerization of the azobenzene moiety employing UV or visible light, respec-
tively, allows to change the orientation of the conjugated sugar. This experimental
approach allowed to test if adhesion of E. coli to live human cells can be photo-
chemically controlled.
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To install the required bioorthogonal azido functional groups on the cell surface of
HMEC-1, cells were incubated with 50 µM tetraacetylated N-azidoacetyl-d-mannosa-
mine (Ac4ManNAz, Figure 8.1). Ac4ManNAz is taken up by the cells and according to
the oligosaccharide metabolism leads to azido labelling of terminal sialic acid units of
membrane glycoproteins. When Ac4GalNAz is employed on the other hand, the azido
label is incorporated into mucin-type glycoproteins.156 For the chemical functional-
ization of the azido-modified cells, the azobenzene derivatives 5-7, carrying an alkyne
functional group were required (Scheme 1). Synthesis of the azobenzene glycosides
5 and 6 started from the known p-aminophenyl glycosides 1143 and 2,306 which were
subjected to a classical azo coupling with phenol to furnish the respective hydrox-
yazobenzene derivatives 3 and 4.307 Then, Williamson etherification with propargyl
bromide led to the desired alkyne-functionalised azobenzene glycosides 5 and 6. The
azobenzene alkyne 7 was needed as control and was directly obtained from hydroxya-
zobenzene.308 As normal, the synthesised azobenzene derivatives were obtained in the
more stable E-configuration.
Figure 8.2: Synthesis of alkyne-functionalised azobenzene glycosides and labelling of
engineered human cells (HMEC-1).
α-d-Mannosides were used as specific ligands for bacterial adhesion, whereas β-
d-glucosides and simple propargylated azobenzene (7) are needed as control com-
pounds. Azido-functionalised HMEC-1 were ligated with azobenzene (AB) deriva-
tives 5-7 in a Cu(I)-catalyzed click reaction.
First, the azobenzene α-d-mannoside 5 was conjugated to azido-functionalised HMEC-
1 after Ac4ManNAz labelling. For this reaction, 200 µM azobenzene α-d-mannoside,
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50 µM CuSO4, 250 µM tris(3-hydroxypropyltriazolylmethyl)amine, 1 mM aminoguani-
dine, and 2.5 mM sodium ascorbate in buffered saline solution were employed at 4°C
for 5 minutes according to the literature.155 Copper (I), which is produced during the
reaction, is known to exhibit toxic side effects after some time, however, we applied
conditions that were shown earlier not to be harmful for cells. Azobenzene manno-
side 5 was employed as 200 µM solution to ensure complete labelling of all azido
groups on the cell surface, based on a control experiment with a fluorescent alkyne (cf.
Figure 12.17). After labelling, cells were split into two portions. To effect E→Z iso-
merization of the conjugated azobenzene moiety, both sets of labelled HMEC-1 were
irradiated with UV light of 365 nm. Then, cells were incubated with GFP-fluorescent
E. coli (1:10 dilution of a suspension with OD600=0.1, cf. Figure 12.18, Figure 12.19,
Figure 12.20, Figure 12.21) and the number of adhered bacteria was counted employ-
ing high-resolution live-cell fluorescence microscopy. For both sets of HMEC-1 the
number of adhered bacteria is similar low at this stage, as it is expected (Figure 8.3).
In a subsequent step, only one of both cell sets was irradiated again; this time with
green light (488 nm) to reverse the initial isomerisation and thus effect Z→E isomer-
ization of the azobenzene configuration. Then, a second incubation with fluorescent E.
coli was performed as before, and adhesion again quantified by counting the number
of adhered bacterial cells. Whereas the adhesivity of the cells without a second irra-
diation treatment remained the same, a significant increase of bacterial adhesion was
measured for the cells that were irradiated at 488 nm (about 50%). We attribute this
observation to the mode of mannose orientation, which is changed with the isomer-
ization of the azobenzene hinge. In accordance with the observation made with pho-
toswitchable glyco-SAMs, the adhesivity of the azobenzene mannoside-modified cell
surface is higher in the E than in the Z state, where the carbohydrate ligand is more hid-
den. At first, the azobenzene α-d-mannoside 5 was conjugated to azido-functionalised
HMEC-1 after Ac4ManNAz labelling. For this reaction, 200 µM azobenzene α-d-
mannoside, 50 µM CuSO4, 250 µM tris(3-hydroxypropyltriazolylmethyl)amine (TH-
PTA), 1 mM aminoguanidine, and 2.5 mM sodium ascorbate in buffered saline so-
lution were employed at 4°C for 5 minutes according to the literature.155 Copper
(I), which is produced during the reaction, is known to exhibit toxic side effects af-
ter some time, however, we applied conditions that were shown earlier not to be
harmful for cells. Azobenzene mannoside 5 was employed as 200 µM solution to
ensure complete labelling of all azido groups on the cell surface, based on a con-
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trol experiment with a fluorescent alkyne (cf. Figure 12.17). After labelling, cells
were split into two portions. To effect E→Z isomerization of the conjugated azoben-
zene moiety, both sets of labelled HMEC-1 were irradiated with UV light of 365 nm.
Then, cells were incubated with GFP-fluorescent E. coli (1:10 dilution of a suspen-
sion with OD600=0.1, cf. Figure 12.18, Figure 12.19, Figure 12.20, Figure 12.21) and
the number of adhered bacteria was counted employing high-resolution live-cell flu-
orescence microscopy. For both sets of HMEC-1 the number of adhered bacteria is
similar low at this stage, as it is expected (Figure 8.3). In a subsequent step, only
one of both cell sets was irradiated again; this time with green light (488 nm) to re-
verse the initial isomerisation and thus effect Z→E isomerization of the azobenzene
configuration. Then, a second incubation with fluorescent E. coli was performed as
before, and adhesion again quantified by counting the number of adhered bacterial
cells. Whereas the adhesivity of the cells without a second irradiation treatment re-
mained the same, a significant increase of bacterial adhesion was measured for the
cells that were irradiated at 488 nm (about 50%). We attribute this observation to the
mode of mannose orientation, which is changed with the isomerization of the azoben-
zene hinge. In accordance with the observation made with photoswitchable glyco-
SAMs, the adhesivity of the azobenzene mannoside-modified cell surface is higher in
the E than in the Z state, where the carbohydrate ligand is more hidden. At first, the
azobenzene α-d-mannoside 5 was conjugated to azido-functionalised HMEC-1 after
Ac4ManNAz labelling. For this reaction, 200 µM azobenzene α-d-mannoside, 50 µM
CuSO4, 250 µM tris(3-hydroxypropyltriazolylmethyl)amine, 1 mM aminoguanidine,
and 2.5 mM sodium ascorbate in buffered saline solution were employed at 4°C for 5
minutes according to the literature.155 Copper (I), which is produced during the reac-
tion, is known to exhibit toxic side effects after some time, however, we applied condi-
tions that were shown earlier not to be harmful for cells. Azobenzene mannoside 5 was
employed as 200 µM solution to ensure complete labelling of all azido groups on the
cell surface, based on a control experiment with a fluorescent alkyne (cf. Figure 12.17).
After labelling, cells were split into two portions. To effect E→Z isomerization of the
conjugated azobenzene moiety, both sets of labelled HMEC-1 were irradiated with UV
light of 365 nm. Then, cells were incubated with GFP-fluorescent E. coli (1:10 dilu-
tion of a suspension with OD600=0.1, cf. Figure 12.18, Figure 12.19, Figure 12.20, Fig-
ure 12.21) and the number of adhered bacteria was counted employing high-resolution
live-cell fluorescence microscopy. For both sets of HMEC-1 the number of adhered
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bacteria is similar low at this stage, as it is expected (Figure 8.3). In a subsequent step,
only one of both cell sets was irradiated again; this time with green light (488 nm)
to reverse the initial isomerisation and thus effect Z→E isomerization of the azoben-
zene configuration. Then, a second incubation with fluorescent E. coli was performed
as before, and adhesion again quantified by counting the number of adhered bacte-
rial cells. Whereas the adhesivity of the cells without a second irradiation treatment
remained the same, a significant increase of bacterial adhesion was measured for the
cells that were irradiated at 488 nm (about 50%). We attribute this observation to the
mode of mannose orientation, which is changed with the isomerization of the azoben-
zene hinge. In accordance with the observation made with photoswitchable glyco-
SAMs, the adhesivity of the azobenzene mannoside-modified cell surface is higher in
the E than in the Z state, where the carbohydrate ligand is more hidden. At first, the
azobenzene α-d-mannoside 5 was conjugated to azido-functionalised HMEC-1 after
Ac4ManNAz labelling. For this reaction, 200 µM azobenzene α-d-mannoside, 50 µM
CuSO4, 250 µM tris(3-hydroxypropyltriazolylmethyl)amine, 1 mM aminoguanidine,
and 2.5 mM sodium ascorbate in buffered saline solution were employed at 4°C for 5
minutes according to the literature.155 Copper (I), which is produced during the reac-
tion, is known to exhibit toxic side effects after some time, however, we applied condi-
tions that were shown earlier not to be harmful for cells. Azobenzene mannoside 5 was
employed as 200 µM solution to ensure complete labelling of all azido groups on the
cell surface, based on a control experiment with a fluorescent alkyne (cf. Figure 12.17).
After labelling, cells were split into two portions. To effect E→Z isomerization of the
conjugated azobenzene moiety, both sets of labelled HMEC-1 were irradiated with UV
light of 365 nm. Then, cells were incubated with GFP-fluorescent E. coli (1:10 dilu-
tion of a suspension with OD600=0.1, cf. Figure 12.18, Figure 12.19, Figure 12.20, Fig-
ure 12.21) and the number of adhered bacteria was counted employing high-resolution
live-cell fluorescence microscopy. For both sets of HMEC-1 the number of adhered
bacteria is similar low at this stage, as it is expected (Figure 8.3). In a subsequent step,
only one of both cell sets was irradiated again; this time with green light (488 nm)
to reverse the initial isomerisation and thus effect Z→E isomerization of the azoben-
zene configuration. Then, a second incubation with fluorescent E. coli was performed
as before, and adhesion again quantified by counting the number of adhered bacte-
rial cells. Whereas the adhesivity of the cells without a second irradiation treatment
remained the same, a significant increase of bacterial adhesion was measured for the
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cells that were irradiated at 488 nm (about 50%). We attribute this observation to the
mode of mannose orientation, which is changed with the isomerization of the azoben-
zene hinge. In accordance with the observation made with photoswitchable glyco-
SAMs, the adhesivity of the azobenzene mannoside-modified cell surface is higher in
the E than in the Z state, where the carbohydrate ligand is more hidden. At first, the
azobenzene α-d-mannoside 5 was conjugated to azido-functionalised HMEC-1 after
Ac4ManNAz labelling. For this reaction, 200 µM azobenzene α-d-mannoside, 50 µM
CuSO4, 250 µM tris(3-hydroxypropyltriazolylmethyl)amine, 1 mM aminoguanidine,
and 2.5 mM sodium ascorbate in buffered saline solution were employed at 4°C for
5 minutes according to the literature.155 Copper (I), which is produced during the
reaction, is known to exhibit toxic side effects after some time, however, we applied
conditions that were shown earlier not to be harmful for cells. Azobenzene manno-
side 5 was employed as 200 µM solution to ensure complete labelling of all azido
groups on the cell surface, based on a control experiment with a fluorescent alkyne (cf.
Figure 12.17). After labelling, cells were split into two portions. To effect E→Z iso-
merization of the conjugated azobenzene moiety, both sets of labelled HMEC-1 were
irradiated with UV light of 365 nm. Then, cells were incubated with GFP-fluorescent
E. coli (1:10 dilution of a suspension with OD600=0.1, cf. Figure 12.18, Figure 12.19,
Figure 12.20, Figure 12.21) and the number of adhered bacteria was counted employ-
ing high-resolution live-cell fluorescence microscopy. For both sets of HMEC-1 the
number of adhered bacteria is similar low at this stage, as it is expected (Figure 8.3).
In a subsequent step, only one of both cell sets was irradiated again; this time with
green light (488 nm) to reverse the initial isomerisation and thus effect Z→E isomer-
ization of the azobenzene configuration. Then, a second incubation with fluorescent
E. coli was performed as before, and adhesion again quantified by counting the num-
ber of adhered bacterial cells. Whereas the adhesivity of the cells without a second
irradiation treatment remained the same, a significant increase of bacterial adhesion
was measured for the cells that were irradiated at 488 nm (about 50%). We attribute
this observation to the mode of mannose orientation, which is changed with the iso-
merization of the azobenzene hinge. In accordance with the observation made with
photoswitchable glyco-SAMs, the adhesivity of the azobenzene mannoside-modified
cell surface is higher in the E than in the Z state, where the carbohydrate ligand is
more hidden.
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Figure 8.3: Switching of ManAB configuration allows to control adhesion of E. coli to
HMEC-1.
After incubation of two sets of cells bearing azido groups at terminal sialic acids
with 5 in Z-configuration, the adhesion of bacteria is similar for both sets. How-
ever, photoswitching of ManAB configuration to E increases the adhesion signifi-
cantly (second incubation). If ManAB remains in Z-configuration, no increase is
observed. Error bars are given as standard error of the mean (SEM) of experiments
with four independent sets of cells/condition. *** = p < 0.001.
So far, photoswitching of the adhesivity of azobenzene mannoside-labelled cells was
investigated under static conditions. In order to investigate photoswitching of cell
adhesion in real-time, flow-based experiments132 were performed next. This has the
advantage that one can follow adhesion in real time and that testing is closer to physi-
ological conditions where flow is often present. Thus, HMEC-1 were cultivated in flow
chambers, again incubated with Ac4ManNAz and labelled with azobenzene manno-
side 5 in analogy to our experiments under static conditions. Then, a bacterial suspen-
sion (1:50 dilution of a suspension with OD600=0.1) was employed at continuous flow
with a shear rate of 1.5 dyn/cm2 a typical shear rate for microvascules). It is worth-
while to note, that the flow was not interrupted during irradiation (300 seconds). Ad-
hering bacteria were monitored by fluorescence microscopy while switching the con-
figuration of azobenzene mannosides conjugated on HMEC-1 multiple times between
E and Z (Figure 8.4). The development of the recorded bacterial GFP-fluorescence is
then a direct measure for the adhesion of E. coli.
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The obtained curves clearly show that alternating irradiation using light of 365 nm and
488 nm has a strong effect on bacterial adhesion (Figure 8.4a). After irradiation of the
flow chamber with 488 nm light, the slopes of the bacterial GFP signal are significantly
higher than after irradiation with 365 nm. This is also clearly seen after fitting of the
curves, assuming a linear development of fluorescence (Figure 8.4b). Only after several
switching events (starting at 1500 s), the measured slopes are no longer correlated with
azobenzene configuration. This can be attributed to increasing coverage of HMEC-1
with bacterial cells and more and more bacteria adhering to other to bacteria. This is
clearly seen in the obtained microscopic images (cf. Figure 12.22). Thus, when bacteria
are adhering to bacterial cells and not to HMEC-1, the adhesion is naturally not sensi-
tive to E/Z isomerization. As under static conditions, the results obtained in the flow
experiments indicate that the orientation of mannoside 5 conjugated to the surface of
HMEC-1 has a strong influence on the adhesion of bacteria. Again, the results suggest
that the bent Z form is less accessible for bacteria than the E form. Thus, adhesion is
reduced after E→Z isomerization. Next, two important control experiments were per-
formed in order to understand the observed effects in greater detail. First, the question
of carbohydrate specificity of the observed effects was addressed. Thus, the azoben-
zene derivative 7 (AB in Figure 8.5), devoid of a carbohydrate, and the β-d-glucoside
6 (cf. Figure 8.2) were employed for HMEC-1 labelling instead of the mannoside 5
which was used so far. The glucoside 6 exhibits a similar structure and polarity as
5 but is no ligand for the bacterial lectin FimH. Labelling of HMEC-1 was again per-
formed with Ac4ManAz, click chemistry carried out with 6 and 7 as before, and then
bacterial adhesion was measured after irradiation. All experiments were compared
to azido-labelled HMEC-1, which had not been reacted with either of the azobenzene
derivatives (control, Figure 8.5). These experiments show that adhesion of E. coli to
cells reacted with either 6 or 7, is significantly decreased compared to untreated cells.
This observation suggests a shielding effect for both derivatives, prohibiting bacterial
adhesion to the surface of HMEC-1 to some extent. On the other hand, this effect is not
significantly sensitive to E/Z isomerization. This finding indicates that the adhesion of
bacteria to cells treated with 5 is indeed carbohydrate-specific and results from the in-
teraction between the bacterial lectin FimH and its α-d-mannosidic ligand. Unspecific
polar interactions, e.g., do not account for bacterial adhesion. Control cells showed a
slight response to irradiation with 365 nm light, but the effects caused by 6 or 7 are
more significant. At this stage of the project, we were asking how the orientation of a
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rather small molecule (such as an azobenzene glycoside) within the complex environ-
ment of a cell’s surface can exert such a pronounced effect on cell adhesion. Hence, we
performed a second control experiment in which the azobenzene mannoside ligand is
positioned differently on the surface of HMEC-1. This is possible by labelling HMEC-1
with Ac4GalNAz instead of Ac4ManNAz. Whereas Ac4ManNAz leads to labelling of
sialic acids, which are almost exclusively found at the terminal position of cell surface
glycans, Ac4GalNAz labels mucin-type glycoproteins. These are characterised by Lac-
NAc moieties, which are localised deeper within the glycosylated cell surface.306 Inter-
estingly, bacterial adhesion to HMEC-1, labelled with Ac4GalNAz and modified with
mannoside 5 is increased in comparison to control cells. This observation can be ratio-
nalised on the increased concentration of mannoside present on the cell surface after
modification; other than in case of modification with 6 or 7, which does not change the
mannosylation pattern of HMEC-1. However, the observed increased adhesion is not
dependent on the configuration of the azobenzene moiety, thus insensitive to irradia-
tion. In this case it seems, that the orientational change of the mannoside ligand is not
effective within the complex environment of the HMEC-1 surface. As LacNAc groups
are typically not localised at terminal positions of glycans, the azobenzene mannoside
moieties might be buried under a layer of other glycoconjugates.
Taken together, we show that the azobenzene mannoside 5 can be employed to influ-
ence adhesion of E. coli to HMEC-1. We postulate the following mechanism that un-
derlies this photocontrol: i) mannose binds to FimH and serves as ligand for specific
interaction between the bacterium and the modified cell surface (cf. Ac4ManNAz+5
vs. Ac4ManNAz+6). ii) If no mannose ligand is present or if it adopts a disadvanta-
geous orientation (Z-configuration), the azobenzene groups shield the cell, leading to
reduced binding of E. coli (cf. Ac4ManNAz+5 vs. Ac4ManNAz+AB). iii) The FimH lig-
and mannose must be localised at the terminus of glycans to ensure that the change in
configuration upon a Z-E-transition is not small (Ac4ManNAz+5 vs. Ac4GalNAz+5). It
is surprising that this orientation effect can be found not only on an artificial, ordered
glyco-SAM as we described before, but even in the complex, in comparison rather
chaotic setting of the cell surface. Of course, this finding bears implications for the
way how cells recognize and are affected by their environment. Further experiments
will have to investigate how the exact processes and consequences of e.g. orientational
variances are, but we hope that our work is a first step in this direction.
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Figure 8.4: Adhesion of E. coli to switchable cell surfaces under flow.
a) The azobenzene 5 was switched several times between Z and E while flowing a
continuous stream of bacteria solution over the cells. The adhesion of bacteria was
lower if 5 was in Z-configuration. Only after several switching cycles this tendency
was no longer observed, caused by increasing coverage of the cells with bacteria,
leading to a high amount of adhering to other bacteria and not to the cell surface.
During irradiation with 365 nm (light grey bars) or 488 nm (dark grey bars), the
flow was not stopped. b) The slopes of linear curves that were fitted to the data of
the middle panel clearly resembles the effect of the reversible switching. Error bars
are given as SEM of the fitting. For easier comparison, the slopes are set to start at a
common origin by subtraction of the fluorescence intensity of the first frame from
the subsequent frames.
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Figure 8.5: Control experiments.
If the azobenzene lacks a mannose group (AB, left) or exhibits a glucose group
to which FimH cannot bind specifically (GlcAB, middle), adhesion is reduced in
comparison to control cells independent of the configuration of the azobenzene,
indicating a shielding effect of AB and GlcAB. If ManAB is attached to mucin-type
proteins (right) and hence not at the terminal position of glycans, the adhesion is
increased but not dependent on the configuration of the azobenzene. Errors are
given as SEM. Experiments were carried out with four independent sets of cells for
each condition. * = p < 0.1, ** = p < 0.01, *** = p < 0.001
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8.4 Experimental Section
General methods: Analytical thin layer chromatography (TLC) was performed on silica gel plates (GF
254, Merck). Visualization was achieved by UV light and/or with 10% sulfuric acid in ethanol followed
by heat treatment at 180°C. Flash chromatography was performed on silica gel 60 (Merck, 230-400
mesh, particle size 0.040-0.063 mm) by using distilled solvents. Melting points (mp) were determined
on a Büchi M-56 apparatus. Optical rotations were measured with a Perkin-Elmer 241 polarimeter
(sodium D-line: 589 nm, length of cell: 1 dm) in the solvents indicated. Proton (1H) nuclear magnetic
resonance spectra and carbon (13C) nuclear magnetic resonance spectra were recorded on a Bruker
DRX-500 and AV-600 spectrometer. Chemical shifts are referenced to the residual proton of the NMR
solvent. Data are presented as follows: chemical shift, multiplicity (s=singlet, d=doublet, t=triplet,
q=quartet, m=multiplet, and br=broad signal), coupling constant in hertz (Hz) and, integration. Full
assignment of the peaks was achieved with the aid of 2D NMR techniques (1H/1H COSY and 1H/13C
HSQC. All NMR spectra of the E-isomers of the azobenzene derivatives were recorded after they were
kept for 16 h in the dark at 40 °C. Infrared (IR) spectra were measured with a Perkin Elmer FT-IR
Paragon 1000 (ATR) spectrometer and were reported in cm-1. ESI mass spectra were recorded on an
Esquire-LC instrument from Bruker Daltonics. UV-vis absorption spectra were performed on Perkin-
Elmer Lambda-241 at a temperature of 20 °C ± 1 °C.
Bacterial Culture: E. coli (strain pPKL1162) were inoculated in LB medium (10 mL) (Sigma-Aldrich, St.
Louis, MO) in presence of chloramphenicol (50 mg/L) and ampicillin (100 mg/L) (both Sigma-Aldrich)
and grown at 37°C overnight under constant agitation. Then, the bacteria were centrifuged and washed
two times with DPBS +Ca2+/Mg2+ (Life Technologies, Carlsbad, St. Louis, MO) and once with cell
medium. Then, the bacteria were resuspended in cell medium (10 mL) and the optical density at 600
nm was determined. For the experiments under static conditions, a 1:10 or 1:20 dilution of a suspension
with OD600=0.1 was used. Under flow conditions, the dilution was 1:50.
Cell Culture: HMEC-1 (CDC, Atlanta, GA) were seeded in collagen coated 8-well LabTekII-slides (Nunc,
Rochester, NY) or in collagen coated Luer I0.8 channels (IBIDI, Martinsried, Germany) and grown to con-
fluency. The cells were cultured in MDCB-131 medium with 1% glutamax, 10% FBS, hEGF (10 ng/mL)
(all Life Technologies), and hydocortisone (1 µg/mL) (Sigma-Aldrich) at 37°C in 5% CO2-atmosphere.
Fluorescence Microscopy: Confocal fluorescence images were obtained with a commercially available
spinning-disk inverted microscope (Zeiss).
Software: Images were analyzed using ImageJ. For data visualization and analysis, OriginPro 8G was
used. Figures were prepared with Corel Draw 12.
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9.1 Abstract
We investigated the properties of four E. coli adhesion inhibitors under static and un-
der flow conditions. On mannan-covered model substrates and under static condi-
tions, all inhibitors were able to almost completely abolish lectin-mediated E. coli ad-
hesion. On a monolayer of living human microvascular endothelial cells (HMEC-1),
the inhibitors reduced under static conditions adhesion as well, but a large fraction
of bacteria still managed to adhere even at highest inhibitor concentrations. In con-
trast, under flow conditions E. coli did not exhibit any adhesion to HMEC-1 already at
inhibitor concentrations where significant adhesion was detected under static condi-
tions. This indicates that the presence of shear stress strongly affects inhibitor proper-
ties and must be taken into account when evaluating the potency of bacterial adhesion
inhibitors.
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9.2 Introduction
The adhesion of bacteria to surfaces is one of the key steps in processes where bacteria
exhibit pathogenic effects. Examples include harmful triggering of cellular signaling
cascades,309 invasion of host cells,310 or biofilm formation.311 One of the most com-
mon infectious diseases caused by bacterial adhesion are urinary tract infections (UTI).
It is estimated that every second woman and 5% of the male population suffers from
a UTI at least once in their lifetime. Uropathogenic E. coli (UPEC) are the primary
reason for these infections.312 The first contact between the eukaryotic cell and the
bacterium, crucial for the subsequent development of the disease, is mediated by ad-
hesive organelles anchored on the outer membrane and projecting from the surface of
UPEC. These so-called fimbriae consist of various protein units with a lectin domain
at the very end. One of the best characterized fimbriae and among the most important
virulent factors of E. coli are the type 1 fimbriae. Their associated lectin is FimH which
is specific for α-d-mannosides. FimH is known to bind to high-mannose type oligosac-
charides of the glycocalyx of eukaryotic cells. Multivalency of this specific protein-
carbohydrate interaction leads to adhesion of bacterial cells.313 To fight bacterial in-
fections like UTI, antibiotics are commonly used. However, one of the main problems
resulting from the widespread use of antibiotics is the appearance of resistant bacte-
rial strains.314 An alternative therapeutic strategy against bacterial infection is an an-
tiadhesion therapy315 in which carbohydrate inhibitors are employed to prevent bac-
terial adhesion. Numerous FimH antagonists have been developed for the inhibition
of type 1 fimbriae-mediated bacterial adhesion.140, 143, 316 Recently, bioisosters glyco-
sides were shown to be promising drugs against UI.317 In spite of the unquestionable
success of the antiadhesion approach, antiadhesion therapy has not yet led to general
solutions against infectious diseases. The reason might be that it is still challenging to
consider all different aspects of a complex natural environment in the development of
antiadhesives. Typically inhibitors of bacterial adhesion are evaluated in a microtiter
plate-based assay under static conditions (Figure 9.1A). However, a glycosylated mi-
croplate or any other artificial glycoarray cannot resemble the full complexity of a cell
surface. Thus it is important to also test the potency of, here, FimH antagonists in cell-
based assays (Figure 9.1B).318 In addition, natural conditions of cell-cell interactions
are characterized by flow and shear stress, respectively.30 Flow is a critical parameter
in bacterial adhesion as it has been described for the bacterial lectin FimH that it exerts
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so-called catch bonds under flow.319 In catch bonding, FimH ligands are bound more
tightly as a consequence of an allosteric process, in which FimH adopts a conformation
of increased mannose affinity.320 Although adhesion of bacteria under shear stress has
been investigated since some time,321–324 the influence of shear stress on inhibition of
bacterial adhesion is not yet in the focus of research.325 Therefore, we commenced a
study to compare the effect of FimH antagonists in an artificial environment, that is a
microtiter plate-based adhesion inhibition assay, with a cell-based assay under physio-
logical conditions (Figure 9.1C). As bacterial adhesion under physiological conditions
is almost never static, it is important to compare inhibition of bacterial adhesion un-
der static conditions with testing under flow. An improved knowledge of inhibition of
cell adhesion processes will eventually facilitate the development of new antiadhesive
inhibitors.
Figure 9.1: En route from artificial to natural.
The mannose-specific fimbriae-mediated adhesion of bacterial cells to surfaces de-
pends on the conditions. (A) Adhesion to artificial surfaces such as mannan-coated
microtiter plates has been regularly used to evaluate the potency of sugar inhibitors
under static conditions. (B) In bacterial adhesion to the glycosylated surface of hu-
man cells (HMEC-1) inhibitors compete with a more complex carbohydrate envi-
ronment. (C) Under natural flow conditions, shear forces activate catch bonding of
the bacterial lectins and thus, for inhibitors of bacterial adhesion different poten-
cies might be found than under static conditions.
For our study, four known α-d-mannosides with interesting properties as inhibitors
of type 1 fimbriae-mediated adhesion of E. coli were selected (Figure 9.2). Based on
their IC50 values as inhibitors of bacterial adhesion to a mannan-coated polystyrene
model surface (microplate), we were interested to measure their inhibitory potency in
a more physiological environment by testing their ability to shut down E. coli adhesion
on a monolayer of human microvascular endothelial cells, variant 1 (HMEC-1). In
an important third step the static testing conditions were changed to flow conditions
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to investigate how the presence of shear stress affects the potency of the inhibitors to
abolish E. coli adhesion.
Figure 9.2: Structures of FimH ligands 1-4, employed for inhibition of type 1 fimbriae-
mediated bacterial adhesion.
9.3 Results and Discussion
9.3.1 Inhibition of E. coli adhesion to mannan surfaces under
static conditions
All four mannosides under investigation, 1-4, were tested in parallel using the well-
known adhesion-inhibition assay.143 Bacteria which express GFP where used to cor-
relate the fluorescent intensity, recorded with a microplate reader, with the bacterial
adhesion. In every assays methyl α-d-mannoside (MeMan) was tested in parallel as
reference inhibitor. From the obtained fluorescence data and the resulting sigmoidal
inhibition curves (cf. Figure 12.23) we determined IC50 values and the corresponding
RIP (relative inhibitory potential, based on MeMan). For all tested inhibitors, the RIP
value was larger than 1 (Table 9.1). Thus, all tested inhibitors were more potent as in-
hibitors of type 1 fimbriae-mediated bacterial adhesion to mannosylated surfaces than
the standard MeMan.
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Table 9.1: Inhibition of type 1 fimbriae-mediated E. coli adhesion to mannan-coated mi-
crotiter plates.
IC50 and RIP values are averaged from mean values from three independent tests.
SD: standard deviation
Inhibitor IC50 [µM (SD) RIP (SD) total inhibition (%)
pAPMan (1) 321 (0.23) 25.4 (0.02) 98 %
OctylMan (2) 124 (0.87) 62.7 (0.79) 98 %
ThiahexMan (3) 3120 (1.23) 2.1 (0.37) 94 %
SAMan (4) 6.65 (0.75) 1169.3 (2.46) 96 %
The measured potencies are in accordance with reported data.140, 143, 326, 327 Due to
the aromatic aglycone, mannosides 1 and 4 are 25 times and almost 1200 times more
potent inhibitors of type 1 fimbriae-mediated bacterial adhesion than MeMan. In par-
ticular the special potency of 4 has been reported and explained earlier.328, 329 Thia-
hexMan is the weakest of the tested four. Interestingly, OctMan (2) is the best inhibitor
in the tested series which might be due to micelle formation. Glycomicelles can ex-
ert multivalency effects, leading to improved inhibitory potency of this compound.279
Overall, the inhibitor potencies decrease in the order of 4>2>1>3. All four manno-
sides could inhibit bacterial adhesion to mannan by almost 100 % at concentrations
5 mM with the exception of ThiahexMan which leaves 5 % of adhered unaffected
until even at a concentration 200 mM.
9.3.2 Inhibition of E. coli adhesion to HMEC-1 under static
conditions
Inhibition of E. coli adhesion to a mannan surface has shown once again, that manno-
sides 1-4 are antagonists of FimH. Next, we went on to test their inhibitory power un-
der physiological conditions, i.e. using cells. Mannosides 1 and 4 were tested earlier as
inhibitors of bacterial adhesion to the human colorectal cancer cell line HT-29 cells.318
Here, we used immortalized human microvascular endothelial cells (HMEC-1) which
are closer to the physiological situation. Hence, HMEC-1 were cultivated in 96-well
plates and incubated with a suspension of E. coli in presence of the four inhibitors
1-4. Each concentration for each inhibitor was tested in four independent wells. In-
hibitor concentrations were chosen around the IC50-value determined in the adhesion
inhibition assays with mannan-coated microtiter plates. Thus 1-4 were employed 0.1-
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10 mM, 0.05-0.5 mM, 0.5-20 mM, and 0.001-1 mM. This time, bacterial adhesion was
investigated using high-resolution live cell microscopy and the inhibitory potencies of
the employed mannosides was determined by counting adhered bacteria after inhibi-
tion and washing (cf. Figure 12.24 for example images). As negative controls, two sets
of cells were employed: On the one hand, untreated HMEC-1; and on the other hand,
HMEC-1 treated with the highest DMSO concentration occurring in the experiments.
This was done because for live-cell experiments, inhibitor stock solutions in DMSO
were prepared. For both sets of controls, bacterial adhesion was identical. We hence
defined the ratio between cells treated with inhibitors and control cells as the relative
adhesion. The results are shown in Figure 9.3.
Figure 9.3: Adhesion of E. coli to HMEC-1 under static conditions.
All four inhibitors are able to reduce adhesion of E. coli to HMEC-1, visible from
the lower relative adhesion. However, for none of the inhibitors the relative adhe-
sion reaches 0. It remains constant at a relative adhesion of about 0.2. Errors are
given as standard error of the mean (SEM). Each bar represents the mean of four
independent wells.
From these results it can be seen that the relative inhibitory potencies of the four tested
mannosides show similar ranking as inhibitors of E. coli adhesion to HMEC than of E.
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coli adhesion to mannan: 4≈2>1>3. At the fourth tested concentration of 15 mM for
2, it did not stay in solution when dissolved in cell medium, which is why the respec-
tive bar is not depicted here. As usual for experiments with life cells, error bars are
relatively large, larger than those obtained with the mannan-coated polystyrene sur-
face: Nevertheless, it can be clearly seen that the relative adhesion settles at a value of
about 0.2 in all cases. This implies that adhesion is even at highest inhibitor concen-
trations not completely abolished. In any case, a 20 % fraction of bacteria compared to
control cells remained adhering even when inhibitory mannosides much higher than
the IC50-value were applied. Since the residual bacterial adhesion is not dependent
on the inhibitor concentration, it is reasonable to attribute his effect to interactions
between bacterial surface structures the surface of HMEC. Considering that in the ar-
tificial environment of a microtiter plate unspecific, non-FimH dependent interactions
are deliberately minimized, it is not astonishing that they play a much bigger role in
the very complex setting of the cell surface.330 Thorough washing of the samples in or-
der to remove unspecifically adhered bacteria did not change the situation. Although
we extensively rinsed the samples to remove residual bacterial adhesion, the fraction
of remained bacteria stayed the same. We were interested to see if constant flow con-
ditions would change the situation.
9.3.3 Inhibition of E. coli adhesion to HMEC-1 under flow
Bacterial adhesion to eukaryotic cells under physiological conditions normally occurs
under flow. We therefore moved to a flow-based setup where E. coli are streamed at
a physiological shear rate of 1.5 dyn/cm2 continuously over HMEC-1 in presence or
absence of inhibitors. Due to the characteristics of the flow setup, we had to inves-
tigate slightly higher inhibitor concentrations than under static conditions, however,
the tested concentration ranges overlap in both cases. Bacterial adhesion was again
followed via fluorescence microscopy (cf. Figure 12.25 for example images). The in-
crease of the recorded fluorescence signal is a direct measure for the bacteria adhering
over time: The more bacteria adhere, the faster the signal rises. We evaluated this
development by fitting a straight line to the obtained curves and calculated its slope,
representing the adhesion rate for this condition. Analogous to the static condition,
the relative adhesion was defined as the ratio between the slope of treated cells and
untreated cells. Of course, for the investigation of one inhibitor a single bacterial sus-
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pension was used where inhibitor solution was added to yield the respective concen-
trations in order to exclude any variations in adhesion due to different concentrations.
Under these conditions, we expected unspecific adhesion to be reduced. The results
are depicted in Figure 9.4.
Figure 9.4: Adhesion of E. coli to HMEC-1 under flow conditions.
For inhibitor concentrations that could not abolish bacterial adhesion under static
conditions, adhesion was under flow close to zero and remained at this level also
for the higher concentrations. It is clearly visible that the relative adhesion is close
to zero for all four inhibitors already at these concentrations. Errors are given as
the SEM of the fit.
The strong effect of shear stress on the effect of the inhibitors on bacterial adhesion is
evident. For all investigated inhibitor concentrations, adhesion was almost completely
abolished under shear stress. This can be attributed to a significantly lower unspecific
binding: Under the continuous force generated by the shear stress, bacteria are only
able to adhere when they can form specific interactions between FimH and mannose
groups on the cell surface. If they are blocked by an inhibitor, the unspecific interac-
tions that are sufficient to retain the bacteria on the cells under static conditions are
not strong enough to prevent the bacteria from being washed away by the flow.
Taken together, we could show that the potency of the tested four E. coli adhesion
inhibitors is strongly affected by the presence of shear stress. Under static conditions
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and on a model substrate, inhibitors are able to abolish bacterial adhesion almost com-
pletely whereas they are only able to diminish adhesion on a monolayer of HMEC-1.
A significant amount of E. coli is able to adhere to the cells even at very high inhibitor
concentrations, presumably due to unspecific interactions. In contrast, the presence of
shear stress strongly decreased unspecific adhesion. At inhibitor concentrations where
significant adhesion was detected under static conditions, adhesion was shut down
completely under flow conditions. We would like to point out that this finding has
consequences for the evaluation of inhibitor potencies: Whenever they are determined
under static conditions whereas the physiological state exhibits flow conditions or the
other way around, it is based on our results possible that the obtained values do not
correspond to the actual values. Therefore, it is of high relevance to investigate in-
hibitor potencies not only under static, but also under flow conditions.
Taken together, our experiments show that bacterial adhesion to human cells occurs
in a complex setting where a variety of factors interfere with each other. This has
consequences for the evaluation of inhibitor potencies. Normally, the assessment is
performed in a simplified, clearly defined and artificial environments to yield repro-
ducible and robust results. Although this is a powerful method to investigate new
inhibitors and rank their potencies, our results strongly suggest that the actual perfor-
mance under physiological conditions is very likely to deviate. Therefore, it is based
on our findings crucial to not only investigate inhibitors of bacterial adhesion in an
idealized environment, but also in realistic settings in order to judge their potency cor-
rectly and elucidate the underlying mechanisms. We hope that our experiments are a
first step in this direction.
9.4 Experimental Section
Selection and synthesis of inhibitors: Structures of the employed FimH antagonists are depicted in Fig-
ure 9.2. They differ with regard to their aglycon. The aromatic moiety of p-aminophenyl mannoside 1
(pAPMan) is known to improve FimH affinity based on ππ-stacking with the lectin’s tyrosine residues
Y48 and Y137, which are located at the entrance of the carbohydrate binding site of the lectin FimH due
to its affinity promoting aglycon.139 The octyl mannoside 2 (OctMan) resembles an example of a series
of potent alkyl mannosides.140 In addition, the octly group was shown to form glycomicelles in solution
which might result in multivalency effects in inhibition of bacterial adhesion. The 6-amino-thiahexyl
mannoside 3 (ThiahexMan) was recently shown to be toxic when applied in high concentrations (> 12.5
mmol).326 Fially, the squaric acid derivative 4 (SAMan) completes the selection of tested mannosides. It
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has been reported to exceed the inhibitory potency of 1 by a factor of 16 due to its affinity promoting
aglycon.328 All inhibitors were synthesized according to known procedures.139, 323–325, 327–329, 331, 332
The obtained analytical data were in full accordance with those reported.
Bacterial culture: GFP-fluorescent E. coli (strain pPKL1162)143 were inoculated in 10 mL LB medium
(Sigma-Aldrich, St. Louis, MO) in presence of chloramphenicol (50 mg/L) and ampicillin (100 mg/L)
(both Sigma-Aldrich) and grown at 37◦C overnight under constant agitation. For the inhibition on
mannan surfaces the bacteria were centrifuged and washed with PBS two times. Then, a suspension
with OD600=0.4 in PBS was prepared for further use. For the inhibition on HMEC-1 the bacteria were
centrifuged and washed two times with DPBS +Ca2+/Mg2+ (Life Technologies, Carlsbad, St. Louis, MO)
and once with cell medium. Then, the bacteria were suspended in 10 mL cell medium and the optical
density at 600 nm was determined. For the experiments under static and under flow condition, a 1:50
dilution of a suspension with OD600=0.1 was used.
Cell culture: HMEC-1 (CDC, Atlanta, GA) were seeded in 96 well microtiter plates (Corning, Corning,
NY) or in collagen coated Luer I0.8 channels (IBIDI, Martinsried, Germany) and grown to confluency.
The cells were cultured in MDCB-131 medium with 1 % glutamax, 10 % FBS, 10 ng/mL hEGF (all Life
Technologies), and 1 µg/mL hydrocortisone (Sigma-Aldrich) at 37◦C in 5 % CO2-atmosphere.
Inhibition of bacterial adhesion: Inhibition on mannan surfaces. Mannan coated 96 well microtiter plates
(Nunc) were blocked with a solution of PVA (1 % in PBS) for 2 hours with 200 rpm at room temperature.
The inhibitors were dissolved in PBS and added in a serial dilution. The bacterial solution was added
and the plates were incubated at 37◦C with 100 rpm for 1 hour. The plates were washed with PBS (3 x
300 µL/well) and the fluorescence intensity was determined.315
Inhibition under static conditions on HMEC-1: Cells were grown to confluency in 96-well plates (Corning).
A 1:50 dilution of E. coli was prepared, inhibitors at the respective concentrations were added, and it
was incubated for 20 minutes. The medium was removed from the cells and 200 µL of the bacteria
suspension was added. It was incubated for 30 minutes at 37◦C on a shaker (400 rpm). Then, it was
washed with 200 µL DPBS +Ca2+/Mg2+ (Life Technologies) for 20 minutes (37◦C, 400 rpm). The DPBS
was removed and replaced by CO2-independent medium (Life Technologies).
Inhibition under flow conditions on HMEC-1: Cells were grown to confluency in Luer I0.8 channels (IBIDI).
For each inhibitor, a single suspension was used. First, bacteria (1:50 dilution of a suspension with
OD600=0.1) were flown over the cells without inhibitor (shear rate=1.5 dyn/cm2). Then, the channel
was changed and inhibitor was added to the respective concentration. Afterwards, the channel was
changed again and inhibitor was added to the next concentration and so on.
Fluorescence microscopy: Confocal fluorescence images of the GFP-fluorescing bacteria were obtained
with a commercially available spinning-disk inverted microscope (Zeiss).
Software: Images were analyzed using ImageJ. For data visualization and analysis, OriginPro 8G was
used. Figures were prepared with Corel Draw 12.
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10.1 Introduction
Already shortly after the discovery of the endothelial glycocalyx, it has been assumed
that it fulfills a barrier and/or filter function for metabolites, small molecules, and
ions. Considering that it is up to several hundreds of nanometers thick, this seems to
be a reasonable assumption. Indeed, it has been shown that the glycocalyx excludes
certain molecules like albumin or dextrans.
However, the term "barrier" is also related to defense against toxic species. Among
others, certain nanometer-sized particles seem to easily penetrate cells and cause un-
wanted, possibly harmful reactions. Since they are also often found in the blood
stream, we decided to investigate whether the endothelial glycocalyx is able to pro-
tect endothelial cells from nanoparticle entry. For this, we decided to use fluorescently
labeled, 50 nm sized particles of two different types: On the one hand, we employed
amino-functionalized particles, on the other hand carboxy-functionalized. The first
have been described to be harmful for cells and cause stress and apoptosis whereas the
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latter have been reported to be inert and not to affect cells. Also, we decided to use
a cell-based in vitro assay employing human umbical vascular endothelial cells (HU-
VECs). They are cells quite close to the physiological case and have also been reported
to express a glycocalyx in vitro.
10.2 Results and Discussion
First, we wanted to demonstrate that HUVECs indeed express a glycocalyx under the
conditions we applied. For this, we cultured HUVECs one, three, five, seven, and ten
days after seeding with medium exchange every two days. After this, cells were fixed
and immunostaining against heparan sulfate, one of the central components of the
glycocalyx, was performed. The result is given in Figure 10.1. It is evident that the flu-
orescence intensity is very low after one day of incubation, then increases, and remains
constant after five days. This indicates that in our setting glycocalyx components are
indeed expressed and that this process takes about five days.
Figure 10.1: Development of heparan sulfate expression on HUVECs cultured for the indi-
cated time.
Clearly, after one day, almost no heparan sulfate signal is detected. However, it
increases gradually and remains approximately constant from five days culture
time onwards. Therefore, the key glycocalyx component heparan sulfate is ex-
pressed within several days in our setting.
Contrast settings equal for all images. Scale bar = 50 µm.
Having shown that HUVECs indeed express a glycocalyx, we investigated its effect on
the internalization of the amino- and carboxy-nanoparticles. For this, we incubated
HUVECs cultured for ten days for 24 h with 0.5, 1, or 5 µg/mL particles. To ana-
lyze the effect of the glycocalyx, we applied a cocktail of heparinase III (2U/mL), neu-
raminidase (0.83 U/mL), and hyaluronidase (25 U/mL) in cell medium for 1 h before
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incubation with particles. These enzymes cleave of the three main glycocalyx compo-
nents. The result of the quantification of intracellular fluorescence originating from
internalized particles is given in Figure 10.2. Representative images can be found in
Figure 10.3.
Figure 10.2: Uptake of amino- and carboxy-nanoparticles into HUVECs in presence and ab-
sence of the glycocalyx.
Both particle types enter HUVECs and sufficiently high concentrations. Amino-
particles show higher internalization rates than carboxy-particles. However, in
presence of the glycocalyx, the uptake is for both particle types lower. Each trip-
licate is shown separately. In each triplicate, four individual wells of a 96-well
plate were investigated.
As it can be clearly seen from the quantification, both particle types are internalized.
However, there are differences between the two types and also between the cells with
intact and with shedded glycocalyx: The amino-particles generally show higher inter-
nalization than the carboxy-particles. This is expected since amino-particles are rather
positively charged in cell medium whereas carboxy-particles are negatively charged.
Since many glycocalyx components carry negatively charged functional groups like
sulfates, amino-particles should exhibit a higher affinity in comparison to carboxy-
particles. However, for cells with intact glycocalyx, the uptake is for all concentrations
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Figure 10.3: Representative Images of Uptake of amino- and carboxy-nanoparticles into
HUVECs in presence and absence of the glycocalyx.
It can be clearly seen that for both particles the amount of internalized particles
is much higher when the glycocalyx is shedded (bottom tow) in comparison to the
intact glycocalyx (top row). Also, amino-particles are internalized stronger than
carboxy-particles. Contrast settings are equal for each particle type. Scale bar =
100 µm.
and for both particle types significantly lower than for cells with shedded glycocalyx.
Especially, this can be seen for carboxy-particles which are practically not internalized
if the glycocalyx is present, but significantly when the glycocalyx is shedded. From
these results we conclude that the endothelial glycocalyx indeed functions as a barrier
against nanoparticle uptake.
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11.1 Abstract
We report the development of dendritic siRNA nanostructures that are able to pene-
trate even difficult to transfect cells such as neurons with the help of a special receptor
ligand. The nanoparticles elicit strong siRNA responses, despite the dendritic struc-
ture. An siRNA dendrimer directed against the crucial rabies virus (RABV) nucleopro-
tein (N protein) and phosphoprotein (P protein) allowed the suppression of the virus
titer in neurons below the detection limit. The cell-penetrating siRNA dendrimers,
which were assembled using click chemistry, open up new avenues toward finding
novel molecules able to cure this deadly disease.
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11.2 Introduction
RNA interference is a powerful tool that allows the sequence-specific suppression of
gene expression by small interfering RNAs (siRNAs).162, 334, 335 The major obstacle
preventing the widespread use of siRNA-based therapeutics is the lack of efficient,
specific, and nontoxic delivery systems to transport siRNA duplexes into cells and
tissue.168, 336 Commonly used siRNA-delivery vehicles, such as liposomes or cationic
polymeric systems, are heterogeneous in size and composition, and severe cytotoxic
effects are observed in sensitive cell types such as neurons.176, 337–342 Recently we re-
ported the ability of all-cis-configured anandamide (arachidonoylethanolamin, AEA)
to target siRNA to cannabinoid receptors, thus leading to the efficient receptor-me-
diated internalization of the siRNA-AEA adducts.343 As cannabinoid receptors are
expressed on immune and neural cells, this approach enables the efficient delivery of
siRNAs into these sensitive cell types.32, 177, 178
Figure 11.1: A dendritic siRNA nanostructure with an anandamide targeting unit.
The siRNA passenger strands are covalently connected to a dendritic framework,
while the siRNA guide strands are hybridized to the nanostructure.
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One important problem associated with receptor-mediated siRNA uptake is the lim-
ited expression of some receptors on cell surfaces. This leads to the rapid saturation
of receptors, which limits the amount of siRNA that can be delivered. Here, we show
that one AEA ligand is able to induce the receptor-mediated uptake of dendritic siRNA
nanostructures with up to nine siRNA duplexes per ligand. Efficient RNA silencing is
thus observed despite the complex structure (Figure 11.1). In principle this allows us
to circumvent the saturation effect and to extend the uptake of siRNA.
11.3 Results and Discussion
A click-chemistry-based approach enabled the efficient synthesis of the required mo-
nodisperse siRNA nanostructures (see Figure 11.1).[6] The synthetic strategy that en-
abled the assembly of the siRNA structures is depicted in Figure 11.2.
The starting material pentaerythritole was converted to the corresponding triazide 1
in two steps. Compound 1 was next reacted with mono-Boc-mono-Ts-functionalized
tetraethyleneglycole 2, which provided the key branching molecule 3. Using CuI-
catalyzed click reactions, compound 3 was extended with the additional alkyne-con-
taining branching molecules 4 and 5, which were both obtained in two steps (Fig-
ure 11.2). The tosylates 6 and 7 were next converted into the corresponding azides 8
and 9. Subsequently, we cleaved the Boc groups in 3, 8, and 9 and reacted the amines
with arachidonic acid. These reactions provided the dendritic anandamide azides 10,
11, and 12. The products of this reaction were next connected to the alkine-modified
siRNA passenger strands using a CuI-catalyzed click reaction to give the dendritic nu-
cleic acid nanostructures.344–349 In all three cases we obtained one main product after
the click reaction. These compounds were isolated using reversephase semipreparative
HPLC. The correct structure and monodispersity of the dendritic siRNA assemblies
was next confirmed by analytical HPLC and MALDI-TOF-analysis (for two examples,
see Figure 11.3). In all cases, we obtained the dendritic structures in excellent purity.
The correct molecular weights were obtained within the experimental limits of the
MALDI-TOF measurements, proving the expected monodispersity of the nanoparti-
cles. The final siRNA dendrimers ready for transfection were obtained by hybridizing
the corresponding numbers of guide strands to the dendritic structures.
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To investigate the biological activity of the siRNA dendrimers, we utilized a reporter
assay in RBL-2H3 cells.343, 350 As depicted in Figure 11.4, all prepared siRNA den-
drimers dendrimers showed strong silencing effects. For the experiments, we kept
the amount of siRNA duplexes constant by reducing the concentration of the den-
dritic structure to the reciprocal of the number of siRNA duplexes per nanoparticle.
The dendrimer AEA-[3siRNA] with three siRNA strands attached showed by far the
strongest silencing effect, even though the concentration of the dendrimer was re-
duced to one third compared to the anadamide-functionalized siRNA duplex. Sur-
prisingly, even the dendrimer AEA-[9siRNA] showed a strong efficacy compared to
the monomeric siRNA, despite its large size and the small total concentration (Figure
3).
The 3’ end of the siRNA guide strand allows further functionalization.351, 352 This
modification can stabilize the RNA inside the cell, which should lead to a better si-
lencing effect.349, 353, 354 In order to exploit this possibility, we next functionalized the
siRNA duplexes of the dendrimers with a glucose molecule at the 3’ ends.355 Glu-
cose forms H-bonds with the RNA duplex and increases the water solubility. The in-
troduction of the 3’ modification was achieved by hybridizing the passenger-strand-
containing dendrimers with the corresponding glucose-modified guide strands. In-
deed, the glucose-end-capped dendrimers showed a significantly enhanced efficacy. It
is likely that the large siRNA dendrimes suffer from serious degradation in the endo-
somes after internalization.353, 356 This may be retarded by glucose capping.357 The
advantage of capping of the trimeric siRNA dendrimer is quite large, as shown in Fig-
ure 3B. The threefold glycosylated structure finally gave a silencing effect of approx-
imately 80%. Thus, in comparison to the monomeric duplex, the silencing efficiency
was increased by a factor of 2.5, despite the reduced total concentration. We next in-
vestigated the possibility of utilizing the dendritic siRNA structure to induce silencing
in difficult to transfect cells such as neurons (Figure 4). Consequently, we tested the
uptake of the nanoparticles into neural stem cells. We prepared siRNA dendrimers in
which we replaced the glucose units at the 3’ end of the guide strand by Alexa Flour
647. Indeed, when we added the fluorophore-modified siRNA trimer to the neural
stem cells, efficient uptake was detected by confocal microscopy (Figure 4A).
In order to prove the ability of the siRNA dendrimers to silence an endogenous gene,
we next transfected the neural stem cells with a trimeric siRNA dendrimer target-
ing Tet1. This enzyme was recently shown to oxidize 5-methylcytosine to 5-hydroxy-
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methylcytosine and 5-carboxycytosine, which is essential for the differentiation pro-
cess.358–360 Using qPCR, we monitored the expression level of Tet1 (Figure 4 B). In-
deed, the siRNA dendrimer led to a significant reduction of the level of endogenous
Tet1 expression, proving the effect of the siRNA despite it being incorporated into a
dendritic structure. Again, we observed the strongest silencing effect with the trimeric
siRNA structure. Finally we were interested in the ability of our dendritic siRNA struc-
tures to exhibit a medicinally relevant function in primary neurons that are hard to
transfect by normal methods.341, 361 As a target, we chose the neurotropic rabies virus
(RABV), which causes over 55000 deaths per year and is not treatable after the on-
set of clinical symptoms.362, 363 For this study, we infected mouse E14 cortical neu-
rons with the RABV and subsequently treated the cells with two siRNA dendrimers
(AEA-[3siRNA]-Glc) against the mRNAs of the viral nucleoprotein (N protein) and the
phosphoprotein (P protein). The siRNA sequences were designed in silico using the
program siDESIGN. Both proteins are essential for viral transcription and replication
and are therefore considered promising targets to efficiently counteract RABV infec-
tion.364–367 In addition, the P protein of RABV is an important antagonist of the in-
nate immune system, completely suppressing both IFNb induction and signaling path-
ways.368, 369 Down-regulation of P protein expression should consequently promote
the innate immune response, thereby further restricting RABV infection. The data of
the experiment clearly show that treatment of the infected neurons with either one of
the dendrimers AEA-[3siRNA]-Glc (anti-P and anti-N) lead to a strongly reduced vi-
ral titer (Figure 4C; for data of targeting N protein Figures S2 and S3). The titer was
reduced by two orders of magnitude in relation to the control experiment performed
with a nontargeting anandamidemodified siRNA. The trimeric dendrimer was able to
reduce the viral titer to a level close to the detection limit of the experiment. Impor-
tant are also the observations that the reduction of the viral titer is dose-dependent and
that with the standard lipofectamin 2000-based transfection, only a tenfold reduction
of the viral titer was observed. These results show the improved efficacy of the siRNA
dendrimers. In summary, we have presented novel dendritic siRNA nanostructures
that allow the transfection of difficult-totransfect cells, such as stem cells and primary
neurons.370 A click-chemistry-based approach, in which the passenger strands of the
siRNAs are covalently bound to the dendritic structure, allowed us to exactly control
the monodispersity of the particles, which enabled the control of the number of siRNA
duplexes bound to one AEA ligand for receptormediated uptake. The dendritic siRNA
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nanostructures allow the effective control of gene expression in neural stem cells and
in primary neurons. We were also able to use the system to reduce the viral titer of
the rabies virus in primary neurons to close to the detection limit, thus illustrating a
possible way to a novel siRNA-based therapy of this deadly disease.
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Figure 11.2: Synthesis of the siRNA dendrimers AEA-[3ORN], AEA- [6ORN], and AEA-
[9ORN].a) NaH, 15-crown-5, DMF, RT, 46%; b) TFA, CHCl3, RT, 94%; c) arachi-
donic acid, TBTU, DIPEA, DMF, RT, 95%; d) 4, CuSO4, sodium ascorbate,
H2O/THF (1:1), RT, 80%; e) 5, CuSO4, sodium ascorbate, H2O/THF (1:1), RT,
65%; f) NaN3, DMF, 110°C, 85%; g) NaN3, DMF, 110°C, 97%; h) TFA, CHCl3, RT,
71%; i) arachidonic acid, HATU, DIPEA, DMF, RT, 81 ; j) TFA, CHCl3, RT, 76%;
k) TBTU, DIPEA, DMF, 40°C, 70%; l) alkyne-modified oligonucleotide (ORN),
CuBr, TBTA, DMSO/H2O, 89%; m) alkyne-modified oligonucleotide (ORN),
CuBr, TBTA, DMSO/H2O, 78%; n) alkynemodified oligonucleotide (ORN), CuBr,
TBTA, DMSO/H2O, 65%.
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Figure 11.3: HPL chromatograms of the purified dendrimers obtained with 10and 12.
The inserts show the MALDI-TOF spectra. MALDI-TOF data: A) calc. (AEA-
[3ORN1]): m/z 20506, found: 20503. B) calc. (AEA- [9ORN2]): m/z 62124, found
61923 (broad signal).
Figure 11.4: Relative silencing of the Renilla luciferase compared to the silencing of Firefly
luciferase mediated by dendritic anandamidesiRNAs in RBL-2H3 cells.
Investigated was: A) the influence of branching (1, 3, 9 siRNA duplexes per lig-
and) on silencing efficacy mediated by novel dendritic structures; B) the influ-
ence of additional glucose modifications introduced by modified siRNA guide
strand. In all cases the total amount of siRNA duplexes was normalized to the
monomeric structure. Quantification was achieved by luciferase activity. a: AEA-
[1siRNA-Luc], b: AEA-[3siRNA-Luc], c: AEA-[9siRNA-Luc], d: AEA- [3siRNA-
Luc]-glucose.
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Figure 11.5: Anandamide-mediated delivery of dendritic siRNA nanostructures to neural
stem cells.
A) Left: trimeric siRNA modified with Alexa Fluor647 was incubated with neural
stem cells. Right: As a negative control the stem cells were incubated with siRNA
lacking the ligand modification (red: siRNA, green: cell membranes. The contrast
settings for siRNA signals were equal for both images). B) Successful delivery of
nanostructures to stem cells was additionally demonstrated by regulation of Tet1
monitored by real-time PCR. a: AEA-[1siRNA-Tet1], b: AEA-[3siRNA-Tet1]-Glc.
C) Down-regulation of RABV titers in E14 cortical neurons by treatment with
different AEAmodified siRNA structures targeting the P protein of rabies virus.
c: AEA-[1siRNA-P-protein], d: AEA-[3siRNA-P-protein]-Glc.
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11.4 Investigation of Uptake Kinetics and Mechanism
of Targeted siRNA
This work was not part of the published article.
In additional experiments, we investigated different targeting types of siRNA con-
structs in order to determine their uptake mechanism and kinetics. The siRNA em-
ployed is shown in Figure 11.6.
Figure 11.6: siRNA used in additional experiments
In the top row, the simple, fluorescently labeled siRNA duplex targeted with AEA,
a construct with three siRNA-arms ("tripod"), and the untargeted siRNA used for
control experiments are shown. In the bottom row, a glucose-modified siRNA and
an AEA-targeted, but not fluorescently labeled siRNA are depicted.
11.4.1 Uptake Mechanism and Kinetics of AEA-Targeted siRNA
First, we determined the uptake of AEA-targeted siRNA into RBL2H3 cells, a murine
model cell line for neuronal stem cells. For this, we compared the intracellular fluores-
cence intensity 1, 8, and 20 hours after addition of siRNA. Investigated constructs were
the duplex-siRNA, the tripod siRNA-construct, and untargeted siRNA. The concentra-
tion of siRNA strands was always 125 nM, i.e. the concentration of the tripod siRNA-
construct was 41.7 nM since the strand concentration is then 125 nM. The result is
given in Figure 11.7. Representative fluorescent images can be found in Figure 12.26.
For all investigated time points, untargeted siRNA is no internalized significantly. Tar-
geted siRNA, in contrast, is already after 1 h taken up and the amount increases for
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Figure 11.7: Uptake of AEA-targeted siRNA into RBL2H3 cells.
Whereas untargeted siRNA shows little uptake for all investigated time points,
the targeted siRNA is internalized efficiently.
the later time points. Interestingly, the tripod siRNA-construct settles after 8 h at a
medium level whereas the simple duplex construct is internalized further and exceeds
the tripod siRNA-construct at an incubation time of 20 h. One can only speculate
about the reasons. One possibility is that the tripod siRNA-construct is quite large ans
bulky, making it difficult to internalize.
Next, we wanted to ensure that the AEA-targeted siRNA is really internalized via
cannabinoid receptors and not, for example, unspecifically via attachment to the mem-
brane: Since AEA is quite a hydrophobic molecule, this option must be taken into ac-
count. For this, we designed a competition experiment where we coincubated RBL2H3
cells with 125 nm fluorescently labeled duplex siRNA and 0, 125, 250, 500, and 750 nM
non-fluorescent, but still AEA-targeted siRNA. If the uptake would be unspecific, one
would expect no big difference between the different samples. However, when the
uptake is receptor-mediated, fluorescent and non-fluorescent siRNA species will com-
pete for binding which should decrease the intracellular fluorescence when increasing
amounts of non-fluorescent siRNA is present. The result is given in Figure 11.8
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Figure 11.8: Quantification of fluorescent AEA-targeted duplex-siRNA in prescence of non-
fluorescent, AEA-targeted duplex-siRNA.
Increasing amounts of non-fluorescent AEA-targeted duplex-siRNA decrease the
amount of internalized fluorescent siRNA (left). The decrease corresponds well
with the expected values (right).
As clearly visible, the presence of non-fluorescent, AEA-targeted siRNA-duplex de-
creases the intracellular fluorescence originating from AEA-targeted, fluorescently la-
beled siRNA-duplex. If the fluorescence is normalized and compared to the expected
decrease (1:0, 1:1, 1:2, 1:4, and 1:6), a good agreement is observed. From these findings
it is fair to assume that the uptake of AEA-targeted duplex-siRNA is not unspecific, but
receptor-mediated since a clear competition effect is detected.
Having shown the specific, efficient uptake of AEA-targeted siRNA into model neu-
ronal cells, we turned towards a more physiological setting. For this, we investigated
again the uptake of AEA-targeted duplex- and tripod-siRNA, however, this time into
murine neuronal stem cells. Again, we investigated the uptake of the duplex and the
tripod siRNA-construct, however this time in a concentration-dependent manner: 125
and 250 nM siRNA was added to murine neuronal stem cells and the fluorescence
was quantified after 24 hours. The result is shown in Figure 11.9 and representative
fluorescent images in Figure 12.27.
Encouraged by these findings, we decided to investigate the uptake of the AEA-targeted
duplex siRNA-construct in the most physiological environment: Inside a living ani-
mal. Since the cannabinoid receptors are highly expressed in the brain, AEA-targeted
duplex siRNA and untargeted siRNA was injected into the brains of living mice. More-
over, as an additional control, AEA-targeted was injected into the brains of mice where
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Figure 11.9: Quantification of duplex, tripod, and untargeted siRNA-constructs into
murine neuronal stem cells.
Both for the duplex and tripod siRNA, strong uptake is detected. Doubling the
concentration leads to about two to three times more internalized siRNA as ex-
pected. Furthermore, unspecific uptake was almost not present.
the cannabinoid receptors were knocked out. Then, fluorescent images of slices of
brains were obtained. In case of specific uptake, siRNA should be found in the hip-
pocampal region of the brain where cannabinoid are strongly expressed. Representa-
tive examples are given in Figure 11.10.
As it can be clearly seen, two conditions must be fulfilled in order for the siRNA to be
enriched in the hippocampus: First, the siRNA must be targeted with AEA. Second,
the receptors for AEA, the cannabinoid receptors, must be present. Interestingly, in
case of targeted siRNA and cannabinoid receptor knockout (Figure 11.10 middle), the
siRNA seems to be distributed around the brain whereas in case of untargeted siRNA
the siRNA stays at the injection site (Figure 11.10 right). This indicates that the siRNA
exhibits some mobility if modified with AEA. Presumably, this is due to diffusion in
cell membranes due to the lipophilic nature of AEA. This would also indicate that only
when the siRNA encounters the cannabinoid receptors present in the hippocampus, it
is enriched there.
The specific internalization of AEA-targeted siRNA into the hippocampus of wild-type
mice was clearly displayed by quantifying the siRNA-related fluorescence in the hip-
pocampus as depicted in Figure 11.11. Here, the fluorescence in the hemisphere where
siRNA was injected was compared to the fluorescence in the other hemisphere where
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Figure 11.10: Uptake of targeted and untargeted siRNA into mouse brains.
Only when both the siRNA is targeted to the cannabinoid receptors with AEA
and the cannabinoid receptors are present, the siRNA is found in the hippocam-
pus (left). If the cannabinoid receptors are knocked out (middle) or siRNA lacks
targeting (right), no enrichment of siRNA is found in the hippocampus. Scale
bar = 500 µm.
no siRNA was injected. The separation between the two hemispheres does not allow
for fast exchange of siRNA, therefore, the untreated hemisphere can be seen as inter-
nal control. As it is clearly visible, only when the siRNA is targeted and cannabinoid
receptors are present, enrichment of siRNA in the hippocampus is detected.
11.4.2 Uptake Mechanism and Kinetics of Glucose-Targeted siRNA
The other modification that we investigated in detail was the glucose modification.
The idea behind the attachment of glucose to the siRNA-constructs is that glucose is
the primary source of energy for many cells and may therefore be used to induce fast
internalization of siRNA. Hence, we tested several cell lines (Hela, HMEC, KB, HUH-7)
for the uptake of glucose-modified siRNA. We compared it to the uptake of untargeted
siRNA and, furthermore, investigated whether glucose present in the medium affects
the internalization kinetics. Therefore, we turned to a medium where glucose as en-
ergy source was exchanged. The result of the quantification of the intracellular fluo-
rescence caused by the internalized siRNA is given in Figure 11.12 and representative
images are shown in Figure 12.28.
Interestingly, not only targeting by glucose, but also the presence of glucose in the
medium is required for efficient internalization. This is to some extent not intuitive,
since the presence of glucose should compete with the Glc-siRNA for the binding sites
and hence depletion of glucose from the medium should increase the uptake. How-
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Figure 11.11: Quantification of AEA-siRNA uptake by the hippocampus
Only when both the siRNA is targeted to the cannabinoid receptors with AEA
and the cannabinoid receptors are present, the ratio of the treated hippocampus
to the untreated hippocampus is below one. The red square indicates the mean
value.
ever, this is not the case. We speculated that upon glucose depletion, the cell stops the
expression of proteins responsible for glucose uptake. Hence, the glucose-modified
siRNA would then find no binding sites on the cell surface. To investigate this, we
transfected cells with RNA encoding GFP-labeled GLUT1 which is the most important
glucose transporter (Figure 12.29). Indeed, we detected much higher levels of GLUT1
expression in presence of glucose in the medium. Therefore, glucose depletion leads
also to a depletion of binding sites for the glucose modification.
We now went on to prove that GLUT1 is indeed a receptor to which the glucose-
modified siRNA binds. For this, we transfected Hela cells with RNA coding for GLUT1-
GFP for 24 h, followed by incubation with fluorescently labeled Glc-siRNA for another
24 h. When we investigated the cells by fluorescence microscopy, we could clearly de-
tect a colocalization between GLUT1-GFP and Glc-siRNA inside the cell as shown in
Figure 11.13. This strongly indicates that Glc-siRNA indeed binds to GLUT1. Also,
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Figure 11.12: Quantification of Glc-siRNA uptake by Hela, HMEC, KB, and HUH-7 cells.
In presence of glucose in the medium, glucose-modified siRNA is internalized
very efficient. However, if no glucose is present in the medium or the siRNA is
not targeted, uptake is very low.
this suggests that the Glc-siRNA blocks the transporter and is internalized together
with it.
Since also glucose must be present in the cell medium for GLUT1 to be expressed, fast
glucose transport through GLUT1 and high copy numbers are required to overcome
the competition effect. Both features are reported in literature for GLUT1: Its process-
ing rate belongs to the fastest among membrane proteins, and it is also present in high
copy numbers. Hence, the competition effect is overcompensated. These two factors
overcompensate the competition effect and lead to efficient uptake of Glc-siRNA into
the investigated cells.
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Figure 11.13: Colocalization between internalized Glc-siRNA and GLUT1
Internalized Glc-siRNA colocalizes clearly with the glucose transporter GLUT1
which is visualized using a GFP-tag. Scale bar = 10 µm.

12 Other Projects not Discussed in
this Thesis
Two further projects not presented in detail in this thesis should be briefly mentioned
here.
12.1 Intracellular Distribution and Action Mechanism
of Antidepressants
This project was a collaboration between the MPI for psychiatry, Munich, the depart-
ment of physical chemistry I, LMU Munich, the department of pharmacy, LMU Mu-
nich, and the HMNC GmbH, Munich. It was guided by Thomas Kirmeier, from the
MPI for psychiatry.
We investigated the uptake, the distribution, and the action mechanism of a major class
of antidepressants: Cationic amphiphilic drugs. Here, we employed azidobupramine,
which can be fluorescently labeled via intracellular click chemistry, to monitor how
the drug is internalized by the cell and spread afterward. We also used genetically in-
corporated fluorescent labels to visualize the cellular response. In the course of these
experiments, we could reveal that the drug enriches very specifically inside the cell
and induces characteristic transitions in the morphology of CD63- and LC3-carrying
vesicles. With this, we could provide the basis to analyze the action of the drug inside
the cell.
This work will be submitted to PlosOne.
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12.2 Metabolic Labeling of Mycobacterium
tuberculosis
This project was a collaboration between the CAU Kiel, the research center Borstel,
and the department of physical chemistry I, LMU Munich. It was guided by Katharina
Kolbe and Thisbe Lindhorst, CAU Kiel.
In this project, azido modified sugars that characteristically occur in the cell wall of
certain bacteria were incorporated into Mycobacterium tuberculosis in order to specif-
ically label them for diagnostic and therapeutic purposes. Here, we could determine
that the cross-reactivity of these sugars with human cells, which is of course unwanted,
can be neglected. In other word, the sugars do not label human cells. Furthermore,
the cytotoxicity of the employed unnatural sugars was determined, another important
aspect in order to realize this approach in a medicinal context.
This work will be submitted to Angewandte Chemie.
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Appendix
Membrane Protein Glycosylation and its Relevance in
Cell Biology
Figure 12.1: Key for sugar symbols.
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Glycosylation Influences Spatiotemporal Membrane
Protein Dynamics
ESI to "Microdomain Formation Controls Spatiotemporal Dynamics of Cell-Surface Glycoproteins"
by Leonhard Möckl, Andrea K. Horst, Katharina Kolbe, Thisbe K. Lindhorst, and Christoph Bräuchle;
ChemBioChem 2015
Figure 12.2: Specificity of the labeling reaction.
In presence of Ac4ManNAz or Ac4GalNAz, sialic acid-bearing proteins (SABPs,
left column) or mucin-type proteins (MTPs, middle column) on the cell
membrane are fluorescently labeled by incubation with the AlexaFluor647-
cyclooctyne-conjugate (DIBO647). In contrast, the lack of an azido sugar leads
to no labeling (right column). This is nicely displayed in the fluorescence images
(contrast settings are equal for all images). Note that the fluorescent endosomes
inside the cell in the left and middle image are caused by internalization of al-
ready labeled glycans during incubation with the labeling solution and not by
uptake of the DIBO647 itself since the negative control does not exhibit any sig-
nificant intracellular fluorescence. Scale bar=10 µm.
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Figure 12.3: Identity of the labeled species.
To check if the metabolic labeling approach targets predominantly glycoproteins
and not glycolipids, we seeded 1.5 · 106 cells in a six-well plate and cultivated
them as described in presence of 50 µM of the indicated azido sugar for two days.
Then, we labeled them for 45 minutes with 35 µM DIBO647 and isolated pro-
teins and lipids using the Mem-PER- and the Lipid Extraction-kit (Thermo Sci-
entific, Waltham, Massachusetts, USA/Sigma Aldrich, St. Louis, Missouri, USA).
The isolated species were solubilized in equal amounts of solvents. 20 µL were
transferred onto a microscope slide and the fluoresence was quantified using a
Zeiss spinning disk confocal microscope. Clearly, only glycoproteins (cyan) are
labeled whereas no significant labeling of glycolipids (orange) was detected. The
experiments were carried out in triplicate. Errors are given as SEM.
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Figure 12.4: Minimum labeling duration.
To ensure that all available azide groups on the cell membrane after incubation
with the respective azido sugar are addressed by the labeling reagent DIBO647,
we varied the incubation time as indicated. It is clearly visible that after 30 min-
utes no further increase in membrane fluorescence intensity occurs. n=30, errors
are given as SEM.
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Figure 12.5: Glycans are localized in endosomes after internalization.
The depicted cells were incubated with Ac4ManNAz to incorporate an azide
group into SABPs and incubated for the indicated time periods (hours) after la-
beling with DIBO647. During this time, fluorescent SABPs are internalized into
the cell. The decrease in membrane fluorescence and the increasingly bright, per-
inuclear fluorescence of endosomes is obvious. Scale bar=10 µm.
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Figure 12.6: Classes of labeled glycans.
Four principle types of proteins are depicted as relevant for our study: SABPs,
MTPs (carrying sialic acids or LacNAc, respectively), SABPs and MTPs (carrying
both sialic acid and LacNAc), or none of the two classes (carrying no or differ-
ent glycosylation). Metabolic labeling with Ac4ManNAz targets SABPs whereas
metabolic labeling with Ac4GalNAz targets MTPs. The possible overlap between
SABPs and MTPs has an important consequence: One may detect and MTP-
specific effect while visualizing SABPs and vice versa. However, we were able
to show that the two classes can be very well separated using metabolic labeling
and fluorescence visualization, indicating that the overlap is not dominant.
Glycosylation pattern simplified, other sugars are omitted for clarity.
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Figure 12.7: Galectin-1 and -3 are present on the membrane of HMEC-1.
(a) Fluorescence images of immunostaining against galectin-1 (top), galectin-3
(middle), and isocontrol (bottom). (b) Differential interference contrast images
corresponding to a). (c) Merge of a) and b) Scale bar = 25 µm, contrast settings
identical for all fluorescence images.
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Figure 12.8: Internalization of MTPs and SABPs into untreated HMEC-1.
Decrease in membrane fluorescence of HMEC-1 through internalization of fluo-
rescently labeled sialic acid-bearing and mucin-type proteins. Note that within
5.5 h the membrane fluorescence decreases strongly in both cases. However,
SABPs show faster decrease owing to less involvement in galectin-lattice for-
mation, thus corroborating the data on spatial mobility. Errors=SEM, n=26-30,
black=SABPs, red=MTPs.
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Figure 12.9: Experimental design to investigate temporal dynamics of membrane proteins.
(a) To measure the incorporation of glycans into the cell membrane, HMEC-1
were incubated with Ac4ManNAz or Ac4GalNAz, respectively, which are inter-
nalized and metabolized in glycan biosynthesis. After an incubation time, the
azido group appears in cell surface glycoproteins. There, it can be bioorthogo-
nally reacted with DIBO647, covalently linking a fluorescent dye to membrane
glycoproteins. As with increasing incubation time (Time B) the number of azido
groups on the cell surface increases, membrane fluorescence is enhanced accord-
ingly. (b) Correspondingly, after incubation with Ac4ManNAz or Ac4GalNAz and
subsequent fluorescent labeling, the decrease in membrane fluorescence is a mea-
sure for the internalization of membrane glycoproteins into the cell.
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Figure 12.10: Final metabolite concentration on the cell membrane in dependence of rates
from cytosol to Golgi apparatus and Golgi apparatus to membrane.
All rates occurring inFigure 6.7 are set to 1 except for the two rates that trans-
port metabolites from the cytosol via the Golgi apparatus to the membrane. If
these rates increase, the final metabolite concentration on the membrane rises,
too. However, this is not physiological since the membrane cannot arbitrarily
increase its capacity (cf. Figure 12.11).
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Figure 12.11: Mutual dependence of kGolgi-Membrane and kMembrane-Endosome.
If the rate Golgi apparatus-membrane increases and the final membrane
metabolite concentration should stay constant, the rate membrane-endosome
must increase accordingly (all other rates are kept constant). For very high val-
ues of kGolgi-Membrane, the rate kMembrane-Endosome does not change much because
in this region an increase in the rate kGolgi-Membrane no longer increases the final
membrane metabolite concentration: In this case, every metabolite that arrives
at the Golgi apparatus is almost immediately transferred to the membrane.
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Figure 12.12: Incorporation of MTPs and SABPs into the membrane of untreated HMEC-1.
Cells were treated for the indicated incubation time with Ac4ManNAz or
Ac4GalNAz, addressed by DIBO647, and fixed. Membrane fluorescence was
quantified. It is clearly visible that the steady state (every azide-bearing mem-
brane protein is replaced by another azide-bearing membrane protein, net
change zero) is earlier reached for SABPs than for MTPs. This development was
also obtained using the above described model (cf. Figure 6.7 and Figure 12.13).
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Figure 12.13: Development of membrane metabolite concentration.
Note the sigmoidal development and the steady state reached. Rates:
All rates are set to 0.1 with the exception of kExtracellular Space-Cytosol=1 and
kCytosol-Golgi apparatus=0.5
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Artificial, Tunable Interconnection of Membrane
Glycans
ESI to "Artificial Formation and Tuning of Glycoprotein Networks on Live Cell Membranes: A
Single-Molecule Tracking Study" by Leonhard Möckl, Thisbe K. Lindhorst, and Christoph Bräuchle;
ChemPhysChem 2015
Figure 12.14: Representative images of single SA molecules (left) or SA-coated quantum
dots (QDs, right) on the membrane of HMEC-1.
Shown are three representative frames obtained in our measurements with
clearly visible signals of single SA molecules and single QDs, respectively. Scale
bar = 10 µm
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Figure 12.15: Simulation of confined diffusion.
For the simulation of confined diffusion, we slightly modified the approach de-
scribed in the online documentation of the Matlab class @msdanalyzer that we
also used for the MSD analysis of the obtained trajectories.252
Briefly, particles were set to a starting position from where they can diffuse freely. However, a restoring
force drives them towards their starting position which increases with increasing distance. This ap-
proach resembles the situation of interconnected particles in a very basic, but still useful way: Particles
inside a network are pushed or pulled back as if they were attached to the equilibrium position. The
higher the interconnection, the higher the restoring force. In the simulation, the restoring force is re-
alized by a parabolic potential around the starting position of the particle, exhibiting a certain width.
With this, different restoring forces are chosen, corresponding to different interconnection strengths of
the network: the more narrow the potential is, the higher is the restoring force at a certain distance,
corresponding to stronger interconnection. The other important parameters of the simulation were set
to reasonable values, e.g. a temperature of 20°C, a frame time of 50 ms, a dimensionality of 2, and a dif-
fusion constant of 10 ·−3 µ2/s. The width of the potential was varied between 10 and 500 nm. The results
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depicted above show clearly that a narrower potential, i.e. stronger interconnection, leads to increased
confinement (trajectories shown in a)-e) with potentials of 10/25/50/100/500 nm width, respectively).
Consistently, the MSD curves are stronger bent (f). Note that the error bars of the MSD curves are very
small because the particles move according to a theoretical model. The only reason that there is an
error at all is the use of random numbers to simulate particles undergoing Brownian motion. Error bars
are given as the weighted standard deviation divided by the square root of the number of degrees of
freedom. Coloring in a)-e) is used only for easier discrimination of single trajectories.
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Figure 12.16: Immunostaining confirms the expression of galectin-1 and -3 on cultured
HMEC-1
As it can be clearly seen from the fluorescent images, a strong signal for galectin-
1 and -3 is obtained whereas the isocontrol does not show any fluorescence. Con-
trast settings are equal for all three fluorescent images, scale bar = 20 µm
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Photocontrol of E. Coli Adhesion to Human Cells
ESI to "Switching first contact: photocontrol of E. coli adhesion to human cells" by Leonhard Möckl,
Anne Müller, Christoph Bräuchle, and Thisbe K. Lindhorst; ChemComm 2015
Figure 12.17: Required alkyne concentration for saturation.
HMEC-1 were cultivated in presence of 50 µM Ac4ManNAz for two days as de-
scribed. Instead of an azobenzene derivate, a fluorescent alkyne was coupled at
various concentrations to the incorporated azido groups under identical condi-
tions. The membrane fluorescence was determined. It can be clearly seen that
at 35 µM a plateau is reached. Hence, the concentration of 200 µM azobenzene
derivate that we used in our experiment ensures that all available azido groups
are tagged.
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Figure 12.18: Adhesion of E. coli to Z and E-configured 5
Two sets of HMEC-1 with sialic acids modified with Z-azobenzene mannoside
were incubated with bacteria (after irradiation with light of 365) (left column).
Next, only one set of HMEC-1 was irradiated with light of 405 nm to effect Z→E
isomerisation. Then, both sets of HMEC were incubated again with bacteria.
By high-resolution fluorescence microscopy it can be seen that the number of
adhered bacteria increases strongly for HMEC-1 in the E-state (bottom right),
whereas it does not change significantly when HMEC-1 were not irradiated with
405 nm light (leaving 5 in the Z-state) (top right). Scale bar = 250 µm.
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Figure 12.19: Adhesion of E. coli to Z and E-configured AB
HMEC-1 were modified at sialic acids with AB or remained untreated as control.
Next, one set of cells was irradiated with 365 nm light in order to switch the
azobenzenes to the Z-state. The other set was not irradiated. After incubation
with bacteria, fluorescence images were obtained. It can be clearly seen that the
presence of 7 in both Z- and E-configuration reduced adhesion of bacteria. Scale
bar = 250 µm.
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Figure 12.20: Adhesion of E. coli to Z and E-configured 6
HMEC-1 were modified at sialic acids with 6 or remained untreated as control.
Next, one set of cells was irradiated with 365 nm light in order to switch the
azobenzenes to the Z-state. The other set was not irradiated. After incubation
with bacteria, fluorescence images were obtained. As for 7, adhesion of bacteria
was decreased. Therefore, the glucose modification of 6 cannot serve as ligand.
Also, unspecific interactions are not increased. Scale bar = 250 µm.
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Figure 12.21: Adhesion of E. coli to Z and E-configured 5 linked to mucin-type proteins.
HMEC were modified with 5 at mucin-type proteins or remained untreated as
control. In comparison to labelling of sialic acids, this leads to attachment of 5
deeper within the glycan tree. Next, one set of cells was irradiated with 365 nm
light in order to switch the azobenzenes to the Z-state. The other set was not
irradiated. After incubation with bacteria, fluorescence images were obtained.
It can be seen that the additional mannose groups increased adhesion in com-
parison to cells not treated with 5, however, switching had no effect. This is
reasonable since the change in orientation upon switching is small compared to
the distance the azobenzene-mannoside is away from the incoming bacteria in
this case. Scale bar = 250 µm.
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Figure 12.22: Clumps of E. coli under flow conditions.
With increasing time of flow, bacteria more and more adhere to already adhered
bacteria and not to HMEC-1, forming clumps (some of them indicated by red
arrow heads). Scale bar = 250 µm.
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Flow Changes the Properties of E. coli Adhesion
Inhibitors
ESI to "En route from artificial to natural: Evaluation of inhibitors of mannose-specific adhesion of
E. coli under flow" by Leonhard Möckl, Claudia Fessele, Christoph Bräuchle, and Thisbe K. Lind-
horst; under revision at Biochimica Biophysica Acta (BBA)
Figure 12.23: Inhibition of bacterial adhesion to mannan surfaces under static conditions.
Solutions of the respective glycosides were prepared and serial dilutions were
added to mannan-coated microtiter plate wells. The prepared bacterial solution
(OD600 0.4) was added and the plate incubated for 1 h at 37◦C and 100 rpm.
The plates were washed with PBS buffer and then the wells were filled with PBS
for the fluorescence read out (485 nm/535 nm). (A) Inhibition tested with man-
noside 2 and 4. (B) Inhibition tested with mannoside 1 and 3. The depicted
binding curves are representative examples from several (>3x) independent ex-
periments. Error bars result from duplicate values on one plate.
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Figure 12.24: Bacterial adhesion to HMEC-1 under static conditions using SAMan as in-
hibitor.
WThe images clearly show that under static conditions, bacteria can adhere up
to high inhibitor concentrations (0 / 0.001 / 0.01 / 0.1 / 1 mM). Contrast is in-
verted for clarity. Contrast settings are equal for all images. Scale bar = 200 µm.
Figure 12.25: Bacterial adhesion to HMEC-1 under flow conditions using SAMan as in-
hibitor.
Under flow conditions, no adhesion was detected already at low inhibitor con-
centrations (0 / 0.1 / 1 / 2 mM). Contrast is inverted for clarity. Contrast settings
are equal for all of images. Depicted adhesion is after five minutes of bacterial
flow. Scale bar = 100 µm.
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Uptake of Targeted siRNA into Model Cells and in vivo
Figure 12.26: Representative fluorescence images showing the uptake of AEA-siRNA du-
plex, AEA-siRNA tripod, and untargeted siRNA duplex into RBL2H3 cells.
newline Scale bar 10 µm
Figure 12.27: Representative fluorescence images showing the uptake of AEA-siRNA du-
plex, AEA-siRNA tripod, and untargeted siRNA duplex into murine neuroanl
stem cells. newline Scale bar 10 µm
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Figure 12.28: Representative fluorescence images showing the uptake of Glc-siRNA into
Hela, HMEC, KB, and HUH-7 cells. newline Scale bar 10 µm
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Figure 12.29: Representative fluorescence images showing GLUT1 expression in presence
(top) or absence (bottom) of glucose in the medium
Contrast settings are equal for all images.
Scale bar 10 µm
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List of Figures
2.1 ER-associated steps in N-glycan synthesis
First, GlcNAc-P is added to Dol-P via ALG7. Then, fourteen sugar residues are added
by different members of the ALG proteins. During the process, the precursor is flipped
from the cytosolic to the lumenal side of the ER. After finishing the precursor synthe-
sis, the whole glycan is transferred to the protein. The final structure of the precursor
(Glc3Man9GlcNAc2 is shown at the bottom. cf. Figure 12.1 for the key to the sugar
symbols. Figure taken from reference65 . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
2.2 The three classes of N-glycans
Although their structural diversity is high, all N-glycans share the Man3GlcNAc2 core
and can be divided into the oligomannose, the complex, and the hybrid type, dependent
on the structure of the modifications that were attached during processing. Figure taken
from reference65 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
2.3 Branching of N-glycans
Multiple GlcNAc residues can be attached to the terminal mannoses of the core struc-
ture of hybrid and complex N-glycans, leading to branching of the N-glycans. These
modifications depend strongly on the nutrient state of the cell and play a key role in,
for example, receptor homeostasis. Figure taken from reference65 . . . . . . . . . . . . . 10
2.4 Four examples for mucin-type O-glycan cores
The respective core structure is highlighted with a gray box. For each core, a typical
extension is depicted. Figure adapted from reference65 . . . . . . . . . . . . . . . . . . . 13
2.5 Synthesis and modification of core 1 and core 2 structures.
After the transfer of GalNAc to an OH-group of serine or threonine, the Tn antigen is
obtained. This can be sialylated (both the Tn and the sialyl-Tn are common in cancer
cells) or modified by galactose to yield the core 1 structure. From there, several modifi-
cations can be introduced. If an N-acetylglucosamine is added to the initial GalNAc via
a β6-linkage, the core 2 structure is obtained which can also be further modified. Note
that two possibilities exist to add N-acetylglucosamine to the core 1 structure which
mutually exclude each other. Figure taken from reference65 . . . . . . . . . . . . . . . . 14
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2.6 Quality control of protein folding.
Newly synthesized N-glycans are located in the ER where they are N-glycosylated with
Glc3Man9GlcNAc2. In the ER, also the first two steps of trimming of the glycan take
place, i.e. the removal of two glucose units. One glucose residue is retained which,
therefore, is recognized by calnexin/calreticulin. If the protein is correctly folded, it
is exported to the Golgi apparatus. However, if not, the misfolded protein is reglycosy-
lated and enters the calnexin/calreticulin cycle one more. If it stays misfolded, mannose
groups are removed which is a signal for export of the misfolded protein to the cytosol
where the rest of the N-glycan is removed and the amino acid chain is degraded by the
proteasome. Figure taken from reference65 . . . . . . . . . . . . . . . . . . . . . . . . . . 15
2.7 Free-energy profile of a glycosylated and non-glycosylated protein.
Intuitively, a protein should be stablilized by glycosylation, either by destabilizing the
unfolded state (∆GGlyco−∆GWT > 0) or by stabilizing the folded state (∆GGlycoF −∆G
WT
F <
0). Figure taken from reference86 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
2.8 Influence of glycosylation on the folding temperature of SH3.
With increasing amounts of both short and long glycans (empty and filled circles) on
the protein, the folding temperature T Glycof increases. Experimental measurements (red
circles) show good agreement. Figure taken from reference86 . . . . . . . . . . . . . . . 17
2.9 The four blood groups in the ABO-system
Sugar structures on red blood cells that give rise to the four different blood groups O,
A, B, and AB. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
2.10 Galectin families
There are three different types of galectins: Homodimers of identical monomers (dimeric,
left); pentamers of identical monomers that assemble via a non-lectin domain (chimera,
middle); and a divalent form where two subunits are solidly connected via a peptide
bridge and hence do not assemble (tandem, right). . . . . . . . . . . . . . . . . . . . . . 20
2.11 Regulation of signaling by membrane protein glycosylation and galectins.
High flux through the hexosamine pathway increases UDP-GlcNAc levels in cells, lead-
ing to stronger N-glycan branching. First, the cell surface residence time of growth
promoting receptors, carrying high numbers of N-glycans, is increased (black arrows).
However, as soon as a threshold is reached, also growth arresting and differentiation
promoting receptors like TβR, which are decorated with few N-glycans, exhibit enough
branched N-glycans to engage in the galectin lattice. In a positive feedback loop, this
leads to growth arrest and differentiation (red arrows). Figure taken from reference101 22
2.12 Regulation of leukocyte adhesion by selectins.
If P- and E-selectin on the surface of endothelial cells are activated, leukocytes that nor-
mally roll over the cell surface are bound. This leads to the further activation of CAM-
molecules that firmly attach the leukocyte to the membrane which, in turn, triggers the
migration of the leukocyte through the endothelium. Figure taken from reference109 . 22
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2.13 Composition of the glycocalyx
Various types of sugar structures constitute the glycocalyx: Covalently attached gly-
cosylations of membrane proteins (green); glycolipids (violet); long, polymeric species
like hyaluronic acid (cyan); or sulfated polymers like chondroitin, heparan, dermatan,
or keratan sulfate (yellow) to which positively charged species like Ca2+ or arginine at-
tach. From hyaluronic acid as backbone and sulfated polymers that are connected to it
via linker proteins, also feather-like proteoglycans can be built. . . . . . . . . . . . . . . 23
2.14 EM images of the glycocalyx in its intact state and after dehydration.
If special, protective protocols are applied, the structure of the glycocalyx is preserved
(top). However, when the glycocalyx is dehydrated, in this case by ischemia, it is largely
destroyed (bottom). Figure taken from reference111 . . . . . . . . . . . . . . . . . . . . . 25
2.15 Mechanosensing and -transduction by the enothelial glycocalyx
The shear flow of the blood causes the fibers of the endothelial glycocalyx to bend,
resulting in an inwards torque and reorganization of the actin cytosceleton inside the
cell (green sawtooth lines). This leads to the formation of adherence and cell-to-cell
junctions (purple), determining the polarity of the cell. Figure taken from reference119 26
2.16 Entry of Yersinia, Salmonella, and Shigella into host cells.
All three bacteria attach to the cells via specialized protein complexes and secrete ef-
fectors activating cellular proteins that lead to uptake of the bacterium by the host cell.
Figure taken from reference124 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
2.17 Electron micrograph of an E. coli bacterium with clearly visible fimbriae.
Figure taken from reference129 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
2.18 Architecture of E. coli fimbriae.
FimH is located at the very tip of the fimbrium. Below, FimG, FimF, and a polymer of
several hundreds to a few thousands FimA units follow. Each Fim protein is cotransla-
tionally injected in the periplasm via SecYEG where the chaperone FimC helps it folding
and translocates it to the channel FimD. Figure taken from reference129 . . . . . . . . . 29
2.19 FimH in complex with its natural ligand mannose Figure taken from reference,131
PDB-ID: 1KLF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
2.20 The tyrosine gate at the entrance of the CRD of FimH.
At the top, the configuration of the two tyrosine residues in the open conformation
is depicted. This indicates that the ligand mannose is not inducing favorable π-π-
interactions. However, if butyl mannose is used, it interacts with the tyrosines which
closes the gate and increases the affinity for FimH. Figure taken from reference23 . . . . 32
2.21 Detection of bacterial adhesion via a sandwich method and by direct fluorescent
readout
E. coli adhering to an artificial, mannose-covered surface can be detected either via a
sandwich-based method employing biotinylated bacteria and horseradish peroxidase-
linked streptavidin (left), or directly via fluorescence readout (right). Figure taken from
reference143 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
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3.1 The stem compound and the three unnatural sugars introduced by Reutter et al. into
membrane glycans
a) N-acetylmannosamine; b) 2-deoxy-2(porpanoyl-amido)-d-mannose; c) 2-deoxy-2(bu-
tanoyl-amido)-d-mannose; d) 2-deoxy-2(pentanoyl-amido)-d-mannose. . . . . . . . . . 36
3.2 Requirements for bioorthogonal labeling of biomolecules
a) The putative bioorthogonal reaction X+Y→ X−Y must tolerate all the other functional
groups like oxygen, water, amines, phosphates etc. typically present in living systems
while not interacting with them. b) A typical bioorthogonal reaction is pictured as
follows: A normal biomolecule is chemically modified with a group X. The biomolecule
is incorporated into the cell in its usual environment since X does not interfere with
the metabolism. Due to the bioorthogonal nature of X, it can be specifically addressed
by a second functional group Y that reacts only with X. Y can carry any tag needed for
detection, for example a fluorophore. Figure taken from reference148 . . . . . . . . . . . 38
3.3 Principle of metabolic labeling
Unnatural, azido-modified sugars are internalized by the cell and incorporated into
glycans where they can be detected after a while (left). The nature of the modified
sugar residue in the glycan is dependent on the unnatural sugar (right). Figure taken
from reference153 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
3.4 Detection of azido groups.
Shown are three common detection methods for azido groups and the resulting reaction
products: Staudinger ligation with triphenylphosphines (top), copper-catalyzed click
chemistry (middle), and copper-free click chemsitry with cyclooctynes (bottom). R and
R’ denote arbitrary chemical groups. If applied in biological systems, R is the label to
be attached, e.g. a fluorophore, and R’ the azide-bearing sugar on the protein. . . . . . . 40
3.5 Simplified mechanism of the copper-catalyzed reaction between alkynes and azides
The catalyzing Cu+ is complexed by some ligand and binds to the triple bond of the
alkyne. Some base cleaves the acidified hydrogen, yielding the copper(I) acetylide.
Then, the azide attacks. Via several intermediate steps, the final product of the cy-
cloaddition is formed and the catalyzing species as well as the base are regenerated. R1
and R2 denote an arbitrary chemical residue. Figure adapted from157 . . . . . . . . . . 41
4.1 Processes during RNAi.
After synthesis of pri-miRNA, it is exported into the cytosol where it gets processed by
Dicer. The resulting siRNA is loaded into RISC by RLC. The corresponding mRNA is
recognized. In case of perfect match, the mRNA is degraded, otherwise, it stays in the
RISC. In the first case, complete silencing, in the second case, reduction of translation
results. Figure taken from81 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
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5.1 Jablonski diagram
The system is excited from the electronic ground state S0 to an excited electronic state
like S2. Then, it undergoes internal conversion to reach the vibronic ground state of S1.
From there, it usually returns to S0, emitting a photon which is detected as fluorescence.
Sometimes, it may undergo intersystem crossing into the triplet state T1, a process for-
bidden by quantum mechanics. From there, the system falls back to S0, but on a much
longer time scale than in case of fluorescence since the return from T1 to S0 is again
forbidden. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49
5.2 Rayleigh criterion
The maxima of two fluorescent emitters are not resolved when they are closer to each
other than the distance between a maximum and the first minimum (left). If the max-
imum of the first is positioned above the first minimum of the second, they are just
resolved (middle). If they are separated even more, they can be well resolved (right).
Figure taken from reference188 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52
5.3 Wide-field microscope for single-molecule detection
Two lasers with wavelengths of 532 nm and 633 nm are used for excitation. They are
directed through a shaken fiber. Behind the fiber, the beam is parallelized and passed
through an aperture from where it is directed through a 100x objective with a numerical
aperture of 1.4 to the sample. A dichroic mirror and filters are used to separate the
emission before the signal is collected by an EM-CCD camera. . . . . . . . . . . . . . . . 55
5.4 A spinning-disk unit
Laser light passes through a lens and a pinhole disc which create several focuses. They
are scanned in parallel across the sample, reducing the acquisition time. Figure taken
from reference193 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56
5.5 Representation of the Zeiss Cell Observer SD
Laser light of four different wavelengths is transferred to the spinning-disc unit via an
optical fiber. From there, it is brought to the specimen where it excites fluorophores
in epifluorescent mode. The emission light is collected, filtered, and detected by two
EMCCD cameras, allowing for parallel detection of up to four fluorophores. For life-cell
imaging over extended periods of time (up to days), the system features also a heated
sample chamber with CO2 atmosphere. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57
5.6 Types of diffusion
a) Normal diffusion: The diffusing particle does not encounter any barriers. b) Anoma-
lous diffusion: The particle encounters obstacles. c) Confined diffusion: The particle is
trapped in a region. d) Diffusion with drift: The particle diffuses freely and does not
encounter barriers, but a constant force drives it in a certain direction. e) MSD curves:
Normal diffusion (black squares) results in a straight line whereas the MSD curve for
confined diffusion (red circles) bends down. However, it does not reach a limit, in con-
trast to confined diffusion (blue triangles). Finally, diffusion with drift (cyan triangles)
yields a parabola. Parameters: d = 2, D = 1, α = 0.75, C = 10, A1 = A2 = 1, v = 0.5 . . . . 62
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5.7 Diffraction limited detection and localization accuracy.
When photons are detected from a single emitter, they form a diffraction-limited pat-
tern called the PSF. The above figures show (a) the original PSF of a single YFP molecule
in a bacteria cell, (b) the pixelated PSF measured on the camera, (c) a two-dimensional
Gaussian fit to the PSF and (d) the high-precision localization of the emitter determined
from the center of the PSF. Figure taken from references201, 202 . . . . . . . . . . . . . . 65
5.8 The principle of localization microscopy.
(a) An arrangement of fluorescent molecules representing La Paloma de la Paz (P. Pi-
casso, 1961) with a spatial frequency below the diffraction limit. (b) Were this structure
to be visualized by conventional microscopy, Abbe’s criterion forbade resolution of the
individual features. (c,d) However, by stochastically switching molecules between a
fluorescent state and a dark state, the PSF of a few sparse emitters can be acquired in
each acquisition step. Their positions are determined with high precision and (e), in
a pointillist approach, the results of all localizations are combined to obtain a super-
resolved reconstruction of the object. Figure taken from reference207 . . . . . . . . . . . 69
5.9 Super-resolved images of mitochondria in COS-7 cells.
(a) A Total Internal Reflection Fluorescence (TIRF) microscopy image and (b) the PALM
super-resolution image of mitochondria in COS-7 cells. The mitochondria were labeled
using a photoactivable fluorescent protein (dEosFP) targeted to the matrix of the mi-
tochondria. Whereas only the approximate shape of the mitochondria can be resolved
using TIRF microscopy, PALM microscopy exhibits features on the length scale of some
tens of nanometers, well below the diffraction limit. Figure taken from reference214 . . 70
6.1 Experimental approach.
Membrane glycoproteins (a) were tagged with azido groups by labeling with Ac4Man-
NAz or Ac4GalNAz (b). In a second step, either a fluorescent dye (c) or a biotin (d)
was coupled to the azido groups by copper-free click chemistry. The fluorescence of
the specifically labeled membrane glycoproteins was used to investigate their spatial
dynamics (diffusion inside the membrane) and temporal dynamics (incorporation into
the membrane and internalization back to the cell interior) as a function of galectin-
induced microdomain formation (e). The biotin tag was employed to induce artificial,
streptavidin-mediated crosslinking of membrane proteins (f). Visualization of the spa-
tiotemporal dynamics used fluorescently labeled streptavidin. . . . . . . . . . . . . . . 74
6.2 Effects of exogenous galectin-1 or -3 on spatial mobility of membrane glycoproteins
determined by FRAP
The mobile fraction of MTPs (galectin ligands) decreases upon addition of 3.3 mg mL-1
galectin-1 or -3, caused by crosslinking (formation of galectin lattices). For SABPs, only
small decreases are visible. Data are mean ±SEM (n=29 or 30); t-test *p<0.1. . . . . . . 75
6.3 Effect of di- and tetravalent SA on spatial mobility of biotin-tagged membrane gly-
coproteins.
Both di- and tetravalent SA lead to a significant decrease in the mobile fraction. Data
are mean ±SEM (n=27-29); t-test, *p<0.1, ***p<0.0001 . . . . . . . . . . . . . . . . . . . 76
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6.4 Representative tracks of SA on the surface of HMEC-1 with biotin tagged MTPs or
SABPs.
a) Five tracks for each glycoprotein type, shifted to a common origin. b) MSD (mean
square displacement) analysis. The trajectories of tetravalent SA cover a much smaller
area (largely overlapping) than those of monovalent SA, thus indicating low spatial mo-
bility as a result of effective crosslinking. Accordingly, the slopes of the MSD curves are
significantly lower for tetravalent SA-mediated crosslinking than for monovalent SA.
Dashed lines indicate the linear fit to the linear part at the beginning of the curves. Er-
ror bars are given as the weighted standard deviation divided by the square root of the
number of degrees of freedom. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 77
6.5 Effects of exogenous galectin-1 and -3 on membrane protein internalization.
Internalization of MTPs, and to a lesser extent SABPs, is slowed by increasing amounts
of galectin-1 and -3. Normalized fluorescence intensity: ratio of membrane fluorescence
of galectin-treated cells to untreated cells after 5 h. Data are mean ±SEM (n=28-30). . . 78
6.6 Effects of di- and tetravalent SA on internalization of biotin-tagged membrane pro-
teins.
For both SABPs and MTPs internalization is strongly slowed by addition of di- or tetrava-
lent SA. The ratio (0.88-0.96) between membrane fluorescence at 5.5 h and 0 h indicates
that little internalization occurred over this time. Untreated cells showed much higher
internalization. Data are mean ±SEM (n=29-30); t-test:**p<0.01, ***p<0.0001. . . . . . 79
6.7 Simulation of cellular compartments and metabolite flow through them.
We assume that a constant flow of metabolites is presented from the extracellular en-
vironment. They are internalized and then either used to generate energy or to build
glycan structures. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 81
6.8 Development of metabolite concentration in the model.
Parameters: a=1, b=0.5, c=0.2, d=1, f=0.1, g=0.05, h=0.1, k=0.01, m=0.1, n=0.1, v(0)=0,
w(0)=0, x(0)=0, y(0)=0, z(0)=0, u(0)=0, q(0)=0, r(0)=0 . . . . . . . . . . . . . . . . . . . 82
6.9 Development of metabolite concentration in the model.
Parameters: a=1, b=0.5, c=0.01, d=0.01, f=0.01, g=0.1, h=0.01, k=0.01, m=1, n=0.01
v(0)=0, w(0)=0, x(0)=0, y(0)=0, z(0)=0, u(0)=0, q(0)=0, r(0)=0 . . . . . . . . . . . . . . . 84
7.1 Schematic representation of the protocol employed for artificial network formation.
Supplementation of the cellular growth medium with azido sugars (Ac4ManNAz or
Ac4GalNAz) leads to metabolic labeling of membrane-bound glycoproteins with azido
groups. This allows tagging with biotin (B) by click chemistry using a cyclooctyne-
biotin conjugate. The resulting biotin-tagged membrane proteins can then be intercon-
nected by tetravalent SA. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89
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7.2 The factors that influence artificial network formation.
(a) Statistical tuning of SA valency by preincubation of SA with biotin; increasing biotin
amounts result in gradually reduced SA mean valency from four to three, two, and
one. (b) Tuning of SA concentration was effected by incubation of the biotin-tagged
cells with different amounts of SA. (c) The concentration of available binding sites for
network-forming SA was tuned by incubation of the azido-tagged cells with different
amounts of DIBO-biotin. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90
7.3 Trajectories of SA on the membrane of HMECs after metabolic labeling with Ac4-
ManNAz and tagging with DIBO-biotin.
Left: All trajectories recorded. Right: Zoom in. (a) Incubation with tetravalent SA
results in trajectories that mostly show a high confinement, visible from the small area
that is covered. (b) In contrast, incubation with SA of a mean valency of one leads
to many trajectories that cover a large area, displaying lower confinement and higher
mobility. n=2300-2600 trajectories. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92
7.4 Effect of mean SA valency on network formation.
Both, for incubation with Ac4ManNAz (a) and Ac4GalNAz (b), the MSD curves (left)
bend stronger with increasing mean valency of interconnecting SA. Correspondingly,
the apparent diffusion constants Dapp and the confinement area C decrease (right). Er-
ror bars are given as the weighted standard deviation divided by the square root of the
number of degrees of freedom. Dashed lines indicate fit curves. 2300-4700 trajecto-
ries/MSD curve. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93
7.5 Effect of SA concentration on network formation
The bending of the MSD curves increases with increasing SA concentration, displaying
decreasing mobility (left) as reflected in the obtained values for the apparent diffusion
constant and the confinement area (right). Error bars are given as the weighted standard
deviation divided by the square root of the number of degrees of freedom. Dashed lines
indicate fit curves. 5100-6100 trajectories/MSD curve. . . . . . . . . . . . . . . . . . . . 95
7.6 Effect of cell surface biotin concentration on network formation.
With increasing DIBO-biotin concentration, the MSD curves increasingly bend, indi-
cating a more and more confined movement. At concentrations ≥ 25 µM DIBO-biotin,
the MSD curves remain constant at a very low level, displaying very high confinement
(left). Consistently, the apparent diffusion constant and the confinement area decrease
with increasing DIBO-biotin concentration (right). Error bars are given as the weighted
standard deviation divided by the square root of the number of degrees of freedom.
Dashed lines indicate fit curves. 800-3400 trajectories/MSD curve. . . . . . . . . . . . . 97
220
List of Figures
7.7 Effect of artificial network formation on endocytosis.
(a) Representative images of HMECs incubated with fluorescent 10 kDa dextran after
artificial network formation with the indicated DIBO-biotin and SA concentrations. It
is clearly visible that for both cases (5 and for 50 µM DIBO-biotin) the endosomal signal
decreases when rising amounts of SA are used for network formation. At 50 µM DIBO-
biotin and 0 µM SA (i.e. no artificial network formation) endocytosis is lower than in
the analogous experiment at 5 µM DIBO-biotin. This observation is presumably due to
the high number of biotin residues present on the cell surface at 50 µM DIBO-biotin
that already hinders endocytosis. Nevertheless, addition of SA further decreases the
endocytosis rate also in this case. (b) Quantification of the endosomal signal reflects the
strong influence of artificial network formation on the endocytosis rate. n=25-94, Scale
bar = 30 µm. Error bars indicate the standard error of the mean and arrows the y-axis
corresponding to 5 and 50 µM biotin, respectively. . . . . . . . . . . . . . . . . . . . . . 99
7.8 Definition of chains as consecutive steps in one direction.
Shown is two times the same part of a trajectory. At the top, it is color-coded for increas-
ing (cyan) and decreasing (magenta) x-values, at the bottom the same way for y-values.
From this, consecutive steps in one direction of "chains" are easily determined. . . . . . 100
7.9 Number of consecutive steps in one direction for different simulated potentials
(a) Normalized histogram for all chains of steps. (b) Detail for longer chains. As it can
be clearly seen, the probability of longer chains decreases the narrower the potential
becomes. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 102
7.10 Comparison of chain lengths between the simulated data and idealized normal dif-
fusion
With decreasing potential size, the ratio deviates towards smaller ratios, indicating that
longer chain lengths become more unlikely. The deviations from the trend at long chain
lengths can be attributed to the low statistical power in this region. . . . . . . . . . . . . 103
7.11 Cumulative weighted chain length
For large confinement sizes, the cumulative weighted chain length is close to 4 which
is the expected value for idealized normal diffusion. For smaller confinements, it de-
creases first slightly, then rapidly. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 104
7.12 Number of consecutive steps in one direction for varying DIBO-biotin concentra-
tions
(a) Normalized histogram for all chains of steps. (b) Detail for longer chains. As it can
be clearly seen, the probability of longer chains decreases for increasing DIBO-biotin
concentrations. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 105
7.13 Comparison of chain lengths between the experimental data and idealized normal
diffusion
For all chain lengths, the ratio is well below 1 (except for very high lengths where the
statistical power is low). This indicates that all diffusion processes are strongly devi-
ating from normal diffusion towards confined diffusion. This tendency increases for
increasing DIBO-biotin concentrations. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 106
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7.14 Cumulative weighted chain length
The value of the cumulative weighted chain length decreases for increasing DIBO-biotin
concentrations, indicating stronger confinement. . . . . . . . . . . . . . . . . . . . . . . 107
8.1 Our approach of switching the adhesivity of cells.
Azido functional groups can be incorporated into cell surface glycoconjugates employ-
ing the synthetic carbohydrates Ac4ManNAz or Ac4GalNAz, respectively, according to
a known methodology called metabolic oligosaccharide engineering (MOE). The per-
acetylated azido sugars are taken up by the cells (HMEC-1) (a), and processed by the
biosynthetic machinery to lead to azido-functionalization of the cell surface (b). Bioorthg-
onal click chemistry then allows conjugation of the cell surface with azobenzene glyco-
sides (such as α-d-mannosides, αMan). Reversible E/Z isomerization of the azobenzene
moiety employing UV or visible light, respectively, allows to change the orientation of
the conjugated sugar. This experimental approach allowed to test if adhesion of E. coli
to live human cells can be photochemically controlled. . . . . . . . . . . . . . . . . . . . 111
8.2 Synthesis of alkyne-functionalised azobenzene glycosides and labelling of engineer-
ed human cells (HMEC-1).
α-d-Mannosides were used as specific ligands for bacterial adhesion, whereas β-d-glu-
cosides and simple propargylated azobenzene (7) are needed as control compounds.
Azido-functionalised HMEC-1 were ligated with azobenzene (AB) derivatives 5-7 in a
Cu(I)-catalyzed click reaction. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 112
8.3 Switching of ManAB configuration allows to control adhesion of E. coli to HMEC-1.
After incubation of two sets of cells bearing azido groups at terminal sialic acids with
5 in Z-configuration, the adhesion of bacteria is similar for both sets. However, pho-
toswitching of ManAB configuration to E increases the adhesion significantly (second
incubation). If ManAB remains in Z-configuration, no increase is observed. Error bars
are given as standard error of the mean (SEM) of experiments with four independent
sets of cells/condition. *** = p < 0.001. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117
8.4 Adhesion of E. coli to switchable cell surfaces under flow.
a) The azobenzene 5 was switched several times between Z and E while flowing a con-
tinuous stream of bacteria solution over the cells. The adhesion of bacteria was lower
if 5 was in Z-configuration. Only after several switching cycles this tendency was no
longer observed, caused by increasing coverage of the cells with bacteria, leading to a
high amount of adhering to other bacteria and not to the cell surface. During irradiation
with 365 nm (light grey bars) or 488 nm (dark grey bars), the flow was not stopped. b)
The slopes of linear curves that were fitted to the data of the middle panel clearly re-
sembles the effect of the reversible switching. Error bars are given as SEM of the fitting.
For easier comparison, the slopes are set to start at a common origin by subtraction of
the fluorescence intensity of the first frame from the subsequent frames. . . . . . . . . . 120
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8.5 Control experiments.
If the azobenzene lacks a mannose group (AB, left) or exhibits a glucose group to which
FimH cannot bind specifically (GlcAB, middle), adhesion is reduced in comparison to
control cells independent of the configuration of the azobenzene, indicating a shielding
effect of AB and GlcAB. If ManAB is attached to mucin-type proteins (right) and hence
not at the terminal position of glycans, the adhesion is increased but not dependent on
the configuration of the azobenzene. Errors are given as SEM. Experiments were carried
out with four independent sets of cells for each condition. * = p < 0.1, ** = p < 0.01, ***
= p < 0.001 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 121
9.1 En route from artificial to natural.
The mannose-specific fimbriae-mediated adhesion of bacterial cells to surfaces depends
on the conditions. (A) Adhesion to artificial surfaces such as mannan-coated microtiter
plates has been regularly used to evaluate the potency of sugar inhibitors under static
conditions. (B) In bacterial adhesion to the glycosylated surface of human cells (HMEC-
1) inhibitors compete with a more complex carbohydrate environment. (C) Under natu-
ral flow conditions, shear forces activate catch bonding of the bacterial lectins and thus,
for inhibitors of bacterial adhesion different potencies might be found than under static
conditions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 125
9.2 Structures of FimH ligands 1-4, employed for inhibition of type 1 fimbriae-mediated
bacterial adhesion. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 126
9.3 Adhesion of E. coli to HMEC-1 under static conditions.
All four inhibitors are able to reduce adhesion of E. coli to HMEC-1, visible from the
lower relative adhesion. However, for none of the inhibitors the relative adhesion reaches
0. It remains constant at a relative adhesion of about 0.2. Errors are given as standard
error of the mean (SEM). Each bar represents the mean of four independent wells. . . . 128
9.4 Adhesion of E. coli to HMEC-1 under flow conditions.
For inhibitor concentrations that could not abolish bacterial adhesion under static con-
ditions, adhesion was under flow close to zero and remained at this level also for the
higher concentrations. It is clearly visible that the relative adhesion is close to zero for
all four inhibitors already at these concentrations. Errors are given as the SEM of the fit. 130
10.1 Development of heparan sulfate expression on HUVECs cultured for the indicated
time.
Clearly, after one day, almost no heparan sulfate signal is detected. However, it increases
gradually and remains approximately constant from five days culture time onwards.
Therefore, the key glycocalyx component heparan sulfate is expressed within several
days in our setting.
Contrast settings equal for all images. Scale bar = 50 µm. . . . . . . . . . . . . . . . . . 134
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10.2 Uptake of amino- and carboxy-nanoparticles into HUVECs in presence and absence
of the glycocalyx.
Both particle types enter HUVECs and sufficiently high concentrations. Amino-particles
show higher internalization rates than carboxy-particles. However, in presence of the
glycocalyx, the uptake is for both particle types lower. Each triplicate is shown sepa-
rately. In each triplicate, four individual wells of a 96-well plate were investigated. . . . 135
10.3 Representative Images of Uptake of amino- and carboxy-nanoparticles into HUVECs
in presence and absence of the glycocalyx.
It can be clearly seen that for both particles the amount of internalized particles is much
higher when the glycocalyx is shedded (bottom tow) in comparison to the intact glyco-
calyx (top row). Also, amino-particles are internalized stronger than carboxy-particles.
Contrast settings are equal for each particle type. Scale bar = 100 µm. . . . . . . . . . . 136
11.1 A dendritic siRNA nanostructure with an anandamide targeting unit.
The siRNA passenger strands are covalently connected to a dendritic framework, while
the siRNA guide strands are hybridized to the nanostructure. . . . . . . . . . . . . . . . 138
11.2 Synthesis of the siRNA dendrimers AEA-[3ORN], AEA- [6ORN], and AEA-[9ORN].a)
NaH, 15-crown-5, DMF, RT, 46%; b) TFA, CHCl3, RT, 94%; c) arachidonic acid, TBTU,
DIPEA, DMF, RT, 95%; d) 4, CuSO4, sodium ascorbate, H2O/THF (1:1), RT, 80%; e)
5, CuSO4, sodium ascorbate, H2O/THF (1:1), RT, 65%; f) NaN3, DMF, 110°C, 85%;
g) NaN3, DMF, 110°C, 97%; h) TFA, CHCl3, RT, 71%; i) arachidonic acid, HATU, DI-
PEA, DMF, RT, 81 ; j) TFA, CHCl3, RT, 76%; k) TBTU, DIPEA, DMF, 40°C, 70%; l)
alkyne-modified oligonucleotide (ORN), CuBr, TBTA, DMSO/H2O, 89%; m) alkyne-
modified oligonucleotide (ORN), CuBr, TBTA, DMSO/H2O, 78%; n) alkynemodified
oligonucleotide (ORN), CuBr, TBTA, DMSO/H2O, 65%. . . . . . . . . . . . . . . . . . . 143
11.3 HPL chromatograms of the purified dendrimers obtained with 10and 12.
The inserts show the MALDI-TOF spectra. MALDI-TOF data: A) calc. (AEA-[3ORN1]):
m/z 20506, found: 20503. B) calc. (AEA- [9ORN2]): m/z 62124, found 61923 (broad
signal). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 144
11.4 Relative silencing of the Renilla luciferase compared to the silencing of Firefly lu-
ciferase mediated by dendritic anandamidesiRNAs in RBL-2H3 cells.
Investigated was: A) the influence of branching (1, 3, 9 siRNA duplexes per ligand) on
silencing efficacy mediated by novel dendritic structures; B) the influence of additional
glucose modifications introduced by modified siRNA guide strand. In all cases the total
amount of siRNA duplexes was normalized to the monomeric structure. Quantification
was achieved by luciferase activity. a: AEA- [1siRNA-Luc], b: AEA-[3siRNA-Luc], c:
AEA-[9siRNA-Luc], d: AEA- [3siRNA-Luc]-glucose. . . . . . . . . . . . . . . . . . . . . . 144
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11.5 Anandamide-mediated delivery of dendritic siRNA nanostructures to neural stem
cells.
A) Left: trimeric siRNA modified with Alexa Fluor647 was incubated with neural stem
cells. Right: As a negative control the stem cells were incubated with siRNA lacking
the ligand modification (red: siRNA, green: cell membranes. The contrast settings for
siRNA signals were equal for both images). B) Successful delivery of nanostructures
to stem cells was additionally demonstrated by regulation of Tet1 monitored by real-
time PCR. a: AEA-[1siRNA-Tet1], b: AEA-[3siRNA-Tet1]-Glc. C) Down-regulation of
RABV titers in E14 cortical neurons by treatment with different AEAmodified siRNA
structures targeting the P protein of rabies virus. c: AEA-[1siRNA-P-protein], d: AEA-
[3siRNA-P-protein]-Glc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 145
11.6 siRNA used in additional experiments
In the top row, the simple, fluorescently labeled siRNA duplex targeted with AEA, a
construct with three siRNA-arms ("tripod"), and the untargeted siRNA used for control
experiments are shown. In the bottom row, a glucose-modified siRNA and an AEA-
targeted, but not fluorescently labeled siRNA are depicted. . . . . . . . . . . . . . . . . 146
11.7 Uptake of AEA-targeted siRNA into RBL2H3 cells.
Whereas untargeted siRNA shows little uptake for all investigated time points, the tar-
geted siRNA is internalized efficiently. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 147
11.8 Quantification of fluorescent AEA-targeted duplex-siRNA in prescence of non-fluo-
rescent, AEA-targeted duplex-siRNA.
Increasing amounts of non-fluorescent AEA-targeted duplex-siRNA decrease the amount
of internalized fluorescent siRNA (left). The decrease corresponds well with the ex-
pected values (right). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 148
11.9 Quantification of duplex, tripod, and untargeted siRNA-constructs into murine neu-
ronal stem cells.
Both for the duplex and tripod siRNA, strong uptake is detected. Doubling the concen-
tration leads to about two to three times more internalized siRNA as expected. Further-
more, unspecific uptake was almost not present. . . . . . . . . . . . . . . . . . . . . . . 149
11.10 Uptake of targeted and untargeted siRNA into mouse brains.
Only when both the siRNA is targeted to the cannabinoid receptors with AEA and the
cannabinoid receptors are present, the siRNA is found in the hippocampus (left). If the
cannabinoid receptors are knocked out (middle) or siRNA lacks targeting (right), no
enrichment of siRNA is found in the hippocampus. Scale bar = 500 µm. . . . . . . . . . 150
11.11 Quantification of AEA-siRNA uptake by the hippocampus
Only when both the siRNA is targeted to the cannabinoid receptors with AEA and the
cannabinoid receptors are present, the ratio of the treated hippocampus to the untreated
hippocampus is below one. The red square indicates the mean value. . . . . . . . . . . . 151
11.12 Quantification of Glc-siRNA uptake by Hela, HMEC, KB, and HUH-7 cells.
In presence of glucose in the medium, glucose-modified siRNA is internalized very ef-
ficient. However, if no glucose is present in the medium or the siRNA is not targeted,
uptake is very low. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 152
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11.13 Colocalization between internalized Glc-siRNA and GLUT1
Internalized Glc-siRNA colocalizes clearly with the glucose transporter GLUT1 which
is visualized using a GFP-tag. Scale bar = 10 µm. . . . . . . . . . . . . . . . . . . . . . . 153
12.1 Key for sugar symbols. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 185
12.2 Specificity of the labeling reaction.
In presence of Ac4ManNAz or Ac4GalNAz, sialic acid-bearing proteins (SABPs, left col-
umn) or mucin-type proteins (MTPs, middle column) on the cell membrane are fluores-
cently labeled by incubation with the AlexaFluor647-cyclooctyne-conjugate (DIBO647).
In contrast, the lack of an azido sugar leads to no labeling (right column). This is nicely
displayed in the fluorescence images (contrast settings are equal for all images). Note
that the fluorescent endosomes inside the cell in the left and middle image are caused
by internalization of already labeled glycans during incubation with the labeling solu-
tion and not by uptake of the DIBO647 itself since the negative control does not exhibit
any significant intracellular fluorescence. Scale bar=10 µm. . . . . . . . . . . . . . . . . 186
12.3 Identity of the labeled species.
To check if the metabolic labeling approach targets predominantly glycoproteins and
not glycolipids, we seeded 1.5 · 106 cells in a six-well plate and cultivated them as de-
scribed in presence of 50 µM of the indicated azido sugar for two days. Then, we labeled
them for 45 minutes with 35 µM DIBO647 and isolated proteins and lipids using the
Mem-PER- and the Lipid Extraction-kit (Thermo Scientific, Waltham, Massachusetts,
USA/Sigma Aldrich, St. Louis, Missouri, USA). The isolated species were solubilized in
equal amounts of solvents. 20 µL were transferred onto a microscope slide and the flu-
oresence was quantified using a Zeiss spinning disk confocal microscope. Clearly, only
glycoproteins (cyan) are labeled whereas no significant labeling of glycolipids (orange)
was detected. The experiments were carried out in triplicate. Errors are given as SEM. . 187
12.4 Minimum labeling duration.
To ensure that all available azide groups on the cell membrane after incubation with
the respective azido sugar are addressed by the labeling reagent DIBO647, we varied
the incubation time as indicated. It is clearly visible that after 30 minutes no further
increase in membrane fluorescence intensity occurs. n=30, errors are given as SEM. . . 188
12.5 Glycans are localized in endosomes after internalization.
The depicted cells were incubated with Ac4ManNAz to incorporate an azide group
into SABPs and incubated for the indicated time periods (hours) after labeling with
DIBO647. During this time, fluorescent SABPs are internalized into the cell. The de-
crease in membrane fluorescence and the increasingly bright, perinuclear fluorescence
of endosomes is obvious. Scale bar=10 µm. . . . . . . . . . . . . . . . . . . . . . . . . . . 189
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12.6 Classes of labeled glycans.
Four principle types of proteins are depicted as relevant for our study: SABPs, MTPs
(carrying sialic acids or LacNAc, respectively), SABPs and MTPs (carrying both sialic
acid and LacNAc), or none of the two classes (carrying no or different glycosylation).
Metabolic labeling with Ac4ManNAz targets SABPs whereas metabolic labeling with
Ac4GalNAz targets MTPs. The possible overlap between SABPs and MTPs has an im-
portant consequence: One may detect and MTP-specific effect while visualizing SABPs
and vice versa. However, we were able to show that the two classes can be very well
separated using metabolic labeling and fluorescence visualization, indicating that the
overlap is not dominant.
Glycosylation pattern simplified, other sugars are omitted for clarity. . . . . . . . . . . 190
12.7 Galectin-1 and -3 are present on the membrane of HMEC-1.
(a) Fluorescence images of immunostaining against galectin-1 (top), galectin-3 (middle),
and isocontrol (bottom). (b) Differential interference contrast images corresponding to
a). (c) Merge of a) and b) Scale bar = 25 µm, contrast settings identical for all fluores-
cence images. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 191
12.8 Internalization of MTPs and SABPs into untreated HMEC-1.
Decrease in membrane fluorescence of HMEC-1 through internalization of fluorescently
labeled sialic acid-bearing and mucin-type proteins. Note that within 5.5 h the mem-
brane fluorescence decreases strongly in both cases. However, SABPs show faster de-
crease owing to less involvement in galectin-lattice formation, thus corroborating the
data on spatial mobility. Errors=SEM, n=26-30, black=SABPs, red=MTPs. . . . . . . . 192
12.9 Experimental design to investigate temporal dynamics of membrane proteins.
(a) To measure the incorporation of glycans into the cell membrane, HMEC-1 were in-
cubated with Ac4ManNAz or Ac4GalNAz, respectively, which are internalized and me-
tabolized in glycan biosynthesis. After an incubation time, the azido group appears
in cell surface glycoproteins. There, it can be bioorthogonally reacted with DIBO647,
covalently linking a fluorescent dye to membrane glycoproteins. As with increasing in-
cubation time (Time B) the number of azido groups on the cell surface increases, mem-
brane fluorescence is enhanced accordingly. (b) Correspondingly, after incubation with
Ac4ManNAz or Ac4GalNAz and subsequent fluorescent labeling, the decrease in mem-
brane fluorescence is a measure for the internalization of membrane glycoproteins into
the cell. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 193
12.10 Final metabolite concentration on the cell membrane in dependence of rates from
cytosol to Golgi apparatus and Golgi apparatus to membrane.
All rates occurring inFigure 6.7 are set to 1 except for the two rates that transport
metabolites from the cytosol via the Golgi apparatus to the membrane. If these rates
increase, the final metabolite concentration on the membrane rises, too. However, this
is not physiological since the membrane cannot arbitrarily increase its capacity (cf. Fig-
ure 12.11). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 194
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12.11 Mutual dependence of kGolgi-Membrane and kMembrane-Endosome.
If the rate Golgi apparatus-membrane increases and the final membrane metabolite
concentration should stay constant, the rate membrane-endosome must increase ac-
cordingly (all other rates are kept constant). For very high values of kGolgi-Membrane, the
rate kMembrane-Endosome does not change much because in this region an increase in the
rate kGolgi-Membrane no longer increases the final membrane metabolite concentration:
In this case, every metabolite that arrives at the Golgi apparatus is almost immediately
transferred to the membrane. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 195
12.12 Incorporation of MTPs and SABPs into the membrane of untreated HMEC-1.
Cells were treated for the indicated incubation time with Ac4ManNAz or Ac4GalNAz,
addressed by DIBO647, and fixed. Membrane fluorescence was quantified. It is clearly
visible that the steady state (every azide-bearing membrane protein is replaced by an-
other azide-bearing membrane protein, net change zero) is earlier reached for SABPs
than for MTPs. This development was also obtained using the above described model
(cf. Figure 6.7 and Figure 12.13). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 196
12.13 Development of membrane metabolite concentration.
Note the sigmoidal development and the steady state reached. Rates: All rates are set
to 0.1 with the exception of kExtracellular Space-Cytosol=1 and kCytosol-Golgi apparatus=0.5 . . . 197
12.14 Representative images of single SA molecules (left) or SA-coated quantum dots (QDs,
right) on the membrane of HMEC-1.
Shown are three representative frames obtained in our measurements with clearly visi-
ble signals of single SA molecules and single QDs, respectively. Scale bar = 10 µm . . . 198
12.15 Simulation of confined diffusion.
For the simulation of confined diffusion, we slightly modified the approach described
in the online documentation of the Matlab class @msdanalyzer that we also used for the
MSD analysis of the obtained trajectories.252 . . . . . . . . . . . . . . . . . . . . . . . . . 199
12.16 Immunostaining confirms the expression of galectin-1 and -3 on cultured HMEC-1
As it can be clearly seen from the fluorescent images, a strong signal for galectin-1 and
-3 is obtained whereas the isocontrol does not show any fluorescence. Contrast settings
are equal for all three fluorescent images, scale bar = 20 µm . . . . . . . . . . . . . . . . 201
12.17 Required alkyne concentration for saturation.
HMEC-1 were cultivated in presence of 50 µM Ac4ManNAz for two days as described.
Instead of an azobenzene derivate, a fluorescent alkyne was coupled at various concen-
trations to the incorporated azido groups under identical conditions. The membrane
fluorescence was determined. It can be clearly seen that at 35 µM a plateau is reached.
Hence, the concentration of 200 µM azobenzene derivate that we used in our experi-
ment ensures that all available azido groups are tagged. . . . . . . . . . . . . . . . . . . 202
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12.18 Adhesion of E. coli to Z and E-configured 5
Two sets of HMEC-1 with sialic acids modified with Z-azobenzene mannoside were
incubated with bacteria (after irradiation with light of 365) (left column). Next, only one
set of HMEC-1 was irradiated with light of 405 nm to effect Z→E isomerisation. Then,
both sets of HMEC were incubated again with bacteria. By high-resolution fluorescence
microscopy it can be seen that the number of adhered bacteria increases strongly for
HMEC-1 in the E-state (bottom right), whereas it does not change significantly when
HMEC-1 were not irradiated with 405 nm light (leaving 5 in the Z-state) (top right).
Scale bar = 250 µm. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 203
12.19 Adhesion of E. coli to Z and E-configured AB
HMEC-1 were modified at sialic acids with AB or remained untreated as control. Next,
one set of cells was irradiated with 365 nm light in order to switch the azobenzenes to
the Z-state. The other set was not irradiated. After incubation with bacteria, fluores-
cence images were obtained. It can be clearly seen that the presence of 7 in both Z- and
E-configuration reduced adhesion of bacteria. Scale bar = 250 µm. . . . . . . . . . . . . 204
12.20 Adhesion of E. coli to Z and E-configured 6
HMEC-1 were modified at sialic acids with 6 or remained untreated as control. Next,
one set of cells was irradiated with 365 nm light in order to switch the azobenzenes to
the Z-state. The other set was not irradiated. After incubation with bacteria, fluores-
cence images were obtained. As for 7, adhesion of bacteria was decreased. Therefore,
the glucose modification of 6 cannot serve as ligand. Also, unspecific interactions are
not increased. Scale bar = 250 µm. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 205
12.21 Adhesion of E. coli to Z and E-configured 5 linked to mucin-type proteins.
HMEC were modified with 5 at mucin-type proteins or remained untreated as control.
In comparison to labelling of sialic acids, this leads to attachment of 5 deeper within the
glycan tree. Next, one set of cells was irradiated with 365 nm light in order to switch
the azobenzenes to the Z-state. The other set was not irradiated. After incubation with
bacteria, fluorescence images were obtained. It can be seen that the additional mannose
groups increased adhesion in comparison to cells not treated with 5, however, switch-
ing had no effect. This is reasonable since the change in orientation upon switching is
small compared to the distance the azobenzene-mannoside is away from the incoming
bacteria in this case. Scale bar = 250 µm. . . . . . . . . . . . . . . . . . . . . . . . . . . . 206
12.22 Clumps of E. coli under flow conditions.
With increasing time of flow, bacteria more and more adhere to already adhered bacteria
and not to HMEC-1, forming clumps (some of them indicated by red arrow heads). Scale
bar = 250 µm. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 207
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12.23 Inhibition of bacterial adhesion to mannan surfaces under static conditions.
Solutions of the respective glycosides were prepared and serial dilutions were added to
mannan-coated microtiter plate wells. The prepared bacterial solution (OD600 0.4) was
added and the plate incubated for 1 h at 37◦C and 100 rpm. The plates were washed
with PBS buffer and then the wells were filled with PBS for the fluorescence read out
(485 nm/535 nm). (A) Inhibition tested with mannoside 2 and 4. (B) Inhibition tested
with mannoside 1 and 3. The depicted binding curves are representative examples from
several (>3x) independent experiments. Error bars result from duplicate values on one
plate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 208
12.24 Bacterial adhesion to HMEC-1 under static conditions using SAMan as inhibitor.
WThe images clearly show that under static conditions, bacteria can adhere up to high
inhibitor concentrations (0 / 0.001 / 0.01 / 0.1 / 1 mM). Contrast is inverted for clarity.
Contrast settings are equal for all images. Scale bar = 200 µm. . . . . . . . . . . . . . . 209
12.25 Bacterial adhesion to HMEC-1 under flow conditions using SAMan as inhibitor.
Under flow conditions, no adhesion was detected already at low inhibitor concentra-
tions (0 / 0.1 / 1 / 2 mM). Contrast is inverted for clarity. Contrast settings are equal
for all of images. Depicted adhesion is after five minutes of bacterial flow. Scale bar =
100 µm. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 209
12.26 Representative fluorescence images showing the uptake of AEA-siRNA duplex, AEA-
siRNA tripod, and untargeted siRNA duplex into RBL2H3 cells. newline Scale bar
10 µm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 210
12.27 Representative fluorescence images showing the uptake of AEA-siRNA duplex, AEA-
siRNA tripod, and untargeted siRNA duplex into murine neuroanl stem cells. new-
line Scale bar 10 µm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 210
12.28 Representative fluorescence images showing the uptake of Glc-siRNA into Hela,
HMEC, KB, and HUH-7 cells. newline Scale bar 10 µm . . . . . . . . . . . . . . . . . . 211
12.29 Representative fluorescence images showing GLUT1 expression in presence (top) or
absence (bottom) of glucose in the medium
Contrast settings are equal for all images.
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